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ABSTRACT. 
The seven canonical Sm proteins of Saccharomyces cerevisiae associate with the 
Ui, U2, U4 and U5 spliceosomal snRNAs, and have roles in the biogenesis and 
localisation of these snRNP particles. The proteins interact extensively with one 
another in an ordered pathway. In contrast, the Ussi protein is a non-canonical 
member of the Sm-like protein family in that it associates with the U6 snRNA. A 
combination of molecular genetic and biochemical analyses has been used to 
investigate the molecular associations of the Uss 1 protein. 
Exhaustive two-hybrid screens revealed interactions with other Sm-like proteins, 
with proteins of the U2 snRNP (and proteins interacting with U2 snRNP proteins) 
and with proteins not previously reported to be involved in pre-mRNA splicing. A 
network of potential interactions was produced from these data. 
Deletion of six open reading frames (ORFs) encoding Sm-like proteins revealed 
three as essential for cell viability (YBL026w, YER146w and USS2) and three as 
non-essential (SPB8, YDR378c and YNL147w) suggesting functional redundancies 
within these non-canonical Sm-like proteins. Conditional alleles of each of the Sm-
like protein-encoding ORFs were produced. Each of the Sm-like proteins were 
tagged with the HA-peptide epitope and used to study the molecular associations of 
the proteins. Significant levels of U6 snRNA were precipitated with all six proteins, 
and with Yjr022p, another Sm-like protein identified in the two-hybrid screens. A 
subset of these proteins is essential for the stability of U6 snRNA in vivo, with over-
production of U6 capable of (partially) rescuing the growth of the conditional 
strains. All seven Sm-like proteins which associate with U6 snRNA also co-
immunoprecipitate with Usslp. This combined with the range of interactions 
revealed by two-hybrid analyses suggests the existence of an Sm-like protein 
complex (or complexes). Since eight Sm-like proteins can associate with U6, 
compared to seven in the canonical snRNPs, alternative complexes, comprising 
different subsets of the Sm-like proteins may exist. 
Other proteins identified in two-hybrid screens suggest alternative functions for 
such complexes. Patip, the product of the YCR077c ORF, interacts in a two-hybrid 
assay with each of the U6 snRNA-associated Sm-like proteins, however inactivation 
of this protein has no effect on the levels of the spliceosomal snRNAs, or on the 
efficiency of pre-mRNA splicing in vivo. The molecular associations of Patip with 
the Sm-like proteins were confirmed by co-immunoprecipitation experiments and 
whilst the cellular function of the Pati protein remains to be determined, its 
apparent association with the Sm-like protein complex also implicates these proteins 
in that function. The reported role of Spb8p (one of the Sm-like proteins) in mRNA 
decapping, and the identification of Dcplp and Xrnlp in two-hybrid screens with 
Sm-like proteins suggests a more general role for these Sm-like proteins (and 
possibly U6 snRNA) in mRNA metabolism. 
Based on the characterisation of the Sm-like proteins, a model is proposed in 
which a subset(s) of Sm-like proteins forms a novel complex(es), analogous to the 
canonical Sm complex, which can associate with U6 snIRNA. As suggested by the 
two-hybrid data, this proposed complex may be involved in cellular processes other 
than pre-mRNA splicing. 
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1.1. Pre-mRNA Splicing. 
Nuclear pre-mRNA splicing was discovered in the late 1970's when it was 
noticed that genomic DNA and pre-mRNA contained stretches of sequence not 
found in the corresponding messenger RNA (Figure 1.1.); (Berget et al., 1977; 
Chowetal., 1977). 




I:! F\dii2l' - 	 pre-rnRNA 
I Pre-mRNA Splicing 
Translation 
Protein 
Figure 1.1. General scheme for pre-mRNA splicing. 
Since their discovery, a great deal of work has gone into the study of these 
intervening sequences (or introns), the mechanisms and machinery which brings 
about their removal and the rejoining, or splicing, of the (required) exon sequences 
(reviewed in Guthrie, 1991; Moore et al., 1993; Reed and Palandjian, 1997; Will 
and Ltihrmann, 1997; Nilsen, 1998). This research has been performed in a number 
of model systems e.g. human HeLa cells, Xenopus oocytes, Saccharomyces 
cerevisiae etc., with each system having advantages and limitations. 
In higher eukaryotes, many protein-encoding genes are interrupted by at least one 
or more introns. The presence of multiple introns can allow the choice of several 
combinations of exons by alternative splicing, to produce different mRNAs from 
identical pre-mRNAs and thereby increases the informational capacity of the 
2 
genome. In contrast, introns are found in only approximately 3% of the 6,000 or so 
genes comprising the genome of S. cerevisiae (referred to as yeast in this work), and 
in all but a few cases only one intron is present. 
Through the parallel investigations performed in the different model systems, an 
incredible complexity in the factors involved in the splicing reaction has been 
revealed, however, extensive similarities between many of these factors and the 
reactions they mediate have also been demonstrated. Conservations are such that in 
all eukaryotes studied to date, the splicing reaction occurs via an ordered pathway 
involving two sequential trans-esterification reactions (Figure 1.2.); (Ruby and 
Ableson, 1991; Moore et al., 1993). 
Intron 
Ixoii 1 	 Lxon 2 	 pre-mRNA 
lS Trans-esterification 
1XU1) 1 	 Intermediates Lariat 
2nd Trans-esterification 
I) 2 	I 	Intron Lariat 	Products 
Figure 1.2. Schematic representation showing pre-mRNA splicing occurs via two 
trans-esterification reactions. Exon sequences are represented by boxes. Intron 
sequences are represented by lines. 
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Although ATP hydrolysis is required for pre-mRNA splicing, the trans-
esterification reactions are believed to be energy-independent. Splicing is dependent 
upon the formation of a large, dynamic ribonucleoprotein complex, the spliceo some, 
formed by the assembly of multiple RNA and protein factors onto the pre-mRNA 
transcript. Assembly of the spliceosome occurs in an ordered stepwise manner (see 
below) with a number of distinct intermediate complexes formed (reviewed in Reed 
and Palandjian, 1997). The energy derived from ATP hydrolysis during the splicing 
reaction may be used to drive spliceosome assembly and/or the spliceosomal 
rearrangements that occur as the reaction proceeds. In addition, ATP hydrolysis may 
have a proof-reading function, influencing the accuracy of splice site selection in a 
model analogous to the ribosomal proof-reading mechanism (Burgess and Guthrie, 
1993; Staley and Guthrie, 1998). 
There is little in the way of conserved information within the intron sequence, 
however three short regions of consensus sequence that define the intron and which 
contribute chemically reactive nucleotides to the splicing reaction have been 
identified (Figure 1.3.). The importance of these sequences has been demonstrated 
through site-directed mutagenesis and analyses of naturally occurring mutations 
both in vivo and in vitro (reviewed in Nilsen, 1998 and references therein). 
The lack of informational content in the intron sequence is probably compensated 
for by the trans-acting components (both RNA and protein) of the spliceosome. 
Extensive RNA-RNA and RNA-protein interactions are involved in splice site 
recognition, and the alignment of the splice sites into a conformation suitable for the 
catalysis of intron removal (reviewed in LUhrmann et al., 1990; Chiara et al., 1996; 
Will and LUhrmann, 1997; Nilsen, 1998). 
.19 
S. cerevisiae 




5' Splice site 
1 







3' Splice site 
YAGI_______ 
Exon 2 
3' Splice site 
YAG I G 
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Figure 1.3. Schematic representation of a yeast and a mammalian intron, indicating 
the sequences of the three conserved elements: the 5' splice site; the branch point 
and the 3' splice site. Exon sequences (boxes) and intron sequences (lines) are 
indicated. The distances between the branch point and the splice sites is intron 
specific. The branch-point adenosine is underlined. R represents purine bases. Y 
represents pyrimidine bases. (Y), represents the poly-pyrimidine tract present in 
mammalian introns. 
The composition of the spliceosome reflects the complexity of the splicing 
reaction. The spliceosome is composed of five small nuclear ribonucleoproteins, or 
snRNPs, and a number of non-snRNP factors (reviewed in Moore et al., 1993; 
Hodges et al, 1997; Will and LUhrmann, 1997; Beggs, 1998). The snRNPs are trans-
acting factors with both RNA and protein components, and are named according to 
the small nuclear RNA (snRNA) each contains (Ui, U2, U4, US and U6). 
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1.2. Spliceosome Assembly Pathway. 
The first step in spliceosome assembly involves the ATP-independent formation 
of the "commitment complex" which contains Ui snRNP and a number of non-
snRNP proteins (Figure 1.4.); (Séraphin and Rosbash, 1989; Rosbash and Séraphin, 
1991). The Ui snRNP binds to the 5' splice site through base pairing between a 
conserved sequence of Ui snRNA and a complementary sequence at the 5' splice 
site. Next, U2 snRNP stably binds to the branch point of the substrate RNA through 
Watson-Crick base pairing, which leaves the branch-point adenosine unpaired and 
therefore free to initiate the first step of splicing (Parker et al., 1987; Query et al., 
1994). U2 snRNP addition is ATP-dependent and is promoted by Ui snRNP and 
other protein factors. Subsequently, the U41U6.U5 tri-snRNP complex and 
numerous non-snRNP factors associate with the pre-spliceosome, to produce the 
active spliceosome. 
During the course of the splicing reaction, many energy-dependent 
rearrangements of both RNA and protein components takes place, in order to 
catalyse the two trans-esterifications (reviewed in Kramer, 1995; Nilsen, 1998; and 
references therein). 
Upon completion of the reaction the spliced mRNA is released and the 
spliceosome is disassembled. The snRNPs, and the non-snRINP proteins are 
recycled for further rounds of splicing, while the intron-lariat is debranched and 
degraded (Figure 1.4.). 
Figure 1.4. Schematic representation of the spliceosome assembly pathway. Ui 
snRNP interacts with the 5' splice site (5'ss) to form a commitment complex (CC). 
U2 snRNP then binds to the branch-point sequence (BP) to form a pre-spliceosome 
complex (PS). U4 and U6 snRNA are found extensively base paired, and associate 
with U5 snRNP prior to addition to the pre-spliceosome as a U4/U6.U5 tri-snRNP. 
Numerous non-snRNP factors also associate to form the active spliceosome. After 
completion of the splicing reaction, the products (mRNA and intron lariat) are 
released, and the spliceosome disassembled. The mRNA is translated into protein; 
the intron lariat is debranched and the RNA degraded; and the snRNPs and non-
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1.3. Composition of the Spliceosome. 
1.3.1. U snRNAs 
Although the length and primary sequence of the snRNAs varies greatly from 
species to species, the secondary structures are highly conserved (Guthrie and 
Patterson, 1988). U6 snRNA, however is highly conserved with respect to both size 
and sequence which may reflect its central position in the spliceosome and its 
potentially catalytic role in the splicing reaction (Brow and Guthrie, 1988; Nilsen, 
1998; and references therein). 
The Ui, U2, U4 and U5 snRNAs are transcribed by RNA polymerase II in the 
nucleus (Dahlberg and Lund, 1988) and acquire a 7-methyl guanosine cap structure, 
co-transcriptionally (Reddy and Busch, 1988). The U snRNAs are then actively 
exported to the cytosol (Figure 1.5.); (Terns et al., 1993) where they are chemically 
modified (primarily by methylation); (Mattaj, 1986). The RNA associates with the 
canonical Sm proteins (see Section 1.3.5.) and the cap is hypennethylated (to tn-
methyl guanosine (TMG)) and the 3' end is shortened. These core snRNPs are then 
imported back into the nucleus in a process which requires both the TMG cap and 
the Sm proteins. The snRNP specific proteins then associate with the core particles 
(snRNPs) and the mature snRNP proceeds into the spliceosome. 
RNA 
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Figure 1.5. Schematic representation of snRNP particle biogenesis. Nascent U 
snRNAs are transported via a receptor-mediated pathway to the cytosol, where they 
associate with the Sm protein complex (see Section 1.3.5. and Figure 1.6.). Binding 
of these proteins triggers hypermethylation of the cap structure and the snRNP is 
then imported back into the nucleus, again in a receptor mediated process. 
The U6 snRNA is transcribed by RNA polymerase III and is processed without 
entering the cytoplasm. The 5' cap structure is modified to a y-methyl phosphate 
(Singh et al., 1990), and the 3' end is elongated by the addition of non-templated 
nucleotides and converted to a 2',3' cyclic phosphate (Lund and Dahlberg, 1992; 
Terns et al., 1992). The U6 snRNA is not thought to leave the nucleus (Vankan et 
al., 1990; Boelens etal., 1995; Pante etal., 1997), although U6 has been detected in 
the cytosol of mouse fibroblasts (Fury and Zieve, 1996). 
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The U6 snRNA does not associate directly with the canonical Sm proteins, 
although Sm-like proteins have been demonstrated to associate with the U6 snRNA 
(see Section 1.3.8.). The U6 snIRNA is present in the cell in several-fold excess over 
the other spliceosomal snRNAs and is found with the U4 snRNA as a U4/U6 di-
snIRNP. Extensive Watson-Crick base-pairing exists between these two molecules 
(Fortner et al., 1994) such that all U4 snRNA is believed to be complexed to U6 
snRNA in vivo. 
1.3.2. SnRNP Particle-Specific Proteins. 
Tables 1.1. and 1.2. summarise the particle specific proteins from mammalian 
cells and from yeast, respectively. Table 1.1. is adapted from Will and LUhrmann 
(1997) with Table 1.2. adapted from Beggs (1998). References for the yeast proteins 
can be found via the SGD database (see Section 2.4. for web address). Further 
putative splicing factors of undetermined snRNA-association have also been 
identified (Fromont-Racine et al., 1997; Neubauer et al., 1998). 
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Table I.I. Mammalian particle-specific snRNP proteins (modified from Will and 
Ltihrmann, 1997; Beggs, 1998). allomenclature  of Kramer (1996) and Reed and 
Palandjian (1997). bSizes  and particle specificity from Will and LUhrmann (1997). 
CStrucmral features: RRM = RNA Recognition Motif; RS = arginine, serine 
dipeptide repeats; surp = potential RNA binding motif; DEAD or DExH = members 
of superfamily of ATP-dependent RNA helicases; WD = protein interaction motif 
characteristic of beta subunit of G proteins. 
Table 1.1. 
Mammalian Particle-Specific snRNP Proteins. 
Prote ina 	Sizeb 	Ui 	U2 	U5 	U4/U6.U5 U4/U6 	Structural Featuresc 
(kDa) 12S 17S 20S 25S 	12S 
C 22 	• Zn fmger, proline-rich 
A 34 	• 2 RRMs, proline-rich 
70K 70 1 RRM, RS domain 
B' 28.5 	 • 2 RRMs 
A' 31 	 • leucine-rich 
33 
35 
SAP49/SF3b50 53 	 • 2 RRMs, pro/gly-rich 
SAP61/SF3a6° 60 Zn finger 
SAP62/SF3 a66 66 	 • Zn finger, proline rich 
92 
SAP! 14/SF3a' 2° 110 	 • 2 surp, proline-rich 
SAP130/SF3b 130  120 
SAP145/SF3b 145 150 pro/gly-rich 
SAP155/SF3b 155 160 
15 
40 
52 	 • 
PSF 100 2 RRMs, pro/gly-rich 
100 	 • 	 • RS, DEAD 
102 
110 
116 	 • acidic N-term, EF2-like 
200 	 • 	 • DEIH, DEVH 
220 
SAP60 60 • 	 WD repeats 
SAP90 90 • 	 basic 
15.5 
20 	 • cyclophilin-like 




Table 1.2. Yeast particle=specific snRNP proteins (modified from Hodges et al., 
1997; Beggs, 1998). aRequired  for the addition of the U2 snRNP to the commitment 
complex. bStrucmral  features: RRM = RNA Recognition Motif; TPR = 
tetratricopeptide repeats; WW = protein motif believed to interact with proline rich 
regions; SR = serine, arginine, dipeptide repeats; RD, arginine, aspartate dipeptide 
repeats; RE, arginine, glutamate dipeptide repeats; DEAD or DExH = members of 
superfamily of ATP-dependent RNA helicases; surp = potential RNA binding motif; 
WD = protein interaction motif characteristic of beta subunit of G proteins. 
Table 1.2. 
Yeast Particle-Specific snRNP Proteins. 
snRNP Protein Size 
(kDa) 
Structural Features" 
Ui Mudi 33 
Ui Nam8 57 3 RRMs 
Ui Prp39 75 TPR repeats 
Ui Prp40 69 2 WW repeats 
Ui Prp42 65 TPR repeats 
Ui Snpl 34 RRM 
Ui Snu56 57 basic, serine-rich 
Ui Snu71 71 acidic, SRIRD/RE 
Ui Yhcl 27 Zn finger 
U2 Cusi 50 
U2 Cus2 32 2 RRMs 
U2 Hsh49 25 2 RRMs 
U2 Msll 13 
U2a Mud2 58 
U2a Prp5 96 DEAD 
U2a Prp9 63 Zn finger 
U2a Prpl 1 30 Zn finger 
U2a Prp21 33 surp 
U41U6 Prp3 56 
U41U6 Prp4 52 WD repeats 
U4/U6 Prp24 51 3 RRMs 
U4/U6 Prp38 28 ser-rich, acidic C-tenn 
U4/U6.U5 Prp6 104 TPR repeats 
U4/U6.U5 Prp3 1 56 
U5 Prp8 280 proline-rich, acidic N-term 
US Prpl8 28 
U5 Snuil4 114 EF2-like 
U5 Snu246 246 DExH 
U6 Uss 1 21 Sm motifs, Asp-rich C-term 
U6 Smx4 10 Sm motifs 
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1.3.3. Non snRNP Proteins. 
In addition to those factors tightly associated with snRNP particles, other trans-
acting, non-snRNP proteins are required for splicing. 
In mammalian cells, several classes of non-snRNP proteins have been identified 
(reviewed in Cáceres and Kramer (1997) and references therein). These included 
proteins important for the addition of the U2 snRNP (U2AF proteins), for the 
rearrangement of the spliceosomal components (DExH-box proteins) and for the 
selection of alternative splice sites (SR/RS proteins). 
Similarly in 'east a number of non-snRNP proteins exist and these are 
summarised in Table 1.3. This Table was adapted from Beggs (1998) and references 
for each of the proteins is available via the SGD database (see Section 2.4.). 
Table 1.3. Yeast Non-snRNP Proteins 
Protein 	Size 	Activity 	 Structural Features" 
(kDa) 
Bbp 53 aBfldS BPS in CC 2 Zn knuckles, proline-rich C-term 
Isyl 28 
Prp2 100 ATPase DEAH 
Prpl6 120 RNA unwinding DEAH 
Prpl7 52 WDrepeats 
Prpl9 57 Recombination Myb-like DNA binding 
Prp22 130 RNA unwinding DEAH 
Prp26 48 Debranchase 
Prp28 67 ATPase DEAD 
Prp43 88 Intron release DEAH 
Siti 1 41 2 Zn fingers, lysine-rich 
S1u7 45 long BP-3' ss recogn'n Zn knuckle 
Snt309 21 Prpl9p-associated 
Spp2 21 lysine-rich 
aBfldS branch-point sequence (BPS) in commitment complex (CC). °Structural 
features as for Table 1.2. 
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1.3.4. Proteins with Sm Motifs. 
In mammalian cells, the canonical Sm proteins associate with the Ui, U2, U4 
and U5 snRNAs and play important roles in the biogenesis of these snRNP 
particles. The eight Sm proteins (B/B', Dl, D2, D3, E, F and G) have been identified 
and their genes cloned (Hermann et al., 1995; and references therein) and with the 
exception of the F protein (p1 4.6), all are basic in nature with p1 values between 8 
and 10 (Woppmann et al., 1990). 
The B and B' proteins are encoded by the same gene, and are produced by 
alternative splicing of the primary transcript (van Dam et al., 1989; Chu and Elkon, 
1991). In high TEMED, SDS polyacrylamide gels, the G protein migrates as a 
doublet (referred to as G and G') with both bands detectable with anti-G antibodies 
(Lehmeier et al., 1990; Heinrichs et al., 1992). The precise relationship between 
these bands is not known as the same pattern is produced by samples expressed 
from the G protein-encoding cDNA (Hermann etal., 1995). 
A further protein, N, structurally similar to the B proteins has been identified in 
snRNPs, but would appear to be expressed only in neural tissue (McAllister et al., 
1989). Recently, the CaSm protein which has 60% similarity to the human Sm G 
protein was described, and although over-expressed in cancerous cells, it is also 
found in normal tissue (Schweinfest et al., 1997). This protein will be discussed in 
Section 1.4. 
The Sm proteins associate tightly with a conserved structural motif of the U 1, 
U2, U4 and US snRNAs i.e. the Sm-site (Branlant et al., 1982; Mattaj and 
DeRobertis, 1985; Mattaj, 1988; Hamm et al., 1990). Nuclease digestion 
experiments in isolated snRNPs revealed the identity of the Sm-site as a 15-20 
nucleotide sequence protected by Sm protein association (Liautard et al., 1982). 
This is a single-stranded region with consensus sequence RAU 36GR (where R is a 
purine base), and is normally found between double hairpin loops (Branlant et al., 
1982). 
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Point mutations and deletions of the Sm site in yeast snRNAs can have a marked 
effect on snRNP assembly and on snRNA stability, and may block splicing in vivo 
and in vitro (McPheeters et al., 1989; Jones and Guthrie, 1990; Siliciano et al., 
1991). However, despite being highly conserved, the Sm-site is tolerant to changes 
with only three positions being sensitive to mutation (Jones and Guthrie, 1990). In 
contrast, deletion or substitution of the Sm-site is lethal in yeast cells, demonstrating 
the functional significance of this site. However, deletion of the Sm-site of the HeLa 
U4 snRNA did not significantly affect in vitro splicing or spliceosome assembly, 
but did abolish Sm protein binding (Wersig and Bindereif, 1992). 
Micro-injection of a synthetic RNA containing the Sm-site sequence into 
Xenopus oocytes suggested that this motif was sufficient for Sm protein binding 
(Mattaj, 1986), however, it has since been shown that Sm-sites from different 
snRNAs are not equivalent as flanking sequences contribute to the efficiency of Sm 
protein assembly (Jarmolowski and Mattaj, 1993). 
1.3.5. Assembly and Binding of the Sm Proteins 
The binding of the Sm proteins to the Sm-site of newly transcribed snRNAs has 
been demonstrated to occur in a well-ordered manner, in the cytoplasm of the cell 
(Feeney et al., 1989). Pulse-chase experiments revealed that a 6S RNA-free protein 
hetero-oligomer forms prior to association with the snRNA (Fisher et al., 1985; 
Sauterer et al., 1990). This complex contains the Dl, D2, E, F and G proteins and is 
capable of binding to the Sm-site. 
Further studies of the assembly of the mammalian Sm protein complex in vitro 
have delineated the pathway further (Figure 1.6.); (Fisher et al., 1985; Sauterer et 
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Figure 1.6. Schematic representation of the assembly of the Sm proteins to form the 
snRNP core. In mammalian cells, the E, F and G proteins associate to form a 3.7S 
particle which then interacts with the pre-formed Dl .D2 dimer to form a 6S RNA-
free complex. This in turn associates with the Sm-site of the nascent snIRNA to form 
the snRNP subcore. Formation of the core is completed by the addition of the pre-
formed B/B'.D3 particle. At present the stoichiometry of all the Sm proteins in the 
complex is unclear, indeed it is not known if both B and B' are found is the same 
snRNP core, or whether they are mutually exclusive. 
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In the absence of the snRNA, a 3.7S complex forms between the E, F and G 
protein, with which a pre-formed Dl .D2 heterodimer can then associate. It has been 
proposed, from the sedimentation co-efficient and from ultra-structural data, that 
two E.F.G. complexes may be present in each snRNP particle (Raker et al., 1996; 
Plessel et al., 1997). However, since both these studies relied upon the in vitro 
reconstitution of snRNPs with only subsets of Sm proteins, the existence of 
artifactual complexes cannot be excluded. The 6S RNA-free particle (containing 
Dl, D2, E, F and G) associates with the snRNA and forms a "subcore snRNP" 
(Raker et al., 1996; Plessel et al., 1997). Although the Ui snRNA has been used as 
a model in these experiments, subcore formation and structure have also been 
confirmed for the other canonical snRNAs. 
The snRNP core assembly pathway is completed by the addition of the BIB'.D3 
heterodimer (Raker et al., 1996) to the subcore particle. Again the B/B'.D3 dimer 
can form in the absence of an snRNA molecule (Hermann et al., 1995). 
The interactions proposed between the Sm proteins by the in vitro analyses 
described above have been confirmed in vivo, using directed two-hybrid assays 
(Fury et al., 1997). For this study the cDNAs encoding each of the Sm proteins were 
cloned as bait and prey and all pairwise combinations tested for interaction. 
No information is available on the stoichiometry of the B/B', Dl, D2 or D3 
proteins in the snRNP core particle, indeed it is still unclear whether B and B' are 
both present in the same core, or whether they are mutually exclusive. 
In addition to the Sm proteins, a 69kDa (non-Sm) protein has been shown to 
associate with the snRNP core, however this interaction is weak compared to those 
between the Sm proteins, and may be only a transient interaction (Hackl et al., 
1994). 
Although the Sm complex is tightly associated with the snRNA, none of the Sm 
proteins contains recognised RNA binding motifs (reviewed in Birney et al., 1993; 
Burd and Dreyfuss, 1994 and references therein). It is currently believed that the 
RNA binding properties of the Sm proteins result from the formation of an RNA 
recognition motif present only when the proteins are complexed in the snRNP core. 
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Other examples of such multi-partite RNA binding have been reported for both 
ribosomal proteins (Mizushim and Nomura, 1970) and signal recognition particle 
proteins (Strub and Walter, 1990). 
To date only the G protein has been found to specifically cross-link to the Sm-
site, as a result of ultra-violet irradiation in reconstituted Ui snRNPs (Heinrichs et 
al., 1992). 
Ultra-structural studies of the snRNP core complex have suggested that the Sm 
proteins form a globular structure, potentially with a central hole or depression 
(Plessel et al., 1997). These authors discuss the possibility that the Sm proteins form 
a ring-like structure, with the snRNA passing through the central hole. The validity 
of this model remains to be tested. 
1.3.6. The Function(s) of the Sm Proteins. 
The formation of the snRNP core complex has implications for the biogenesis 
and maturation of the snRNP particles. Primarily this complex appears to stabilise 
the newly transcribed snRNAs and provides a flexible platform for the binding of 
other proteins (Nelissen et al., 1994). These other proteins may belong to the 
snRNP-specific group (see Section 1.3.2.), or may be only transiently associated. An 
example of this latter group is snIRNA (guanosine-N2)-methyltransferase which 
binds and mediates the hypermethylation of the snRNP cap structure (Mattaj, 1986; 
Plessel et al., 1994). Providing the signal for the hypermethylation reaction would 
appear to be one of the main functions of the snRNP core complex. 
The promotion of snRNP-specific protein binding by the snRNP core complex 
has been demonstrated in the Ui snRNP. Nelissen et al., (1994) detected protein-
protein interactions between the Ui-specific proteins (70K, A and C) and the core 
proteins B, B' and D2. These interactions occur in addition to documented protein-
RNA interactions of the 70K and A proteins with the Ui snRNA (Query et al., 
1989; Scherly et al., 1989). 
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Binding of the core proteins, cap hyper-methylation and 3' end processing are all 
essential processes for the import of the newly assembled snRNP particles into the 
nucleus (Fischer and LUhrmann, 1990; Zieve and Sauterer, 1990; Mattaj et al., 
1993; Huber et al., 1998; Izaurralde and Adam, 1998; and references therein). 
Competition experiments have shown that the nuclear localisation signal for 
snRNPs is composed of both the TMG cap and the Sm core complex (Hamm et a!, 
1.990; Izaurralde and Adam, 1998; and references therein), and that snRNP import to 
the nucleus uses a different mechanism from that of karyophylic proteins (reviewed 
in Mattaj et al., 1993). Recently, the identification and characterisation of the 
snurportin 1 protein has revealed that at least two distinct import receptors may exist 
and interact with the components of the snRNP nuclear localisation signal (Huber et 
al., 1998). 
It is important to note here that U6 is considered not to leave the nucleus, and 
therefore does not undergo the core protein associations or cap modification 
described above. However, free U6 has been detected in the cytoplasm of mouse 
fibroblasts, although its function or biogenic state in this compartment are not 
known (Fury and Zieve, 1996). 
1.3.7. Yeast Sm Proteins. 
All of the above data have been gathered from mammalian and Xenopus studies, 
however, neither system allows the use of genetic techniques. Alternatively, S. 
cerevisiae enables the use of powerful genetic approaches to study pre-mRNA 
splicing. The lack of alternative splicing, and therefore the more rigid splicing 
process makes this an excellent model system. the integration of different 
approaches, genetics combined with modern molecular biology, has led to some 
interesting discoveries in the elucidation of the splicing pathway and the factors 
involved (reviewed in Cheng and Ableson, 1987; Rymond and Rosbash, 1992; 
Hodges et al., 1997; Beggs, 1998; and references therein). 
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While yeast homologues have been found for the snRNAs, and many of the 
snRNP-specific splicing factors (reviewed in Guthrie and Patterson, 1989; Beggs, 
1998; and references therein) until recently the existence of homologues to the 
metazoan snRNP core proteins remained hypothetical. This was probably due to 
conventional genetic screens of splicing mutants being far from saturating, and 
because the low abundance of yeast snRNP particles hampered the identification of 
snRNP proteins by the traditional biochemical techniques successfully used in the 
HeLa system. 
However, several lines of evidence suggested that Sm proteins also existed in 
yeast: i) yeast snRNAs have consensus sequences for Sm-sites (Siliciano et al., 
1987); ii) anti-Sm antisera precipitated yeast snRNPs (Tollervey and Mattaj, 1987; 
Riedel et al., 1987); iii) certain Sm-site mutations are lethal or inhibitory to yeast 
growth (Jones and Guthrie, 1990) and iv) a set of 6-8 small proteins was found in 
biochemically purified Ui and U41U6.U5 snRNPs (Fabrizio et al., 1994). 
The existence of yeast Sm proteins was confirmed by the identification and 
characterisation of the Smd 1, Smd3 and Sme 1 proteins (Rymond, 1993; Roy et a! 
1995; Bordonné and Tarassov, 1996). Smdip and Smd3p were identified by their 
proximity to known genes, and the similarity of their respective amino acid 
sequences to those of the mammalian Dl and D3 proteins. Smeip was identified 
during the sequencing of yeast chromosome XV, by virtue of its similarity to the 
human protein. All three yeast proteins are required for pre-mRNA splicing and U 
snRNA stability, with their depletion producing decreased levels of the 
spliceosomal snRNAs (except U6). The strongest evidence for their being true Sm 
proteins comes from the ability of the human Dl and E proteins to functionally 
complement null alleles of their respective yeast homologues (Rymond et al., 1993; 
Bordonné and Tarassov, 1996). 
Sequence comparisons of the Sm proteins from a range of species led to the 
identification of a conserved motif, the Sm, or snRNP core protein motif (Cooper et 
al., 1995; Hermann et al., 1995; Séraphin, 1995). The motif is composed of two 
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conserved blocks of amino acids (32 and 14 residues) separated by a non-conserved 
spacer region of variable length, with only one invariant residue, an aspartate in Sm 
motif 1. Conservation of the physio chemical nature of residues at a number of other 
sites indicates that the structural fold of the Sm motif may be more important for the 
function of these proteins than the primary sequence. This is supported by the 
observation that a number of mutations which map to the Sm-motif of the S. 
cerevisiae SmE protein do not significantly affect the interactions made with SniP 
or SmG, in vivo or in vitro (Camasses et al., 1998). However, truncation of the Sm-
motif of either human SmB' or SmD3 prevents these proteins forming a complex, 
suggesting that both conserved regions are required for inter-molecular interactions 
(Hermann et al., 1995). 
With the completion of the yeast genome sequencing project and the definition of 
the Sm motif, putative yeast homologues for the remaining Sm proteins were 
proposed. The biochemical purification and sequencing of the proteins of the yeast 
Ui snRNP confirmed the identity of these homologues, and revealed that yeast 
snRNPs contain a set of seven Sm proteins analogous to the situation in humans 
(Neubauer et al., 1997; Gottschalk et al., 1998). In addition to the canonical Sm 
proteins, other sequences containing the Sm motif have been identified in yeast. 
Ussip, which was identified genetically and was biochemically characterised as a 
novel splicing factor (Cooper et al., 1995), and Smx4p, which was recognised by its 
genomic sequence as containing an Sm motif (Séraphin, 1995), both associate 
primarily with U6 snRNA (Section 1.3.8.). Another of the Sm-like proteins, Spb8p 
has been proposed to play a role in the decapping of mRNAs (Boeck et al., 1998). 
Mutations in the SPB8 locus were identified as bypass suppressors of a poly (A)-
binding protein (PAB]) gene deletion and were found to stabilise the cap structure 
of the mRNA. This leads to an accumulation of capped, but poly (A)-deficient 
mRNAs. Spb8p is therefore proposed to be needed for normal rates of mRNA 
decapping, and therefore degradation, in yeast. 
24 
Searches of the S. cerevisiae genome database identified other ORFs encoding 
putative Sm-like proteins. Four of these, together with Ussip, Smx4p and Spb8p, 
were grouped into seven sub-families with the human and S. cerevisiae canonical 
Sm proteins on the basis of sequence similarity (Fromont-Racine et al., 1997). 
Another two hypothetical proteins, Yjr022p and Smxlp, contain the Sm motif but 
are not otherwise structurally similar to any family group in the sequence alignment. 
Nevertheless, two-hybrid screening with Yjr022p as bait identified interactions with 
the Sm-like proteins Ussip and Yb1026p, and Yjr022p was identified in a two-
hybrid screen with Hsh49p (Fromont-Racine et al., 1997), the yeast homologue of 
the human splicing factor SAP49 (Gozani et al., 1996). In contrast exhaustive two-
hybrid screens with Smxlp as bait did not produce any convincing interactions (P. 
Legrain and M. Fromont-Racine, unpublished data), and a protein A-tagged Smxlp 
shows no interaction with the spliceosomal snRNAs (Séraphin, 1995). Thus, 
sequence alignment of all the Sm and Sm-like proteins, together with the two-hybrid 
data suggest that some of the Sm-like proteins might form a complex (analogous to 
the Sm complex) capable of associating primarily with U6 snRNA. 
1.3.8. U6 snRNA-associated Proteins. 
The Ussi protein: The Ussi protein was originally identified as a high-copy number 
suppressor of a cell cycle mutant, dbJ2-1 (Parkes and Johnston, 1992), and has 
subsequently been identified in a screen searching for proteins involved in bud 
morphogenesis (Chun and Goebl, 1996). As such, Ussip is one of a growing list of 
proteins implicated in both pre-mRNA splicing and in progression through the cell 
cycle. Other examples include Cdc40/Prpl7p (Ben Yehuda et al., 1998); Prp3p 
(Johnston and Thomas, 1982); Prp8/Dbf3p (Shea et al., 1994); Prp22p (Hwang and 
Murray, 1997) and the human SmB proteins (Seghezzi et al., 1998). At present the 
functional significance of these links between splicing and the cell cycle are not 
fully understood. 
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The Ussi protein is most similar to the D3 sub-family of Sm proteins, and is 
encoded by an essential gene (Cooper et al., 1995). Usslp is required for pre-mRNA 
splicing both in vivo and in vitro, and has been shown to be required prior to the 
first step of the splicing reaction, in vitro. Cooper et al. (1995) also demonstrated 
that in vivo depletion of Ussip led to a decrease in the stability of the U6 snRNA, 
and that antiserum raised against the protein could co-immunoprecipitate U6 
snRNA. Recently, Ussip has been shown to contact the U6 snRNA in reconstituted 
(functional) particles (Vidal, 1998). Only the N-terminal half of Ussip, which 
contains both Sm motifs, is required for the function of the protein, since truncation 
of the asparagine-rich C-terminal tail has no obvious effect on cell viability 
(Cooper, 1995). In contrast, Usslp exacerbates the temperature-sensitive growth 
phenotypes of mutations in the genes encoding the Prp3, Prp4 and Prp24 proteins 
(Cooper, 1995). 
Thus, Ussip was the first, and is still the most fully, characterised U6 snRNA-
associated Sm-like protein. Putative homologues of Ussip have been identified in a 
number of organisms (Cooper, 1995; Chun and Goebi, 1996) indicating that U6 
snRNA-associated Sm-like proteins may not be yeast specific (although the snRNA-
associations of these putative homologues has not been tested or reported). 
The Smx4 Protein: the Smx4 protein is encoded by the USS2 gene, and was 
identified through its sequence similarity to the canonical Sm proteins (Séraphin, 
1995). It was shown by immunoprecipitation to be associated with U6 snRNA 
(Séraphin, 1995) and most closely resembles the members of the D2 sub-family 
(Fromont-Racine et al., 1997). Camasses et al. (1998) reported Smx4 as interacting 
with the canonical SmE protein, although the significance of this two-hybrid 
interaction remains unclear. No further characterisation of Smx4 has been reported. 
Similarly, none of the other Sm-like proteins proposed to be U6 snRNA 
associated (Fromont-Racine et al., 1997) have been characterised (with the 
exception of Spb8p (Boeck etal., 1998)). 
Other Proteins Associated with U6 snRNA: Several non-Sm proteins have also been 
reported to associate with the U6 snRNA, although in all cases, the association. 
occurs in the U4/U6 di-snRNP particles. 
The Prp3 protein is a component of the di-snRNP, and has been shown to be 
required for the integrity of both the U4/U6 and U4/U6.U5 particles (Anthony et al., 
1997). 
The Prp4 protein is also associated with the U41U6 particle (Banroques and 
Abelson, 1989; Petersen-Bjøm et al., 1989) and is implicated in spliceosome 
assembly (Ayadi et al., 1997). Although it is believed to associate closely with the 
U4 snRNA (Bordonné et al., 1990; Hu et al., 1994), no direct protein-RNA 
interaction has been demonstrated, and heat-inactivation of temperature-sensitive 
prp4-1 cells leads to a reduction in the level of U6 snRNA, but not U4 (Galisson 
and Legrain, 1993). 
The Prp24 protein is responsible for re-annealing the U4 and U6 snRNAs after 
completion of the splicing reaction, in order to recycle the snRNP particles for 
subsequent rounds of splicing (Shannon and Guthrie, 1991; Ghetti et al., 1995; 
Raghunathan and Guthrie, 1998). As for Prp4p, heat-inactivation of temperature-
sensitive prp24-1 cells causes a reduction in the level of U6 snRNA, but not U4 
(Blanton et al., 1992). However, a binding site for Prp24p has been identified on the 
U6 snRNA (Jandrositz and Guthrie. 1995). 
The Prp3 8 protein is also required specifically for the stability of the U6 snRNA 
(Blanton et al., 1992) and has been proposed to be involved in the dissociation of 
the U4/LJ6 di-snRNP prior to the integration of the U6 snRNA into the active site of 
the spliceosome (Xie etal., 1998). 
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1.4. Sm-like Proteins and Disease. 
The Sm-like proteins have been implicated in a number of different disease 
processes. The human canonical Sm proteins are known to cross-react strongly with 
the auto-antibodies produced by patients with systemic lupus erythematosus, or SLE 
(Lemer and Steitz, 1979). Similarly, antisera from patients with certain rheumatic 
conditions also contain antibodies which cross-react with a subset of the Sm 
proteins (van Venrooij, 1987). Whether the Sm proteins are the major antigenic 
targets for these auto-antibodies is not clear at this time. 
More recently, it has been reported that the CaSm protein is over-expressed in 
pancreatic cancer cells and is important for maintaining the transformed state of 
these cells (Schweinfest et al, 1997). What, if any, snRNA-associations this Sm-like 
protein makes is not reported, and it is interesting to note that the most closely 
related yeast protein (67.7% similarity) is Spb8p i.e. the Sm-like protein implicated 
in mRNA decapping and degradation (Boeck et al., 1998). 
A subset of the human canonical Sm proteins has also been reported to associate 
in a complex with the spinal muscular atrophy disease gene product (SMN); (Liu et 
al., 1997; Fischer et al., 1997). Investigations into these associations and the 
biogenesis of snRNP particles (and the Sm proteins) are therefore aiding the 
understanding of the molecular mechanism of spinal muscular atrophy. 
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1.5. This Thesis. 
This thesis describes the initial biochemical characterisation of the yeast Sm-like 
proteins and their molecular interactions. The ORFs encoding uncharacterised, non-
canonical Sm-like proteins have been deleted, and conditional strains made. The 
requirement for only a subset of these proteins for normal growth is demonstrated, 
together with analyses of the RNA profiles obtained upon in vivo depletion of each 
of the proteins. 
Exhaustive two-hybrid analyses and immunoprecipitation experiments have been 
used to investigate the protein-protein and protein-RNA associations of the Sm-like 
proteins. From these analyses it is proposed that a subset of the non-canonical Sm-
like proteins associate with U6 snRNA and can form into a novel Sm-like 
complex(es) that likely functions in U6 snRNP biogenesis and maturation. 
The existence of Sm-like complexes potentially involved in cellular processes 
other than pre-mRNA splicing is proposed and discussed. 
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CHAPTER Two. 
MATERIALS AND METHODS. 
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2.1. Materials. 
2.1.1. General Reagents. 
2.1.1.1. Chemicals. 
Chemicals were purchased from the following sources, except where stated 
otherwise: Amersham, Fischer, Fisons, Melford Labs., National Diagnostics, 
Scotlab, Sigma. 
2.1.1.2. Enzymes. 
Restriction enzymes, DNA and RNA polymerases, RNases and other enzymes 
used in this work were purchased from the following sources unless otherwise 
stated: Boehringer Mannheim, Gibco BRL, New England Biolabs, Pharmacia, 
Promega, QIAGEN. 
2.1.1.3. Growth Reagents. 
Reagents for all growth media were purchased from: Beta Lab, Difco 
Laboratories, Oxoid or Sigma. 
2.1.1.4. Antibiotics. 
Ampicillin, Tetracycline and Kanamycin were purchased from Beecham 
Research. 
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2.1.2. Bacterial and Yeast Growth Media. 
2.1.2.1. General Information. 
All growth media were autoclaved prior to use, and stored at room temperature. 
For solid media, 2% (w/v) agar was added prior to autoclaving. 
2.1.2.2. Bacterial Media. 
Table 2.1.1. 
Bacterial Media 
Medium 	 Components 
Luria-Broth (LB) 	1% (w/v) Bacto-tryptone 
0.5% (w/v) Yeast extract 
0.5% (w/v) NaCl 
pH was adjusted to 7.2 with NaOH 
SOC 	 2% (w/v) Bacto-tryptone 
0.5% (w/v) Yeast extract 
0.06% (w/v) NaCl 
0.02% (wlv) KC1 
0.1% (w/v) MgCl 2 
0.12% (w/v) MgSO4 
0.4% (w/v) Glucose 
1 Ox M9 salts 	 6% (w/v) Na2HPO4 
3% (w/v) KH2PO4 
0.5% (w/v) NaCl 
1% (w/v) NH4C1 
M9 -LEU 	 10% (w/v) -LEU dropout mix 
0.2% (w/v) Glucose 
10% (vlv) 1 Ox M9 saltsa 
0.024% (w/v) MgSO4a 
0.022% (w/v) CaC12a 
a  added after autoclaving. 
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2.1.2.3. Antibiotics. 
Antibiotics were added to liquid media immediately prior to use, while for solid 




Antibiotic Abbreviation Solvent 	Stock Solution Final concentration 
(mg/ml) (j.ig/ml) 
Ampicillin Amp Water 	100 50-100 
Kanamycin Kan Water 	10 10 
Tetracycline Tet Ethanol 	5 5 
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2.1.2.4. Yeast Media. 
Table 2.1.3. 
Yeast Media. 
Medium 	 Components 
YPDA 	 1% (w/v) Yeast extract 
2% (w/v) Bacto-peptone 
2% (wlv) Glucose 
0.003% (w/v) Adenine sulphate 
YPGa1A 	 1% (w/v) Yeast extract 
2% (w/v) Bacto-peptone 
2% (w/v) Galactose 
0.003% (w/v) Adenine sulphate 
yMMa 	 0.67% (w/v) Yeast Nitrogen Base w/o amino acids 
2% (w/v) Glucose 
YMGa1a 	 0.67% (w/v) Yeast Nitrogen Base w/o amino acids 
2% (w/v) Galactose 
Sporulationb 	1% (w/v) potassium acetate 
0.1% (w/v) Bacto-yeast extract 
0.05% (w/v) Glucose (or Galactose) 
a Selective media were supplemented with nutrients from drop-out mix as required. 
Drop-out powder was added prior to autoclaving. 
bSpomlation medium was supplemented only with those nutrients needed for 
vegetative growth of the strain being studied. 
For the preparation of solid media 2% (w/v) agar was added prior to autoclaving. 
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2.1.2.5. Nutrients and Supplements. 
Drop-out powder was prepared by mixing 2g of each of the following nutrients: 
Adenine; Alanine; Arginine; Asparagine; Aspartic acid; Cysteine; Glutamic acid; 
Glutamine; Glycine; Histidine; Isoleucine; Lysine; Methionine; Phenylalanine; 
Proline; Serine; Threonine; Tyrosine; Tryptophan; Uracil; Valine. If required, 4g of 
Leucine was included in the mix. The drop-out mix was ground with a mortar and 
pestle to ensure complete mixing and was used at 0.2% (w/v). To each 500m1 of 
media containing drop-out powder, one pellet of NaOH was added to adjust the pH. 
Stock solutions of individual growth supplements were sterilised by autoclaving, 
stored at 4°C and added to media immediately prior to use. 
Table 2.1.4. 
Nutrients and Supplements. 
Nutrient 	 Stock solution 	Final concentration 
% (w/v) 	 (mg/l) 
Adenine Suiphatea 	0.2 	 20 
Uracil 	 0.2 	 20 
L-Tryptophan 	1.0 	 20 
L-Histidine 	1.0 	 20 
L-Methionine 	1.0 	 20 
L-Leucine 	 1.0 	 30 
a  stored at room temperature. 
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2.1.3. Commonly Used Buffers. 
Table 2.1.5. 
Commonly Used Buffers. 
Buffer 	 Components 
lOx SSC 	 3MNaC1 
0.3M Sodium citrate 
Unsterilised. 
lOx TAE 	 O.4M Tris-acetate, pH 7.5 
20mM EDTA 
Unsterilised. 
lOx TBE 	 0.9M Tris-borate, pH 8.3 
20mM EDTA 
Unsterilised. 
lOx TBS 	 0.5M Tris-HC1, pH 7.5 
1.5MNaC1 
Sterilised by autoclaving. 
lOx TBS-T 	0.5M Tris-HC1, pH 7.5 
l.5M NaCl 
1% (v/v) Tween-20. 
Unsterilised. 
lOx TE 	 0.1M Tris-HC1, pH 7.5 
O.O1M EDTA 
Sterilised by autoclaving. 
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2.1.4. Escherichia coli Strains. 
Strains of bacteria used in this work are listed in Table 2.1.6. DH5aF' and 
MC 1066 cells were used for cloning and propagation of plasmid DNA. MC 1066 
cells were also used for rescue of plasmid DNA from yeast cells (Section 2.3.4.4.). 
TOP1O cells were used specifically for cloning and propagation steps involving the 
pZErO-2 plasmid (Table 2.1 .11) 
Table 2.1.6. 
Bacterial Strains. 
Strain 	Genotype 	 Source 
DH5aF' 	F, 80dlacZE,M15, A(1acZYA-argF) U169, deoR, Gibco BRL. 
recAl, endAl, hsdR17 ( rK, mK), supE44, ?, thi-1, 
gyrA96, relAl. 
MC 1066 	A(lacI POZYA)74, galU, galK, StrA t , leuB6, trp 	P. Legrain 
C9830, pyrF  74::Tn5 (Kn'), hsdR 
TOP10 	F, mcrA, deoR, recAl, rpsL, L(mrv-hsdRMS- 	Invitrogen. 
mcrBC), 801acZiXM15, &acX74, araD139, A(ara- 
leu)7697, galU, galK, endAl, nupG. 
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2.1.5. S. cerevisiae Strains. 
Strains of S. cerevisiae used in this work are listed in Table 2.1.7. 
Table 2.1.7. 
S. cerevisiae Strains. 
Strain 	Genotype 	 Source 
BMA38* 	M4Ta/a, trpItxl, his3L200, ura3-1, leu2-3,412, ade2-1, can]-100 B. Dujon. 
BMA38a 	MATa, 1rpM], his3L200, ura3-1, Ieu2-3,412, ade2-1, can 1-100 	This work. 
BMA64* 	MAT a/a, 1rpM], his3-11,45, ura3-1, leu2-3,412, ade2-1, cani- F. Lacroute. 
100 
BMA64a 	MAT a, trp1L1, his3-11,45, ura3-1, leu2-3,-112, ade2-1, can]- This work. 
100 
JDY6* 	MATa/a, trpM99, his3Lx200, ura3Li99, leu2tJ, ade2-101, cir° 	J.D. Brown. 
W303* 	MAT a/a, ade2-1, trp]AI, leu2-3,412, his3-11,45, ura3-1, can]- This lab. 
]00. 
W303n 	MAT a, ade2-1, trp]LiI, leu2-3,412, his3-11,45, ura3-1, can]- This lab. 
100. 
KY1 17 MATa, his3z200, lys2-801, ade2, 1rpM], ura3-52, GAL+ 
KY118 MATa, his3A200, lys2-801, ade2, (rpM], ura3-52, GAL+ 
D7* M4 Ta/a, ilv-192, trp5, ade2, chj21CHY 22. This lab. 
AEMY3* MAT a/a, ade2-1, trp]A1, leu2-3,412, his3-11,45, ura3-1, can]- This work. 
100, YLR386w/y1r386w::HJS3.. 
AEMY3n MAT a, ade2-1, trp]A], leu2-3,412, his3-11,45, ura3-1, can]- This work. 
100, y1r386w::HJS3. 
AEMY9* MAT a/a, trpM], his3-]],45, ura3-1, leu2-3,412, ade2-1, canl- This work. 
100, YER146w/yerl46w:: TRP] 
AEMY12* MAT a/a, trpM], his3t200, ura3-1, leu2-3,412, ade2-I, can]- This work. 
100, YDR378c/ydr378ci::HIS3 
Table 2.1.7. cont. 
S. cerevisiae Strains. 
Strain 	Genotype 	 Source 
AEMY15* 	MAT a/a, trpMl, his3Lx200, ura3-1, leu2-3,412, ade2-1, can]- This work. 
100, YNL147w/ynIl47wi\:.HIS3 
AEMY18* MAT a/a, (rpM], his3-11,45, ura3-1, leu2-3,412, ade2-1, canl- This work. 
100, SPB81spb8z:: TRPI 
AEMY19 MAT a, trplAl, his3A200, ura3-1, leu2-3,412, ade2-1, can]-]00, This work. 
ydr378c: :HIS3 
AEMY22 MAT a, trpMl, his3E,200, ura3-1, leu2-3,412, ade2-1, can]-]00, This work. 
yn1147wi:.HIS3 
AEMY23* MAT a/a, trplAl, his3A200, ura3-1, leu2-3,-112, ade2-1, can]- This work. 
100, YBL026w/ybIO26w& .HIS3 
AEMY24 MAT a, trpMl, his3-11,45, ura3-1, leu2-3,412, ade2-1, can]- This work. 
100, spb8E:: TRP] 
AEMY26* MAT a/a, trplAl, his3-]],45, ura3-1, leu2-3,412, ade2-1, can]- This work. 
100, USS21uss2t:: TRP] 
AEMY28 Mat a, trplA], his3-11,45, ura3-1, leu2-3,4]2, ade2-1, can]-]00, This work. 
HA:SPB8 
AEMY29 	MAT a, trp]z], his3-11,45, ura3-1, leu2-3,-]]2, ade2-1, cani- This work. 
100, yer146w:. TRP] [pAEM70] 
AEMY30 	MAT a, trp]tx], his3t200, ura3-1, leu2-3,412, ade2-1, can]-]00, This work. 
ybI026w::HJS3 [pAEM55] 
AEMY31 	MAT a, trpMl, his3-1],45, ura3-1, leu2-3,4]2, ade2-1, can]- This work. 
100, uss2L:: TRPI [pAEM64] 
AEMY32 	MAT a, trpIAI, his3-]],45, ura3-1, leu2-3,4]2, ade2-1, can]- This work. 
100, [pAEM64] 
AEMY33 	MAT a, trpMl, his3Lx200, ura3-1, leu2-3,412, ade2-1, can]-100, This work. 
yb1026wA: :HIS3 [pAEM68] 
LMA4* 	MAT a/a, trpM], his3-11,45, ura3-1, leu2-3,412, ade2-1, can]- This work. 
100, YJR022w/yjrO22wA:: TRPI 
LMA4-2A 	MAT a, trpMl, his3-11,45, ura3-1, leu2-3,-1]2, ade2-1, can]- This work. 
100, yjr022wi::TRP] [pAEM71] 
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Table 2.1.7. cont. 
S. cerevisiae Strains. 
Strain Genotype Source 
CG1945 MAT a, gal4-542, gal80-538, ade2-101, his3t200, trpi-901, leu2- Clontech. 
3,-1 12, 	ura3-52, 	lys2-801 	URA3::(GAL4 	1 7mers) 3-CYC1-lacZ 
lys2::GALJUAS-HJS3 Cyhr2 
L40 MAT a, 	ade2, 	trpl-901, 	leu2-3,-112, 	his3A200, 	lys2-801am, Hollenberg 
URA3::(iexAop) 8-LacZ, LYS2..(1exAop,) rHIS3 et al., 1995. 
Yl 87 MAT a, gal4-542, gal8O-538, ade2-101, his3,200, trpi-901, leu2- Clontech. 
3-112, ura3-52, URA3::GALJ-lacZ 
DJY36 Mat a, ura3-52, ade2-1, prp2-1 D. Jamieson 
MCY4 MAT a, adel-iOi, his3-1, leu2-3,-112, trpl-289, ura3-52, LEU2- Cooper etal. 
PGALJ-USSJ, GAL+ 1995. 
PW50 MAT a, ura3-52, leu2z, ade2-101, lys2, cyh2. Wang et al., 
1996. 
PW50zWatl MAT a, ura3-52, leu2E,, ade2-101, lys2, cyh2, patl::LEU2. Wang et al., 
1996. 
Cy103 MAT a, ura3-52, trpl-289, leu2-3,-112, his3L, cyh', prp9-1. Chapon and 
Legrain, 
1992. 
A635 MATa, his4-512, leu2, ura3-52, lyrl, prpii-i, gal-. Legrain and 
Rosbash, 
1989. 
*All diploid strains are isogenic for the auxotrophic markers described. 
All strains in which HIS3 replaces a deleted ORF are derived from BMA3 8 
All strains in which TRPJ replaces a deleted ORF are derived from BMA64 
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2.1.6. Oligonucleotides. 
Oligonucleotides used in this work are listed in Tables 2.1 .8.-2. 1.10. All 
oligonucleotides were purchased from Oswell DNA service (Southampton), 
Genosys Biotechnologies Ltd. (Cambridgeshire) or Bioline (London), with the 
exception of TIGER oligonucleotide which was synthesised by Caroline Russell 
(This lab). Taq6A oligonucleotide was a gift from David Brow (University of 
Wisconsin). P RNA, MRP RNA, and 5S rRNA oligonucleotides were a gift from 
David Tollervey (University of Edinburgh). 
Table 2.1.8 
General and Cloning Oligonucleotides. 
Oligo 	Description 	Sequence (5'-3') 	pmol/j.il 
413G 	M13 reverse AGCGGATAACAATTTCACACAG 	159.0 
primer 	GA 
N6728 	T7 promoter in AATACGACTCACTATAG 	 17.0 
polylinker 
M5392 	Stop codon TCGATTAACTAACTAG 	 17.1 
linker 
M5393 Stop codon TCGACTAGTTAGTTAA 11.8 
linker 
Sp6 5p6 promoter in ATTTAGGTGACACTATAG 111.0 
polylinker 
T4183 GALl promoter TACTTTAACGTCAAGGAG 19.0 
N3027 GAL4 DNA-BD TCATCGGAAGAGAGTAG 21.8 
T9476 	GAL4 AD 	GGCTTACCCATACGATGTTC 	25.5 
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Table 2.1.8. cont. 
General and Cloning Oligonucleotides. 
Oligo 	Description 	Sequence (5'-3') 	pmol/pi 
P5149 pACTII reverse TGAGATGGTGCACGATGC 22.7 
primer 
W2248 LexA DNA-BD CTTCGTCAGCAGAGCTTC 14.7 
LexRev pBTM1 16 TTTTAAAACCTAAGAGTCAC 160.0 
reverse primer 
M7499 USS] promoter GAACTACTCTAGAGGGACAG 101.0 
M4159 USSJ promoter GAGGATCCATATTCTATTGTG 20.0 
N0831 USS] promoter ATGCTAAAGCTTGGCAATAG 19.0 
TIGER USS] promoter GGAAGCGGTAAAG 20.0 
M4158 USSJ sequence CCGCGGATCCAATGCTACCTT 23.0 
788R USS] sequence CTGCAGTCGACGGTAATCAACAT 137.0 
TCAC 
M0055 USS] sequence GCAGTCGACTTGCTGCTTGACCT 22.0 
T 
S6479 USS] sequence GCCATGGAGATGCTACCTTTA 27.0 
S6476 USSJ sequence TGGATCCTTAAAATTCGAC 25.0 
S6475 USS] sequence AGGATCCTTGCTGCTTGAC 30.0 
S6477 USS2 sequence GGTACCATGGAGACACCTTTG 24.4 
S6478 USS2 sequence AGGATCCTATCTCCACTG 17.5 
AM5 PRP24 sequence ACCATGGAGTATGGAC 11.0 
AM6 PRP24 sequence GGATCCTACTCACCTAG 14.0 
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Table 2.1.8. cont. 
General and Cloning Oligonucleotides. 
Oligo 	Description 	Sequence (5'-3') 	pmol/tl 
Fl YDR378c GAATTCATGCCAAATAAGCAAC 21.9 
sequence G 
F2 YDR378c GGATCCATTAGAGGAGA 23.5 
sequence 
U6FPACT YDR378c GGGAATTCTGCCAAATAAGCAA 131.0 
sequence CG 
U6EProm YER146w CGCAAAGCTTGTGTCAGT 153.0 
promoter 
V5579 YLR386w CACTACAGTCCCGGGTTGATC 20.1 
promoter 
V5580 YLR386w TTGACCAACGGTACCAACTCC 21.6 
sequence 
Gi YNL147w GAATTCATGCATCAGCAACACTC 85.7 
sequence CCAAAGGAAAAAATTCGAAGGC 
G2 YNL147w GGAAGGGATCCTATATGAG 59.7 
sequence 
BACT5 SPB8 sequence AATGTCTGCAAATAGCAAGG 80.8 









Oligonucleotides Used to Probe Northern Blots. 
Oligo 	Description 	Sequence (5'-3') 
	
pmol4il 
G8102 Ui snRNA 
G8 103 U2 snRNA 
483A U4snRNA 
485A U5 snRNA 
Taq6A U6 snRNA 
PRNA PRNA 
MRP RNA MRP RNA 





















Oligonucleotides Used for ORF Deletions. 
Oligo 	ORF 	Marker 	 Sequence 
5BTRPJ 	SPB8 TRPJ 	CCTATAAAAGAAAGCAGCCCTCGA 
ATCGAATTAATTCACCAAAACTATT 
TCTTAGCATTTTTGACG 
3BTRPJ 	SPB8 TRPJ 	GAGTTTACTCCAGGATATATGTTGG 
TAGTATTGTGTTTTTCTTTCCAAAC 
GGCAGCCCCGATC 
5D1HIS3 	YBL026w HIS3 	CAATACTTTCGAACACATATCTCAC 
GCTGATAACACCCTAGCAAGTTCG 
TTCAGAATGACACG 
3D1HIS3 	YBL026w HIS3 	TAAAAAACTAATGAGAAAAAATGC 
CATGAGGATAGACTGCATAATTCC 
TCTTGGCCTCCTCTAG 
5D2TRPJ 	USS2 TRPJ 	GCAGATAAATACACACACACACAC 
AACATCACGCACACTCAAGAAACT 
ATTTCTTAGCATTTTTGACG 
3D2TRPJ 	USS2 TRPJ 	TAAAAAAATACGTACTGTTTCCCTT 
TGTTTTCTCCTCCTCTTTGCCAAAC 
GGCAGCCCCGATC 
5ETRPJ 	YER146w TRPJ 	ATAGCGTATACACGTGCACCTCAC 
AAGCATACACAGAAGCGCGCAAAC 
TATTTCTTAGCATTTTTGACG 




Table 2.1.10. cont. 
Oligonucleotides Used for ORF Deletions. 
Oligo 	ORF 	Marker 	 Sequence 
5FHIS3 YDR378c 	HIS3 
3FHIS3 YDR378c 	HIS3 
5GHIS3 YNL147w HIS3 















The plasmids used in this work are described in Tables 2.1.11 and 2.1.12. 
Table 2.1.11. 
Cloning Vectors. 
Plasmid 	 Features 	 Reference. 
pBluescript KS Phagemid cloning vector: Multiple cloning 	Stratagene. 
site; lacZa, AmpR;  fi on; Co1E1; T3 and T7 
promoters. 
pGEM-T 	Phagemid cloning vector: Multiple cloning 	Promega. 
R site; iacZa; Amp ; fi on; Sp6 and T7 
promoters. 
pZErO-2 	Phagemid cloning vector: Multiple cloning 	Invitrogen. 
site; iacZa 	R; ccdB; Kan ; fi on; CoIE1; Sp6 
and T7 promoters. 
pFL45S 	Yeast-E. coli shuttle vector: Multiple Bonneaud et al., 
cloning site; lacZa; Amp''; 2jt; TRPJ. 	 1991. 
pBM125 	Yeast-E. coil shuttle vector: GALJ-GALJO 	Johnston and 
promoter sequence; AmpR ; TetR; CEN4, Davis, 1984. 
ARS]; URA3. 
pRS3 13 	Yeast-E. coli shuttle vector: Multiple 	Sikorski and 
cloning site; lacZa; AmpR;  CEN6, ARSH4; Hieter, 1989. 
HIS3 
pRS3 16 	Yeast-E. coil shuttle vector: Multiple 	Sikorski and 
cloning site; iacZa; AmpR;  CEN6, ARSH4; Hieter, 1989. 
URA3 
pBTM1 16 	Yeast-E. coil shuttle vector: ADHJ promoter 	Vojtek et al., 
sequence, LexA DNA-BD sequence (an 1- 1993. 
202); Amp'; 2t; TRPJ. 
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Table 2.1.11. cont. 
Cloning Vectors. 
Plasmid 	 Features 	 Reference. 
pACTII 	Yeast-E. coil shuttle vector: ADHJ promoter 	Clontech. 
sequence, Ga14AD sequence (aa 768-88 1), 
HA-epitope sequence; Amp R; 2t; LEU2. 
YTpl 	 Yeast integrative vector: Amp'; HIS3. 	Struhi et al., 
1979. 
YEp13 	Yeast-E. coil shuttle vector: AmpR; TetR; 2t; 	Broach et al., 
LEU2. 	 1979. 
YCpIF 16 	Yeast-E. coil shuttle vector: GAL] promoter 	Foreman and 
sequence, HA-epitope sequence; AmpR; Davis, 1994. 
CEN4,ARS]; TRPJ. 
YEp24 	Yeast-E. coli shuttle vector: AmpR;  2t; 	Botstein et al., 
URA3. 	 1979. 
YCp50 	Yeast-E. coli shuttle vector: Amp'; CEN4, Rose et al., 1987. 
ARS]; URA3. 
YEplac 195 	Yeast-E. coil shuttle vector: Multiple Gietz and Sugino, 






Description 	 Reference 
pAEM1 Modified pRS313. A 1,325bp fragment of USS] This work. 
5' UTR sequence was generated by PCR using 
YEp24-USSJ as template and primers M7499 and 
M4159 (Table 2.1.8.). PCR product was cut with 
BamHI and XbaI, restriction sites incorporated 
into the PCR primers, and cloned between the 
BamHT and XbaI sites ofpRS3l3. 
pAEM2 Modified 	pAEM1. 	Plasmid 	pAEM1 	was This work. 
linearised with Sail restriction enzyme and a 
stop-codon 	linker, 	generated 	using 	primers 
M5392 and M 5393 (Table 2.1.8.), inserted. 
pAEM4 Modified pAEM1. USS] coding sequence was This work. 
generated 	by 	PCR 	using 	YEp24-USSJ 	as 
template and primers M4158 and 788R (Table 
2.1.8.). PCR product was cut with BamHl and 
Sail, restriction sites incorporated into the PCR 
primers, and cloned between the BamHI and Sail 
sites of pAEM1. Coding sequence was verified 
by sequencing. 
pAEM5 Modified pAEM2. USSJA coding sequence was This work. 
generated 	by. PCR 	using 	YEp24-USSJ 	as 
template and primers M4158 and M0055 (Table 
2.1.8.). PCR product was cut with BamHI and 
Sail, restriction sites incorporated into the PCR 
primers, and cloned between the BamHI and Sail 
sites of pAEM2. Coding sequence was verified 
by sequencing. 
pAEM6 Modified pGEM-T. USS] coding sequence was This work. 
generated 	by 	PCR 	using 	YEp24-USSJ 	as 
template and primers S6479 and S6476 (Table 
2.1.8.). PCR product was cloned directly into 
pGEM-T, such that the "5'-end" of the coding 
sequence was at the "77-end" of the polylinker. 
Coding sequence was verified by sequencing. 
Table 2.1.12. cont. 
Modified Vectors. 
Plasmid Description Reference 
pAEM7 Modified pACTIL A 1330bp fragment of PRP24 This work. 
was isolated from pAEM1 I as an NcoI/BamHI 
fragment, and cloned into the NcoI and BamHJ 
sites of pACTII. 
pAEM8 Modified pGEM-T. USSJt\ coding sequence was This work. 
generated 	by 	PCR 	using 	YEp24-USSJ 	as 
template and primers S6479 and S6475 (Table 
2.1.8.). PCR product was cloned directly into 
pGEM-T, such that the "5'-end" of the coding 
sequence was at the "Sp6-end" of the polylinker. 
Coding sequence was verified by sequencing. 
pAEM9 Modified pGEM-T. USS2 coding sequence was This work. 
generated 	by 	PCR 	using 	YEp24-USSJ 	as 
template and primers S6477 and S6478 (Table 
2.1.8.). PCR product was cloned directly into 
pGEM-T, such that the "5'-end" of the coding 
sequence was at the "77-end" of the polylinker. 
Coding sequence was verified by sequencing. 
pAEMI 1 Modified pGEM-T. PRP24 coding sequence was This work. 
generated by PCR using YCpXba as template and 
primers AM5 and AM6 (Table 2.1.8.). PCR 
product was cloned directly into pGEM-T, such 
that the "5'-end" of the coding sequence was at 
the "77-end" of the polylinker. Coding sequence 
was verified by sequencing. 
pAEM12 	Modified pRS316. USS] coding sequence and 	This work. 
promoter region was isolated from pAEM4 as a 
XbaI/SalI fragment and cloned into the XbaI and 
Sail sites ofpRS3l6. 
pAEM13 	Modified pAS2M. USSJ coding sequence was 	This work. 
isolated from pAEM6 as an NcoI/Baml-H 
fragment, and cloned into the NcoI and BamHl 
sites of pAS2AA. 
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Table 2.1.12. cont. 
Modified Vectors. 
Plasmid 	 Description 	 Reference 
pAEM14 	Modified pACTII. USSJ coding sequence was 	This work. 
isolated from pAEM6 as an NcoI/BamHI 
fragment, and cloned into the NcoI and BamHJ 
sites of pACTII. 
pAEM1 5 	Modified pAS2M. USSJi\ coding sequence was 	This work. 
isolated from pAEM8 as an NcoI/BamHI 
fragment, and cloned into the NcoI and BamHI 
sites of pAS2M. 
pAEM16 	Modified pACTII. USSJA coding sequence was 	This work. 
isolated from pAEM8 as an NcoI/BamHl 
fragment, and cloned into the NcoI and BamHI 
sites of pACTII. 
pAEM17 	Modified pAS2&.. USS2 coding sequence was 	This work. 
isolated from pAEM9 as an NcoIIBamHI 
fragment, and cloned into the NcoI and BamHI 
sites of pAS2M. 
pAEM18 	Modified pACTII. USS2 coding sequence was 	This work. 
isolated from pAEM9 as an NcoI/BamHI 
fragment, and cloned into the NcoI and BamHI 
sites of pACTII. 
pAEM23 	Modified pAS2AA. PRP24 coding sequence was 	This work. 
isolated from pAEM1 1 as an NcoIIBamHT 
fragment, and cloned into the NcoI and BamHI 
sites of pAS2AA. 
pAEM29 	Modified pAS2AABg. Smi motif encoding 	This work. 
fragment of USSJ (USS1-A) was isolated from 
pMC 102 as a BamHI/XhoI fragment, and cloned 
into the BamHJ and Sail sites of pAS2iABg. 
pAEM30 	Modified pAS2MBg. Sm2 motif encoding 	This work. 
fragment of USSJ (USSJ-B) was isolated from 
• pMC 103 as a EcoRI/Sall fragment, and cloned 








pAEM3 1 	Modified 	pAS2AA. 	Two-hybrid 	prey 	insert This work. 
fragment of PRPJJ was isolated from pAEM74 
as a BamHT fragment, and cloned into the BamHI 
site of pAS2M. 
pAEM32 	Modified pBluescript KS. YDR378c coding N. Gromak, 
sequence was generated by PCR using yeast this lab. 
genomic DNA as template and primers Fl and F2 
(Table 2.1.8.). PCR product was cloned directly 
into 	the 	Smal 	site 	of 	pBluescript. 	Coding 
sequence was verified by sequencing. 
pAEM33 	Modified pAS2AA. YDR378c coding sequence N. Gromak, 
was isolated from pAEM32 as an EcoRI/BamHI this lab. 
fragment, and cloned into the EcoRI and BamHI 
sites of pAS2AA. 
pAEM34 	Modified pBTM1 16. YDR378c coding sequence 	N. Gromak, 
was isolated from pAEM32 as an EcoRI/Bam HI this lab. 
fragment, and cloned into the EcoRI and BamHI 
sites of pBTM116. 
pAEM36 	Modified YEplac 195. PRP9 coding sequence and 	This work. 
promoter region was isolated from pPL12 as a 
HindIII/BamHI fragment and cloned into the 
Hindill and BamHI sites of pRS3 16. 
pAEM39 	Modified pBluescript KS. A 617bp fragment of 	This work. 
YLR386w (53 lbp of 5' UTR and 86bp of coding 
sequence) was generated by PCR using yeast 
genomic DNA as template and primers V5579 
and V5580 (Table 2.1.8.). PCR product was 
cloned directly into the EcoRV site of pBluescript 
(Figure 5.5). Insert sequence was verified by 
sequencing. 
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Table 2.1.12. cont. 
Modified Vectors. 
Plasmid 	 Description 	 Reference 
pAEM40 	Modified pAEM39. A fragment encoding the C- 	This work. 
terminal region of Y1r386p was isolated as a 
HindIII/XhoI fragment (from a two-hybrid prey 
plasmid identified in the pAEM13 screen) and 
cloned into the Hindill and XlzoI sites of 
pAEM39 (Figure 5.5). 
pAEM4 1 	Modified pRS3 16. A fragment encompassing 	This work. 
both the 5'-UTR region and the C-terminal 
encoding region of Y1r386p was isolated as a 
NotI/X7zoI fragment and cloned into the NotI and 
XhoI sites ofpRS3l6 (Figure 5.5). 
pAEM42 	Modified pAEM4 1. pAEM4 1 was linearised with 	This work. 
ClaI and Hindill and transformed into W303 
cells. Gap repaired plasmids were recovered and 
verified by restriction analysis. Plasmid contains 
whole YLR386w coding sequence and 531bp of 
5'-UTR (Figure 5.5). 
pAEM43 	Modified pAEM42. A 2,866bp fragment 	This work. 
encoding the HIS3 gene was isolated from Ylpi 
as a ClaI/XhoI fragment and cloned into pAEM42 
digested with ClaI and XhoI. 
pAEM44 	Modified YEplac195. YLR386w coding sequence 	This work. 
and 5'-UTR were isolated from pAEM42 as an 
EcoRI fragment and cloned into the EcoRI site of 
YEplacl95, such that the "5'-end" of the insert is 
at the "Hindill-end" of the polylinker. 
pAEM45 	Modified pAS2AAC. YLR386w coding sequence 	This work. 
was isolated from pAEM42 as a ClaI/XhoI 
fragment, and cloned into the ClaI and J7ioI sites 
of pAS2AAC. 
pAEM46 	Modified pBTM1 16. YLR386w coding sequence 	This work. 
was isolated from pAEM45 as an EcoRI 
fragment, and cloned into the EcoRI site of 
pBTM116. 
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Table 2.1.12. cont. 
Modified Vectors. 
Plasmid 	 Description 	 Reference 
pAEM53 	Modified pBTM1 16. YERI46w coding sequence 	This work. 
was isolated from pAEM70 as a BamHl 
fragment, and cloned into the BamI-ll site of 
pBTM116. 
pAEM54 	Modified pACTIIst. YDR378c coding sequence 	This work. 
was generated by PCR using pAEM34 as 
template and primers U6FPACT and LexRev 
(Table 2.1.8.). PCR product was cut with EcoPJ 
and Sail and cloned between the EcoRI and .X7ioI 
sites of pACTIIst. Coding sequence was verified 
by sequencing. 
pAEM55 	Modified pACTIIst. A fragment of YBL026w 	This work. 
from nt 4 to nt 913 (relative to the AUG) was 
generated by PCR, using a two-hybrid prey 
plasmid (received from P. Legrain) and primers 
T9476 and P5149 (Table 2.1.8.). PCR product 
was cut with ScaI, and the -770bp fragment gel 
purified. This plasmid was co-transformed into 
W303 cells together with a two-hybrid prey 
plasmid encoding the 5'-end of YBL026w (and 
67bp of 5'-UTR) identified in the Ydr378p screen 
(Section 3.6.). Gap repaired plasmids were 
recovered and verified by sequencing. Plasmid 
contains whole YBL026w, and 67bp of 5'-UTR. 
pAEM56 	Modified pBTM1 16(+1). SPB8 coding sequence 	This work. 
was isolated from a two-hybrid prey plasmid 
(identified in the Yerl46p mini-screen (Section 
3.9.)) as a BamHI fragment, and cloned into the 
BamHI site of pBTM1 16(+1). 
pAEM57 	Modified pBTM1 16(+1). YBL026w coding 	This work. 
sequence was isolated from a two-hybrid prey 
plasmid (identified in a Yjr022p screen (obtained 
from P. Legrain)) as a BamHI fragment, and 
cloned into the BamHI site of pBTM116(+1). 
Insert starts at nt 3 of the coding sequence, and 
contains the whole ORF, including the intron 
sequence. 
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Description 	 Reference 
pAEM59 Modified 	pBTM1 16(+1). 	YNL147w 	coding This work. 
sequence was generated by PCR using yeast 
genomic DNA as template and primers Gi and 
G2 	(Table 2.1.8.). 	PCR product was 	cloned 
directly into the Smal site of pBTMI 16(+1). 
Insert lacks the intron sequence of the ORF and 
was verified by sequencing. 
pAEM60 Modified pACTIIst. SPB8 coding sequence was This work. 
generated by PCR using a two-hybrid prey 
plasmid (identified in the Yerl46p mini-screen 
(Section 3.9.)) as template and primers BACT5 
and LexRev (Table 2.1.8.). PCR product was 
cloned directly into the Smal site of pACTIIst. 
Insert sequence was verified by sequencing. 
pAEM61 Modified YCpIF16. YDR378c coding sequence This work. 
was isolated from pAEM32 as an EcoRJJNotI 
fragment, and cloned into the EcoRJ and NotI 
sites ofYCpIFl6. 
pAEM62 Modified YCpIF16. YNL147w coding sequence This work. 
was isolated from pAEM59 as an EcoRI/BamHI 
fragment, and cloned into the EcoRI and BamHI 
sites ofYCpIFl6. 
pAEM64 Modified pBM125. HA:USS2 coding sequence This work. 
was isolated from pAEM18 as a BglII fragment, 
and cloned into the BamHI site of pBM125. 
pAEM67 Modified 	pZErO-2. 	YBL026w:HA 	coding This work. 
sequence was generated by PCR using pAEM55 
as template and primers T9476 and 31-lAD I 
(Table 2.1.8.). PCR product was cloned directly 
into the EcoRV site of pZErO-2. Insert contains 
the intron, and was verified by sequencing. 
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Table 2.1.12. cont. 
Modified Vectors. 
Plasmid 	 Description 	 Reference 
pAEM68 	Modified pBM 125. YBL026w:HA coding 	This work. 
sequence was generated by PCR using pAEM67 
as template and primers BAMD 1 and Sp6 (Table 
2.1.8.). PCR product was cut with BamHI and 
cloned into the BamHI site of pBM 125. Insert 
contains the intron, and was verified by 
sequencing. 
pAEM70 	Two-hybrid library prey plasmid containing 	P. Legrain, 
YER146w coding sequence from nt -2 to 276 Paris 
(relative to the AUG). Identified in LexA: 
Yjr022p screen (Clone #99). 
pAEM71 	Two-hybrid library prey plasmid containing 	This work. 
YJR022w coding sequence from nt -2 to beyond 
the end of the coding sequence. Identified in 
LexA:Ydr378p screen (Clone #20) (Section 3.6.). 
pAEM72 	Two-hybrid library prey plasmid containing 	This work. 
YNL147w coding sequence from nt -51 to 414 
(relative to the AUG). Plasmid also contains two 
two-hybrid library linkers upstream of YNL147w 
sequence. Identified in LexA:Ydr378p mini-
screen (Clone #F) (Section 3.5.). 
pAEM73 	Two-hybrid library prey plasmid containing Fromont-Racine 
YER029c coding sequence from nt 5 to beyond 	etal., 1997 
the end of the coding sequence. Identified in 
Gal4:Smd3p screen (Clone #9). 
pAEM74 	Two-hybrid library prey plasmid containing 	This work. 
PRP1J coding sequence from nt 195 to 675 
(relative to the AUG). Identified in Gal4:Usslp 
screen (Clone #5) (Section 3.3. and Section 6.2.). 
pAS2AA 	Modified pAS2. Two-hybrid bait plasmid deleted Fromont-Racine 
for the CYH2 gene and the HA-epitope. 	 et al., 1997. 
pAS2AABg 	Modified pAS2AA. Frame shifted two-hybrid bait 	A. Colley, 
plasmid. In (4) reading frame. 	 this lab. 
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pAS2A/C 	Modified pAS2AA. Frame shifted two-hybrid bait 	A. Colley, 
plasmid. In (+1) reading frame. 	 this lab. 
pBTM116(-1) Modified pBTM116. Frame shifted two-hybrid R. van Nues, 
bait plasmid. In (-1) reading frame. this lab. 
pBTM1 16(+1) Modified pBTM1 16. Frame shifted two-hybrid R. van Nues, 
bait plasmid. In (+1) reading frame. this lab. 
pACTIIst Modified 	pACTII. 	Two-hybrid 	prey plasmid Fromont-Racine 
containing 	linker 	encoding 	multiple STOP etal., 1997. 
codons. 
pAS2: Modified pAS2M: Two-hybrid bait plasmid Fromont-Racine 
PRP9 encoding PRP9 open reading frame. et al., 1997. 
pAS2AA: Modified pAS2AA: 	Two-hybrid bait plasmid Fromont-Racine 
PRPJJ encoding PRPJJ open reading frame. etal., 1997. 
pAS2AA: Modified pAS2AA: 	Two-hybrid bait plasmid Fromont-Racine 
PRP21 encoding PRP21 open reading frame. et al., 1997. 
pAS2i\A: Modified pAS2&: 	Two-hybrid 	bait plasmid Fromont-Racine 
SMB encoding SMB (YER029c) open reading frame. et al., 1997. 
pAS2AA: Modified pAS2zA: 	Two-hybrid 	bait plasmid Fromont-Racine 
SMDJ encoding SMDJ open reading frame. et al., 1997. 
pAS2AA: Modified 	pAS2zA: 	Two-hybrid 	bait plasmid Fromont-Racine 
SMD3 encoding SMD3 open reading frame. etal., 1997. 
pAS2A: Modified pAS2A: 	Two-hybrid 	bait plasmid Fromont-Racine 
YJR022w encoding YJR022w open reading frame. etal., 1997. 
pBTM1 16: Modified pBTM1 16: Two-hybrid bait plasmid P. Legrain, 
YJR022w encoding YJIR022w open reading frame. Paris 
pACTIIst: 	Modified pACTIIst: Two-hybrid prey plasmid 	P. Legrain, 
PRP9 	 encoding PRP9 open reading frame. 	 Paris 
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Modified Vectors. 
Plasmid 	 Description 	 Reference 
pACTIIst: 	Modified pACTIIst: Two-hybrid prey plasmid 	P. Legrain, 
PRPJ1 encoding PRPJJ open reading frame. 	 Paris 
pACTIIst: 	Modified pACTIIst: Two-hybrid prey plasmid 	P. Legrain, 
PRP21 encoding PRP21 open reading frame. 	 Paris 
pPL12 	Modified YCp50. PRP9 coding sequence and 5'- 	P. Legrain, 
UTR between Hindlil and EagI of YCp50. 	 Paris 
C379 	Modified YEp13. PRPJJ coding sequence and 5'- 	D. Shore, 
UTR between Hindill and BamHI of YEp13. 	 this lab. 
p283 	 Modified pGEM-1. AluI fragment of ACTJ 	O'Keefe etal., 
sequence in pGEM-1. 	 1996 
YEp24-USSJ 	Original SDB23(USSJ) clone isolated in a screen 	Parkes and 
for high copy-number suppressors of dbj2-1. Johnston, 1992. 
Contains the entire SDB23(USSJ) gene with its 
own promoter, and truncated SWI4 gene on a 
BamHI fragment. 
pUSSJ-2 	Modified pFL45S. USSI fragment was isolated M. Cooper, 
from YEp24-USSJ as a Hindill fragment, and this lab. 
cloned into the Hindu! site of pFL45S. 
pMC9 	Modified 	pFL45S. 	USS1A 	fragment 	was M. Cooper, 
generated by PCR, cut with Hindlil and Sall and this lab. 
cloned into the Hindu! and Sail sites of pFL45S. 
pMC 102 	Modified pAEM2. Sm! motif encoding fragment M. Cooper, 
of USSJ (USSJ-A) was generated by PCR, cut this lab. 
with BamHI/EcoRI, and cloned into the BamHI 
and EcoRI sites of pAEM2. 
pMC 103 	Modified pAEM2. Fragments encoding motifs 	M. Cooper, 
Smi and Sm2 of USSJ (USS1-A and USSJ-B, this lab. 
respectively) were generated by PCR, cut with 
BamI-H/EcoRI (for USS1-A) and EcoRJ/Salu (for 
USSJ-B), and cloned into the BamHl and Sail 
sites of pAEM2 in a triple ligation reaction. 
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Modified Vectors. 
Plasmid 	 Description 	 Reference 
pYX1 17 	Modified YEp24. The U6 snRNA gene was 	Hu etal., 1994. 
generated by PCR and cloned with its own 
promoter sequence between the Smal and BamHI 
sites of YEp24. 
pYX172 	Modified YEpI3. The U6 snRNA gene was 	Hu etal., 1994. 
generated by PCR and cloned with its own 
promoter sequence between the Hindlil and 
BamHT sites ofYEpl3. 
YCpXba 	Modified YCp50. Contains a 3,500bp XbaI 	Shannon and 
fragment harbouring the PRP24 coding sequence Guthrie, 1991. 
with upstream and downstream sequences. 
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2.1.8. Antisera. 
The antisera used in this work are described in Table 2.1.13. 
Table 2.1.13. 
Antisera. 
Antibody 	Description 	 Reference 
Anti-Ussi 	Rabbit polyclonal antibodies raised against a j3- 	Cooper etal., 
galactosidase-Uss 1 fusion protein, containing the 1995. 
entire 187 amino acid Ussip. 
1:5,000 dilution for Western Blots. 
25j.tl per immunoprecipitation. 
Anti-HA 	Mouse monoclonal antibodies raised against the 	D. Xu, Univ. 
haemagglutinin HA-i protein epitope of the of Toronto. 
influenza virus. 
1:10,000 dilution for Western blots. 
1 jJ per immunoprecipitation. 
Anti-Pati 	Rabbit polyclonal antibodies raised against amino 	Rodriguez- 
acids 7-18 of Patip fused to keyhole limpet Cousino etal., 
haemocyanin. 	 1995. 
1:5,000 dilution for Western Blots. 
25jil per immunoprecipitation. 
Anti-Ga14 	Rabbit polyclonal antibodies. 	 Santa Cruz 
DNA-BD. 1:1,000 dilution for Western blots. 	 Biotechnology. 
Anti-Rabbit 	Anti-rabbit IgG (Fe) Alkaline Phosphatase 	Promega. 
IgG-AP 	conjugate. 
1:7,500 dilution for Western Blots. 
Anti-Rabbit 	Anti-rabbit IgG Horse Radish Peroxidase linked 	Amersham. 
IgG-HRP whole antibody (from donkey). 
1:5,000 dilution for Western Blots. 
Anti-Mouse 	Anti-mouse IgG Horse Radish Peroxidase linked 	Amersham. 
IgG-HRP whole antibody (from sheep). 
1:5,000 dilution for Western Blots. 
2.2. Microbiological Methods. 
2.2.1. Growth of Strains. 
2.2.1.1. Growth of Bacteria. 
E. coil strains were routinely grown at 37°C in rich LB or minimal M9 media 
(Table 2.1.1.). To maintain selection for plasmid DNA, transformed bacteria were 
grown in medium containing the appropriate antibiotic (Table 2.1.2.). 
2.2.1.2. Growth of Yeast. 
Yeast strains were routinely grown at 30°C on YPDA or YPGa1A (Table 2.1.3.). 
To maintain selection for plasmid DNA, and/or for a metabolic reporter gene 
inserted on the genome, cells were grown at 30°C on YMM or YMGa1 (Table 
2.1.3.) supplemented with the appropriate drop-out powder or nutrients (Section 
2.1.2.5.). Temperature-sensitive yeast strains were routinely grown at 23°C, in the 
appropriate medium for that strain. 
2.2.2. Preservation of Strains. 
2.2.2.1. Preservation of Bacteria. 
E. coil strains were stored for up to two weeks on solid medium at 4°C. Strains 
were stored indefinitely at -70°C in 15% (v/v) glycerol. A stationary culture of the 
strain to be frozen was grown in appropriate medium. Eight hundred microlitres of 
culture was mixed with an equal volume of sterile 30% (v/v) glycerol and snap-
frozen on dry ice. 
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2.2.2.2. Preservation of Yeast. 
Yeast strains were stored for up to four weeks on solid medium at 4°C. Strains 
were stored indefinitely at -70°C in 15% (v/v) glycerol. A culture of the strain to be 
frozen was grown to mid-logarithmic phase in appropriate medium. Eight hundred 
microlitres of this culture was mixed with an equal volume of sterile 30% (v/v) 
glycerol and snap-frozen on dry ice. 
2.2.3. Sporulation of Yeast. 
2.2.3.1. Growth of Diploid. 
Diploid yeast cells of the strain to be sporulated were grown on solid medium. 
Cells were patched onto solid sporulation medium (Table 2.1.3.) supplemented with 
the nutrients (Table 2.1.4.) required for the growth of the diploid strain. Plates were 
incubated at 23°C to induce sporulation and tetrad formation. Cells were examined 
microscopically to determine if sporulation and tetrad formation had occurred. 
2.2.3.2. Tetrad Dissection. 
Upon successful sporulation and tetrad formation, cells were scraped from the 
sporulation plate with a toothpick and resuspended in 500p1 of sterile, distilled 
water. The cells were washed twice in sterile, distilled water and resuspended in 
100p.1 of sterile, distilled water. To this suspension, 3-5t1 of -glucuronidase (10 
Units/p 1 stock solution) was added, mixed gently and incubated at room temperature 
for 30-60 minutes. Cell wall digestion was assayed microscopically during the 
incubation period. Tetrads were dissected using a Singer MSM system micro-
manipulator, on YPDA or YPGa1A medium (Table 2.1.3.). In those cases where the 
diploid cells carried a plasmid, spores were dissected on YMM or YMGa1 medium 
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(Table 2.1.3.) containing the appropriate drop-out powder to maintain selection for 
the plasmid. After dissection, spores were incubated at 23°C for 4-8 days. 
2.2.3.3. Random Spore Analysis. 
Upon successful sporulation and tetrad formation, cells were scraped from the 
sporulation plate with a toothpick and resuspended in 500t1 of sterile, distilled 
water. To this tube, 500p.l of water-saturated diethylether was added, and vortexed 
for 60 seconds. Phase separation was allowed to occur for 5 minutes at room 
temperature. The (upper) ether phase was removed, and 50p.l  samples from the 
aqueous phase were spread on solid medium supplemented as appropriate. Plates 
were incubated at 23°C for 4-8 days. 
2.2.3.4. Determination of Mating-Type. 
Following tetrad dissection, haploid progeny (usually Leu-, Lys+) were 
propagated on solid media (Table 2.1.3.). KY1 17 and KY1 18 cells (Leu+, Lys-); 
(Table 2.1.7.) were simultaneously propagated on YPDA (Table 2.1.3.), and replica-
plated onto those cells of undetermined mating type on YPDA medium. Plates were 
incubated overnight at 30°C and replica-plated to YMM -LK. Plates were incubated 
at 30°C. Only those cells which had undergone successful mating were able to grow. 
The mating type of the haploid progeny could thus be determined since only MATa 
cells can mate with KY 118 (MA Ta), and only MA Ta cells can mate with KY 117 
(MA Ta). 
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2.2.4. Transformation of E. coli. 
2.2.4.1. Preparation of Electro-competent Cells. 
E. coli cells were taken from a stock at -70°C and grown overnight at 37°C on 
solid LB medium (Table 2.1.1.). A single colony from this plate was inoculated into 
5m1 of LB liquid medium and grown at 37°C overnight. This culture was used to 
inoculate 500m1 of pre-warmed LB liquid medium to an optical density at 600nm of 
0.1 units. The culture was incubated at 37°C until the 0D 600 was 0.6 units. At this 
point, cells were placed on ice for 15 minutes, prior to sedimentation (in pre-chilled 
bottles) for 20 minutes at 4,200 rpm (4°C; Beckman 10.500 rotor). Cells were 
washed twice in 500m1 of pre-chilled sterile, distilled water and sedimented as 
before. Cells were then washed twice in 250m1 of pre-chilled 10% (v/v) glycerol 
and sedimented as before. Cells were finally resuspended in 2m1 of 10% (vlv) 
glycerol (pre-chilled) and aliquoted into Eppendorf tubes on ice (40jil aliquots). 
Cells were then snap frozen on dry ice and stored at -70°C. 
2.2.4.2. Transformation of Electro-competent E. coli cells. 
Electro-competent cells were thawed on ice, and mixed with up to 1 OOng of 
transforming DNA. Cells were then transferred to a pre-chilled electroporation 
cuvette (0.2cm electrode gap) on ice. Electroporation was performed using a Biorad 
Gene Pulser II set at 200 ohms, 25F, 2.5Kvolts. Care was taken to ensure that the 
base of the electroporation cuvette was dry prior to electroporation. Immediately 
upon electroporation, lml of SOC (Table 2.1.1.) was added and the cells transferred 
to a fresh Eppendorf tube. Cells were allowed to recover for 60 minutes at 37°C on a 
rotating wheel, prior to sedimentation at 14,000 rpm for 30 seconds. Cells were 
resuspended in 1 OOpi of SOC and spread on solid medium supplemented with the 
antibiotic appropriate to maintain selection for the transformed plasmid. 
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2.2.5. Transformation of Yeast. 
Yeast cells were transformed using the method of Gietz etal. (1992). 
2.2.5.1. Standard Yeast Transformation. 
Yeast cells to be transformed were inoculated into 25m1 of liquid medium (Table 
2.1.3.) and grown overnight at 30°C to 1-2 x 10 7 cells/mi. The cells were then 
diluted in fresh, pre-warmed medium to approximately 2 x 106  cells/mi (approx. 
0D600 0.1) and regrown to 1 x 10 7 cells/mi (approx. 0D 600 0.35). Cells were 
harvested by centrifugation at 3,500 rpm for 3 minutes (Mistral 1000 centrifuge) 
and washed twice in 50m1 of sterile, distilled water. Cells were transferred to an 
Eppendorf tube and washed twice in imi of lx TE/LiAc (made fresh from lOx 
stocks (Table 2.2.1.). Cells were finally resuspended at 2 x 10 9 cells/mi in lx 
TE/LiAc. Fifty microlitres of cell suspension was mixed with ljig of transforming 
DNA and 50tg of single stranded salmon sperm carrier DNA (boiled at 100°C for 5 
minutes prior to use). Three hundred microlitres of 40% PEG solution (made fresh 
from 50% PEG, lOx TE and lOx LiAc stocks (Table 2.2.1.)) was added, vortexed to 
mix and incubated at 30°C for 30 minutes on a rotating wheel. Cells were heat-
shocked at 42°C for 15 minutes then sedimented by centrifugation at 14,000 rpm for 
15 seconds. The pelleted cells were resuspended in lOOjil of lx TE and plated onto 
solid medium supplemented with the appropriate nutrients to maintain selection for 
the transforming DNA (Section 2.1.2.5.). Plates were incubated at 30°C for 2-3 
days. 
lOx TE: 0.1M Tris-HC1, pH 7.5 
0.O1M EDTA 
. lOx LiAc: 1M Lithium acetate adjusted to pH 7.5 with dilute acetic acid. 
. 50% PEG:50% (w/v) PEG 3500. 
All solutions were filter-sterilised. 
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2.2.5.2. Transformation of Temperature-Sensitive Yeast Strains. 
Temperature-sensitive yeast cells were transformed using essentially the same 
method as in Section 2.2.5.1. with the following differences. Temperature-sensitive 
yeast cells were typically grown at 23°C (not 30°C). Similarly, temperature-sensitive 
yeast cells were incubated for 30 minutes at 23°C on a rotating wheel following the 
addition of the transforming DNA. The heat-shock was performed at 42°C, but for 
only 10 minutes, with the cells subsequently plated out and incubated at 23°C for 3-
4 days. 
2.2.6. Direct ORF Replacements in Yeast. 
Replacement of ORFs in yeast was performed using the method of Baudin et al., 
1993. 
A linear DNA fragment was generated by PCR, that comprises either the HIS3 or 
TRPJ gene as marker flanked by approximately 45 base pairs of sequence identical 
to the DNA immediately 5' and 3' to the coding sequence to be replaced. The PCR 
was typically performed with genomic DNA from yeast strain D7 (Table 2.1.7.) as a 
template. The primers used were typically around 65 nucleotides in length (to allow 
for 45 nucleotides of flanking sequence, and 20 nucleotides of sequence to prime the 
amplification of the auxotrophic marker (Table 2.1 .10.)). 
The linear DNA fragment was transformed (Section 2.2.5.) into diploid yeast 
cells of strain BMA38, BMA64 or JDY6 (Table 2.1.7.). Cells were spread on 
medium selecting for the appropriate marker and the plates incubated for up to 5 
days at 3 0°C. Clones growing on these plates were restreaked and analysed by 
Southern Blotting (Section 2.3.4.16.) to confirm the gene replacement. Haploid cells 
carrying the gene replacement were produced by sporulation (Section 2.2.3.) of the 
diploid cells, with the mating type of the haploid cells determined (Section 2.2.3.4.). 
NO- 
2.2.7. Growth Curves. 
Growth curve analysis was performed on yeast cells which were either 
temperature-sensitive, or which had a carbon source dependence. Cells were grown 
in liquid media to mid-logarithmic phase under the permissive conditions (typically 
23°C or in galactose-containing media (Table 2.1.3.). Cells were then harvested, 
washed and resuspended in pre-warmed medium (containing the appropriate carbon 
source) to an 0D 600 of approximately 0.1. Cultures were then incubated at the 
appropriate temperature, with the growth rate followed by measuring the 0D 600 at 
regular intervals, typically every 2 hours. Cultures were diluted with the appropriate 
pre-warmed medium, to keep all 0D 600 reading below 0.8, thereby maintaining the 
cells in logarithmic growth. 
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2.2.8. Yeast Two-Hybrid Screen. 
Yeast two-hybrid screens were performed using the method of Fromont-Racine 
etal., 1997. 
2.2.8.1. Bait Construction. 
Two-hybrid bait fusions were constructed in plasmids derived from pBTM1 16 
(Table 2.1.11.) or pAS2AA (Table 2.1.12.) using standard recombinant DNA 
procedures (Section 2.3.4.). All bait constructs were verified by sequencing prior to 
use, and where possible tested for the expression of the fusion protein, and for the 
functional capacity of that protein. 
The auto-activation properties of each bait construct were tested either by co-
transformation (Section 2.2.5.1.) with FRYL library DNA into CG1945 x Y187 
diploid cells (for pAS2AA baits), or in a "mini-screen", performed essentially as for 
a full screen (Section 2.2.8.2.), but with only approximately one tenth of the number 
of FRYL library-containing cells used in a full screen.. For either case, diploid cells 
were plated onto YMM -LW and YMM -LWH medium (Table 2.1.3.) and the plates 
incubated at 30°C for 3 days. A comparison of the number of clones able to grow on 
YMM -LWH (i.e. diploid cells containing both bait and prey plasmids and 
supporting a two-hybrid interaction) to the number of clones able to grow on YMM 
-LW (i.e. diploid cells containing both bait and prey plasmids) gives an indication of 
the auto-activating potential of the bait construct and of the number of positive 
clones which could be expected from a full coverage of the FRYL library. 
2.2.8.2. Construction of the FRYL Library. 
The FRYL library used in the two-hybrid screens described in this work was 
constructed by Micheline Fromont-Racine in the lab of Pierre Legrain (Fromont-
Racine et al., 1997). 
68 
Genomic DNA was sonicated and treated with three modification enzymes 
(Mung bean nuclease, T4 DNA polymerase and Klenow) to produce blunt ended 
fragments. Adaptors were ligated to these fragments, producing a 3' overhang which 
and were then ligated into the pACTIIst plasmid (Table 2.1.12.) which had 
previously been digested with BamHI and "filled-in" with dGTP by the Vent (Exo) 
polymerase. Library was transformed into E. coli cells MR32, transformant colonies 
were scraped from the plates, pooled and frozen. Cells were stored at -70°C. 
Library DNA was extracted from these bacterial cells and transformed into Yl 87 
cells. Cells were scraped from the transformation plates, pooled and aliquoted. 
Aliquots (imi) were stored in 15% (v/v) glycerol at -70°C. 
2.2.8.3. Mating and Collection of Diploids. 
Bait plasmids were transformed (Section 2.2.5.1.) into their respective carrier 
yeast strains (CG1945 for pAS2AA plasmids; L40 for pBTM1 16 plasmids (Table 
2.1.7.) and propagated on YMM -w medium (Table 2.1.3.). Bait cells were grown 
to an 0D600 of 0.8-1.0 units. An aliquot of Yl 87 cells containing the FRYL library 
was thawed on ice, inoculated into 20m1 of YPDA + Tet (Tables 2.1.2. and 2.1.3.) 
and incubated at 30°C for 15 minutes, with gentle shaking (approximately 120 rpm). 
Bait cells equivalent to 80 0D 600 units (approximately 8 x 108  cells) were mixed 
with the library-containing cells, and the cells concentrated onto twelve Millipore 
filters ( 45mm filters, 0.22p.m) Each filter was washed with 5 ml of fresh YPDA + 
Tet medium and incubated for 5 hours on solid YPDA + Tet medium at 3 0°C. Cells 
were collected by washing from the filters with YMM -LWH (Table 2.1.3.) into a 
total volume of approximately 25m1. Collected cells were mixed thoroughly and 
50il removed for control plates. (These cells were diluted to 1:1000 by serial 
dilution in YMM, and 50d plated onto each of YMM -L, YMM -w and YMM - 
LW medium (Table 2.1.3.). Plates were incubated at 30°C for 2 days (see Section 
2.2.8.4. for calculation of mating efficiency and coverage of the library)). 
The mated cells were spread onto YMM -LWH + Tet medium (Tables 2.1.2. and 
2.1.3.) at about 250tl perplate, and incubated at 30°C for 3 days. 
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2.2.8.4. Calculation of Mating Efficiency and Library Coverage. 
The number of colonies growing after two days on each of the control plates was 
counted. Those colonies growing on YMM -L represent cells (haploid and diploid) 
which contain library plasmid DNA, while those growing on YMM -LW represent 
diploid cells containing both bait and prey (library) plasmid DNA. 
Formula to calculate the mating efficiency: 
Mating efficiency (%) = Number of colonies on YMM -LW x 100 
Number of colonies on YMM -L 
Formula to calculate the library coverage: 
Diploids screened = Colonies on YMM -LW x Dilution factor x Volume of culture. 
In order to cover the full FRYL library, 1.5 x 10 diploids must be screened (see 
Section 3.1.). 
2.2.8.5. Overlay assay. 
Overlay mix for the assay of 3-ga1actosidase activity was prepared fresh from 
stock solutions immediately prior to use. Ten millilitres of overlay mix (maintained 
at 50°C in a water bath) was pipetted gently onto each plate from the two-hybrid 
screen and allowed to set at room temperature. The plates were then incubated at 
30°C and examined at regular intervals (usually every three hours). 
o Overlay mix (Final concs.): 0.5% (w/v) agara 
0.1% (w/v) SDS 
3.5 5% (w/v) Na2HPO4a 
0.2% (v/v) ortho-phosphoric acid 
6% (v/v) Dimethyl formamide 
0.04% (w/v) X-Gal (in dimethyl formamide) 
a autoclaved independently and stored at 65°C until use. 
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2.2.8.6. Filter-lift assay. 
Filter-lift assays were performed as described in Transy and Legrain (1995). 
Filter-lift assay solution (Table 2.2.2) for the detection of 13-galactosidase activity 
was prepared fresh from stock solutions immediately prior to use. Cells were 
transferred to Hybond-C Extra filters (Amersham), and the filters immersed in 
liquid nitrogen for 10 seconds. Filters were placed (cell-side up) onto Whatman 
3MM paper soaked in assay solution, incubated at 30°C and examined at regular 
intervals (usually every two hours). The reaction was stopped by transferring the 
filter to Whatman 3MM paper soaked in STOP solution (Table 2.2.2.) for 60 
seconds, and then to Whatman 3MM paper soaked in sterile water for 60 seconds. 
Z-buffer: 100mM NaPO 4 , pH 7.5 
10mM KCI 
1mM MgSO4 .7H20 
Sterilised by autoclaving. 
• Assay solution: 0.27% (v/v) 3-mercaptoethanol 
0.04% (w/v) X-Gal (in dimethyl formamide) 
Prepared in Z-buffer. 
• STOP solution: lM Na 2CO3 
Sterilised by autoclaving. 
2.2.8.7. Analysis of Positive Colonies from Two-Hybrid Screens. 
Colonies which passed all test criteria i.e. His+ and LacZ+ (in overlay and filter-
lift assays) were analysed to identify the library plasmid responsible for the two-
hybrid interaction. Plasmid DNA was rescued from the yeast cells by the method 
described in Section 2.3.4.4., and transformed (Section 2.2.4.) into electro-
competent MC1066 cells (Table 2.1.6.). These cells were plated onto M9 -Leu 
medium (Table 2.1.1.) which allowed growth of only those cells carrying a plasmid 
71 
with the LEU2 marker i.e. library plasmid. The plasmid DNA was propagated in 
these cells and prepared by the method described in Section 2.3.4.1. Insert size was 
determined following restriction digestion (Section 2.3.4.5.) with BamHI (which 
cuts in the library adaptor sequence at both ends of the insert) and agarose gel 
electrophoresis (Section 2.3.4.9.). The fusion between the vector sequence and the 
genomic DNA insert was determined by sequencing as described in Section 
2.3.4.14. The identity of the genomic insert was determined by searches of the 
Saccharomyces Genome Database (SGD) Section 2.4. 
2.2.9. Yeast Two-Hybrid Direct Mating Assay. 
Direct matings were performed as described by Finley and Brent (1994). 
A direct-mating strategy was used to assay potential two-hybrid interactions 
between cloned bait(s) and prey fusions. Yeast strains CG1945 (Table 2.1.7.) 
(transformed with pAS2-based bait plasmids), or L40 (Table 2.1.7.) (transformed 
with pBTM116-based bait plasmids) and Y187 (Table 2.1.7.) (transformed with 
prey plasmids) were grown on selective media (Table 2.1.3.). Bait and prey strains 
were mated by replica-plating onto YPDA (Table 2.1.3.) and incubated overnight at 
30°C. Diploids were grown on medium selecting for both bait and prey plasmids, 
and tested on medium selecting for a successful two-hybrid interaction by 
incubating at 3 0°C. The stringency of the interaction was examined by assaying the 
growth of the diploids on selective medium containing 3-AT ranging from 0 to 
50mM. Assays were also performed to determine 3-galactosidase activity as 
described in Sections 2.2.8.5. and 2.2.8.6. 
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2.3. Molecular Biology Methods. 
2.3.1. General Methods. 
2.3.1.1. Spectrophotometric Determination of Nucleic Acid 
Concentrations. 
The concentration of DNA or RNA was determined by measuring the absorption 
of diluted solutions at 260nm using a Cecil CE 2040 spectrophotometer, and a 
quartz cuvette. For double-stranded DNA an 0D 260 value of 1.0 represents a DNA 
concentration of 50jig/ml. For single-stranded RNA an 0D 260 value of 1.0 
represents an RNA concentration of 40jtg/ml. 
DNA purity was determined by measuring the absorption at wavelengths of 
260nm and 280nm. Protein-free preparations of DNA and RNA should give an 
0D260:0D280 ratio close to 1.8 and 2.0 respectively. 
2.3.1.2. Spectrophotometric Determination of Protein Concentrations. 
Protein concentrations were determined by the Bradford method using Bio-Rad 
protein detection solution as instructed by the manufacturer. BSA was used as 
standard. 
2.3.1.3. Extraction with Phenol :Chloroform:IAA 
Nucleic acids were separated from solutions also containing residual proteins by 
adding an equal volume of phenol: chloroform: indole acetic acid (25:24:1), 
vortexing for 5 seconds and centrifuging at 14,000 rpm for 2 minutes. The upper, 
aqueous phase contained the nucleic acids and was removed to a fresh tube. 
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2.3.1.4. Precipitation of Nucleic Acids. 
Nucleic acids were precipitated from solution by mixing with 2.5 volumes of 
ethanol, containing 0.12M NaOAc (pH 5.2) and freezing for 10 minutes at -70°C. 
Nucleic acids were sedimented by centrifugation at 14,000 rpm for 10 minutes at 
4°C with the pellet then washed in 70% (v/v) ethanol. The pellet was dried under 
vacuum and resuspended in the appropriate volume of lx TE (Table 2.1.6.). 
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2.3.4. DNA Methods. 
2.3.4.1. Small Scale Preparation of Plasmid DNA by Alkaline Lysis. 
This method is based on the alkaline lysis method of Zhou et al. (1990). 
Five millilitres of LB medium (Table 2.1.1.) supplemented with the appropriate 
antibiotic (Table 2.1.2.) was inoculated with a single colony of the plasmid-bearing 
E. coil strain and incubated overnight at 37°C with constant shaking. Three 
millilitres of the culture were centrifuged at 14,000 rpm for 30 seconds, the 
supernate decanted and the cell pellet resuspended in the residual medium. Three 
hundred microlitres of TENS solution was added and the mixture vortexed for 5 
seconds. One hundred and fifty microlitres of 3M NaOAc (pH 5.2) was added and 
the mixture was again vortexed for 5 seconds. Cell debris and chromosomal DNA 
were pelleted by centrifugation at 14,000 rpm for 2 minutes, and the plasmid DNA 
extracted from the supernate with phenol:chloroform:IAA (Section 2.3.1.3.). The 
aqueous phase was removed to a fresh tube, and the plasmid DNA precipitated with 
ethanol and dried (Section 2.3.1.4.). The pellet was resuspended in 50p1 of 
TE/RNase A and stored at -20°C. 
. TENS solution: 10mM Tris-HC1, pH 7.5 
1mM EDTA 
100mM NaOH 
0.5% (w/v) SDS. 




2.3.4.2. Small Scale Preparation of Plasmid DNA by Spin Column. 
For automated DNA sequencing (Section 2.3.4.15.) plasmid DNA was prepared 
using the QlAprep kit (QIAGEN), following the manufacturers' guidelines. DNA 
was extracted from 3m1 of cells, resuspended in 50p.l of lx TE and stored at -20°C. 
2.3.4.3. Large Scale Preparation of Plasmid DNA. 
Five hundred millilitres of LB medium (Table 2.1.1.) supplemented with the 
appropriate antibiotic (Table 2.1.2.) was inoculated using 1 ml of a plasmid-bearing 
E. coli culture, and incubated overnight at 37°C with constant shaking. Cells were 
harvested by centrifugation at 5,000 rpm for 10 minutes (Beckman JLA 10.500 
rotor) and resuspended in 4m1 of GTE. To this cell suspension, imi of lysozyme (25 
mg/ml in GTE) was added, mixed and incubated at room temperature for 10 
minutes. Ten millilitres of 0.2M NaOH/1% SDS solution was added, mixed and 
incubated on ice for 10 minutes, followed by addition of 7.5m1 of 5M KOAc. This 
lysed cell suspension was mixed and incubated on ice for 10 minutes. Cell debris 
and chromosomal DNA were pelleted by centrifugation at 12,500 rpm for 20 
minutes (4°C; Beckman JA25.50 rotor), and the supernate decanted to a fresh tube. 
Isopropanol (0.6 volumes) was added, mixed and the tube centrifuged at 4,000 rpm 
for 15 minutes (Mistral 1000 centrifuge). The pellet was washed with 5 ml of 70% 
(v/v) ethanol and dried under vacuum. Once dried, the pellet was fully resuspended 
in 5.49 ml of TNE, and 6.19g of CsC1 and 41 1.il of ethidium bromide (10 mg/mi 
stock solution) added and mixed. The mixture was transferred to Quickseal tubes 
(Beckman) and centrifuged at 45,000 rpm for 16 hours (23°C; Beckman 70.lTi 
rotor). The plasmid DNA band was collected from the CsC1 gradient with a syringe, 
and residual ethidium bromide extracted with water-saturated butanol. Three 
volumes of TNE were added to the ethidium bromide-free solution. Plasmid DNA 
was then precipitated by addition of 2.5 volumes of ethanol, incubation at -70°C for 
60 minutes and centrifugation at 10,000 rpm for 20 minutes (4°C; Beckman JA25.50 
rpm 
rotor). The DNA pellet was washed with 70% (v/v) ethanol, dried under vacuum 
and resuspended in 500 jtl of sterile, distilled water. DNA was stored at -20°C. 
• GTE: 50mM Glucose 
25mM Tris-HC1, pH 8.0 
10mM EDTA. 
• TNE: 10mM Tris-HC1, pH 8.0 
100mM NaC1 
1mM EDTA 
2.3.4.4. Plasmid Rescue! Yeast Genomic DNA Preparation. 
The protocol described below was used for both the extraction/rescue of plasmid 
DNA from yeast cells, and for the preparation of yeast genomic DNA. 
DNA was routinely prepared from 10 ml of mid-logarithmic culture grown in the 
appropriate medium (Table 2.1.3.). Cells were harvested by centrifugation at 3,500 
rpm for 3 minutes (Mistral 1000 centrifuge) and washed twice in 1 OmI of sterile, 
distilled water. Cells were transferred to an Eppendorf tube, pelleted at 14,000 rpm 
for 15 seconds and the supernate discarded. Three hundred milligrams of glass 
beads, 200itl of lysis solution and 200jii of phenol: chloroform: IAA (25:24:1) were 
added, and the tube vortexed for 5 minutes. Two hundred microlitres of sterile, 
distilled water were added, mixed by vortexing briefly and the tube centrifuged at 
14,000 rpm for 3 minutes. The upper phase was removed and the DNA precipitated 
with ethanol (Section 2.3.1.4.) and the pellet dried. 
For recovery of plasmid DNA, the pellet was resuspended in 20j.il of sterile, 
distilled water, with 0.5t1 used to transform electro-competent E. coli cells (Section 
2.2.4.). 
For preparation of yeast genomic DNA, the pellet was resuspended in 100tl of 
lx TE, with 16p1 used for digestion with restriction enzymes for Southern blots, and 
2p1 used as template in a SOp! PCR. 
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• Lysis solution: 2% (v/v) Triton X-100 
1% (w/v) SDS 
100mM NaCl 
10mM Tris-HCL, pH 8.0 
1mM EDTA 
2.3.4.5. Restriction Digests of DNA. 
Restriction endonuclease digestion of DNA was typically performed in volumes 
of 20-100j.il. These contained the requisite quantity of DNA and the appropriate 
buffer (as supplied by the manufacturer) at lx concentration. Between two and five 
units of restriction enzyme were added, with the restriction enzyme volume kept 
below 10% of the total reaction volume. The digest was incubated at the 
temperature recommended by the supplier, typically for a period of 2 hours. The 
products of the digestion were either analysed directly by agarose gel 
electrophoresis (Section 2.3.4.9.) or extracted with phenol: chloroform: IAA (Section 
2.3.1.3.) and precipitated with ethanol (Section 2.3.1.4.) prior to further 
manipulations. 
2.3.4.6. Removal of Phosphates from DNA ends. 
Plasmid DNA digested with restriction endonucleases (Section 2.3.4.5.) was 
incubated with 5 units of Calf Intestinal (Alkaline) Phosphatase (CIP) (for 20jil 
reactions) for 30 minutes at 37°C to remove terminal phosphate groups and thereby 
prevent the recircularisation of the vector DNA. 
2.3.4.7. Amplification of DNA Using the Polymerase Chain Reaction. 
Specific regions of DNA were amplified using the polymerase chain reaction 
(PCR). Template DNA was either a small quantity of plasmid DNA or yeast 
genomic DNA (Section 2.3.4.4.), using commercially produced primers. 
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A typical 50pJ reaction using plasmid DNA as template was as follows: 
lOx Polymerase Buffer 	 5tl 
100mM MgC12 * 
	
1 jtl 
2.5mM dNTPs (dATP, dCTP, dGTP, dTTP) 5il 
Oligonucleotides primer 1 (50pmol/pi) 
	
1 p.1 
Oligonucleotides primer 2 (50pmol/tl) 
	
1 p.1 
Template DNA (1 Ong/pi) 
	
1 p.1 
DNA polymerase (2U/ixl) 
	
1 p.1 
Sterile distilled water 
	
35 p.1 
* MgC12 concentration was titrated to 2, 4 or 6 mM as required. 
Reaction mix was overlaid with a drop of mineral oil (Sigma) to prevent 
evaporation during the reaction cycles. 
All PCRs were carried out in a Hybaid Thermal Reactor or in a PTC-100 Hot Lid 
reactor (Genetic Research Instrumentation Ltd), programmed according to the 
length of the desired product, and the annealing temperature of the oligonucleotide 
primers being used. A programme is given below, with typically 30 cycles used. 
Step 1. Denaturation: 95°C for 60 seconds 
Step 2. Primer annealing: 4060oC*  for 45 seconds 
Step 3. Extension: 72°C for 60-180 seconds. 
* calculated for oligonucleotides up to 20 bases in length using the formula: 
Annealing Temperature = [4 (G + C) +2 (A + T)] - 5°C. 
2.3.4.8. Purification of PCR products. 
DNA fragments generated by PCR were purified from oligonucleotide primers, 
nucleotides, polymerases and salts using QlAquick PCR purification columns 
(QIAGEN) as per the manufacturers' protocols. From a 50p.l reaction, purified DNA 
was typically eluted in 30p.l of sterile, distilled water and stored at -20°C. 
at 
2.3.4.9. Agarose Gel Electrophoresis. 
DNA fragments produced by restriction endonuclease digest or generated by 
amplification in PCR were analysed in 0.7-1.5% (w/v) agarose gels. Gels were 
prepared by melting agarose in lx TAE buffer (Table 2.1.5.) and adding ethidium 
bromide to a final concentration of 0.5pgIm1. Samples to be analysed were loaded 
directly using Ficoll loading buffer. 
1 Ox Ficoll loading buffer: 20% (w/v) Ficoll 
1% (w/v/) SDS 
0.25% (w/v) Bromophenol blue 
0.25% (w/v) Xylene cyanol 
100mM EDTA 
2.3 .4.10. Isolation of DNA from Agarose Gel Slices. 
To isolate and purify specific DNA bands from agarose gels, the QlAquick Gel 
Extraction kit (QIAGEN) was used as per the manufacturers' protocols. DNA 
fragments were separated by agarose gel electrophoresis (Section 2.3.4.9.) and the 
bands visualised on a UV transilluminator. The band to be purified was excised with 
a clean razor blade, and purified. DNA was typically eluted in 20.il of sterile, 
distilled water and stored at -20°C. 
2.3 .4.11. Ligation of DNA Molecules. 
Ligations were typically performed in a final volume of 10t1, containing 0.5-1.0 
tg total DNA, lx ligation buffer, 1mM, ATP and 0.5 Units Fast-Link DNA ligase 
(Epicentre Technologies). Vector and insert DNA were present in approximately a 
1:1 or 1:2 ratio. Reactions were allowed to proceed at room temperature for up to 2 
hours before being stopped by 15 minutes incubation at 70°C. Between 0.5-2 j.ii of 
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the reaction mix were used to transform electro-competent E. coli cells (Section 
2.2.4.2.). 
2.3.4.12. Radio-labelling of DNA Fragments by Random Priming. 
DNA fragments were radio-labelled using the random priming method of 
Feinberg and Voigeistein (1983; 1984). 
The DNA fragment to be radiolabelled was prepared by restriction digest 
(Section 2.3.4.5.) or generated by PCR (Section 2.3.4.7.) and gel purified (Section 
2.3.4.10.).. Sterile distilled water was used to increase the volume of the DNA 
solution (typically containing 50-100ng of DNA) to 27tl, and the solution boiled 
for 5 minutes the stored on ice. The random priming reaction was prepared as 
follows and incubated for 6-8 hours at room temperature: 
Denatured DNA in water 27p1 
Oligo.-iabeliing buffer (OLB*) 1 Opi 
BSA (2mg/mi) lOp! 
[a-32P] dCTP (-'5000Ci/mmoi) 3pi 
Klenow DNA polymerase I 2 units 
* OLB consists of a 1:2.5:1.5 mixture of soiutions A:B:C prepared as follows and 
stored at -20°C: 
Solution A: 1 8jil -mercaptoethano1 pius 5p.l each of 100mM dATP, dGTP and 
dTTP diluted to lmI with solution 0. Stored at -20°C. 
Solution B: 2M HEPES buffer, pH 6.6 (adjusted with NaOH). Stored at -20°C. 
Solution C: Random hexadeoxyribonucleotides (Pharmacia) at 90 OD Units/mi in 
sterile, distilled water. Stored at -20°C. 
Solution 0: 1.25M Tris-HC1, pH 8.0, 0.125M MgCl 2 
Random primed DNA was separated from unincorporated nucleotides using a 
NAP-S column (Pharmacia) according to the manufacturer's protocol. 
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2.3.4.13. End-labelling of Oligonucleotides. 
Oligonucleotides were labelled in a 20p.l reaction at 37°C for 45 minutes using 
NEB T4 polynucleotide kinase (PNK). The reaction mix was prepared as follows: 
Oligonucleotide 	 1 Opmoles (volumes vary) 
lOx T4 PNK buffer 	 2.0p.l 
T4 PNK (1OU/pi) 	 0.5j.il 
[y-32P] ATP (-5 000Ci/mmol)* 	2.0p.l 
Volume was adjusted to 20tl with sterile, distilled water. 
* Replaced by 5j.xl of 2mM ATP for non-radioactive kinasing of oligonucleotides. 
2.3.4.14. Manual DNA Sequencing. 
All manual DNA sequencing was carried out using the Sequenase Version 2.0 
sequencing kit (USB) according to the manufacturer's protocol. All sequencing was 
performed on double-stranded template DNA prepared by the "TENS" mini-prep 
method (Section 2.3.4.1.). 
Preparation of Template DNA. Ten microlitres of double-stranded DNA was 
mixed with lOp.l of sterile, distilled water and 20p1 of 2x denaturation buffer (0.4M 
NaOH, 0.4mM EDTA). The mixture was incubated at 37°C for 20 minutes, 100tl of 
ethanol and 4p.l of NaOAc, pH 5.2 added, and the mixture placed on dry ice for 10 
minutes. DNA was pelleted by centrifugation at 14,000 rpm for 10 minutes at 4°C 
and dried under vacuum. 
Primer Annealing Reaction: The pellet was resuspended in lOp.l of lx reaction 
buffer (2il 5x Sequenase reaction buffer, 1 j.il primer (1 .Opmol), 7pJ sterile, distilled 
water) and incubated at 37°C for 30 minutes. The samples were placed on ice until 
use. 
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Labelling Reaction: A labelling reaction mix was set up as follows, adding the 
components in the order given: 
0.1M DTT 
	
1 . 0J-t 1 
dGTP labelling mix (diluted 1:5 with water) 	2.0pi 
[a-35S] dATP (-1000Ci/mol) 	 0.5p.l 
Sequenase enzyme (diluted 1:8 with dilution buffer) 	2.0pi 
Labelling mix (5.5j..tl) was added to annealed primer/templates and the mixture 
incubated at room temperature for 5 minutes. 
To read sequences closer to the primer, 0.25-1 .Otl of Mn buffer was added in the 
labelling mix, and the reactions performed as normal. 
Termination Reactions: For each template to be sequenced, four Eppendorf tubes 
were labelled "G", "A", "T" and "C" respectively and 2.5.tl of each of the four 
ddNTP termination mixes were added into the appropriately labelled tube. These 
tubes were incubated at 37°C during the 5 minutes of the labelling reaction. 
Termination was initiated by adding 3.5p1 of the labelling reaction to each of the 
pre-warmed ddNTP tubes. The solutions were mixed and incubated at 37°C for 8 
minutes. The reactions were stopped by the addition of 4j.il of STOP solution (98% 
formamide, 10mM EDTA. 0.025% xylene cyanol, 0.025% bromophenol blue). 
Reactions were stored at -20°C until required for electrophoresis. 
The sequencing reactions were heated to 90°C for 3 minutes immediately before 
loading onto a 6% (w/v) denaturing polyacrylamide gel (National Diagnostics 
Sequagel-6: Sequagel complete buffer reagent (4:1)). Gels were run with lx TBE 
buffer (Table 2.1.5.) at 35mA for 2-4 hours then dried on a vacuum drier (Hybaid) 
at 80°C for 60 minutes. Sequence was visualised by autoradiography. 
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2.3.4.15. DNA Sequencing by PCR-mediated Cycle Sequencing. 
Plasmid DNA to be sequenced was prepared using the QlAprep spin columns 
(Section 2.3.4.2) and quantitated by visualisation on an agarose gel. Reactions were 
performed with the dRhodamine terminator cycle sequencing kit (Perkin Elmer) in a 
PTC-100 Hot Lid reactor (Genetic Research Instrumentation Ltd). 
A typical reaction mix was set up as follows: 
Template DNA (0.5pg) 	4.0j.il 
Terminator mix 	 4.Oj.il 
Primer (1 .Spmol) 	 2.0pi 
Twenty-five cycles as described below were performed: 
Step 1: 96°C for 30 seconds 
Step 2: 50°C for 15 seconds 
Step 3: 60°C for 4 minutes 
DNA was precipitated from the reaction mix by adding 25pJ of ethanol and 1 j.d of 
3M NaOAc, pH 5.2., incubating on ice for 15 minutes followed by centrifugation at 
14,000 rpm for 15 minutes at 4°C. The pellet was washed with 250p1 of 70% (v/v) 
ethanol and dried under vacuum. Samples were run by Nicola Preston (University of 
Edinburgh) on an ABI PRISM 377 DNA sequencer and the sequence analysed using 
the Gene Jockey II programme on a Macintosh computer. 
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2.3.4.16. Southern Blotting Analysis. 
Yeast genomic DNA was prepared (Section 2.3.4.4), digested with the required 
•restriction enzymes (Section 2.3.4.5.) and electrophoresed through an agarose gel 
(Section 2.3.4.9.). The gel was immersed in denaturing buffer (0.5M NaOHJ 1.5M 
NaC1) for 45 minutes with gentle agitation, then transferred to neutralisation buffer 
(1.5M NaCl, 0.5M Tris-HC1, pH 7.5, 1mM EDTA) for 45 minutes with gentle 
agitation. 
Transfer of DNA from Agarose Gels to Nylon Membranes. Hybond-N nylon 
membrane (Amersham) and four sheets of Whatman 3MM paper were cut to the 
same size as the gel. One strip of Whatman 3MM paper was saturated with 20x SSC 
(Table 2.1.5) and placed over a clean glass plate arranged so that it hung over the 
edge of the plate with the ends of the paper in a plastic tray containing 20x SSC. 
The pre-treated gel was placed on top of the saturated Whatman 3MM paper and 
Saran wrap carefully placed on top of regions of the paper left uncovered by the gel 
to prevent unnecessary evaporation. The nylon membrane was placed on top of the 
gel, and the four sheets of pre-cut Whatman 3MM paper were saturated in 20x SSC 
and placed on top of the membrane. On top of this, 2-4 cm of dry paper towels were 
arranged, and the whole structure weighted to provide even pressure. Transfer was 
allowed to take place overnight. After the transfer was complete, the membrane was 
briefly rinsed in 20x SSC, blotted dry, and UV-irradiated in a Stratagene UV 
Stratalinker using the "autocrosslink" setting (1200 mjoules, 254nm) to immobilise 
the DNA to the filter. 
Hybridisation of Randomly-labelled Probes to Nylon Membranes. Hybridisations 
were performed in Hybaid 'Hybridiser ovens' using an adaptation of the method of 
Church and Gilbert (1984). 
The nylon membrane was pre-hybridised in 20 ml of SES 1 Buffer for at least 1 hour 
at 65°C to prevent non-specific hybridisation of the probe to the membrane. Fresh 
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SES 1 buffer was added to the membrane immediately before the addition of the 
radiolabelled probe. The labelled probe (Section 2.3.4.12.) was added to the SES1 
buffer and the incubation continued overnight at 65°C. The following morning the 
probe was decanted off and stored at —20°C for possible re-use. The membrane was 
then washed with SES2 for 20 min at 60°C four times, with fresh buffer for each 
wash. The membrane was then blotted dry, placed between Saran wrap, and the 
result of the experiment visualised by autoradiography. 
. SES1 Buffer: 	7% (w/v) SDS 
1 mM EDTA 
0.5 M Sodium phosphate buffer, pH 7.2. 
. SES2 Buffer: 	5% (w/v) SDS 
1 mM EDTA 
40 mM Sodium phosphate buffer, pH 7.2. 
Membrane Stripping for Re-probing. For successful removal of probes, membranes 
were never allowed to dry during or after hybridisation and washing. A boiling 
solution of 0.1% (w/v) SDS was poured onto the Hybond-N nylon membrane to be 
stripped and allowed to cool to room temperature. The membrane was blotted dry 
and stored between Saran wrap for future use. 
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2.3.5. RNA Methods. 
2.3.5.1. Total RNA Preparation from Yeast. 
Total Yeast RNA was prepared using the method of Schmitt et al. (1990). 
Ten millilitres of appropriate medium (Table 2.1.3.) were inoculated with a 
single colony of the yeast strain and incubated at the appropriate temperature. The 
cells were harvested by centrifugation at 3,500 rpm for 3 minutes (Mistral 1000 
centrifuge) and resuspended in 400tl of EA buffer (50mM NaOAc, 10mM EDTA). 
Forty microlitres of 10% (w/v) SDS were added to the cell suspension and vortexed 
to mix. Five hundred microlitres of phenol, equilibrated with EA buffer, was added, 
mixed and incubated at 65°C for 4 minutes. The samples were snap frozen on dry 
ice, and allowed to thaw before centriftigation at 14,000 rpm for 2 minutes. The 
aqueous layer was removed and extracted as described in Section 2.3.1.3. The 
aqueous layer was again removed, and precipitated as described in Section 2.3.1.4. 
The precipitated RNA was dried under vacuum and resuspended in 30.il of sterile, 
distilled water. 
2.3.5.2. Northern Blot Analysis of mRNA. 
Denaturing Agarose Electrophoresis. Gels (1% (w/v)) were prepared by dissolving 
1.5g of agarose in liOmi of water, allowing to cool slightly and adding 15m1 of lOx 
HEPES buffer. The mixture was cooled to 50°C and 25m1 of 37% (v/v) 
formaldehyde added together with 10.i1 of 10mg/mi ethidium bromide. Totai RNA 
was prepared as described in Section 2.3.5.1., mixed with 3x loading buffer and 
heated to 65°C for 5 minutes immediately prior to loading. Electrophoresis was 
performed in lx HEPES running buffer at 5V/cm, with the buffer circulated slowly 
by a peristaltic pump. 
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• lOx HEPES buffer: 0.5M HEPES (adjusted to pH 7.8 with KOH) 
10mM EDTA 
3x Loading buffer: 50% (v/v) formamide 
6% (v/v) formaldehyde 
0.4x HEPES buffer 
0.075% (w/v) bromophenol blue 
0.075% (w/v) xylene cyanol 
10% (v/v) glycerol. 
Transfer of RNA from Agarose Gels to Nylon Membrane. RNA was transferred 
directly from the agarose gel to Hybond-N nylon membrane essentially as described 
in Section 2.3.4.16. For RNA gels however the pre-treatment used was one 45 
minute incubation in 20x SSC. 
Hybridisation of Randomly-labelled Probes to Nylon Membranes. Hybridisations 
were performed as described in Section 2.3 .4.16. 
2.3.5.3. Northern Blot Analysis of snRNAs. 
Polyacrylamide Gel Electrophoresis of RNA. Gels (6% (w/v)) were prepared using 
Sequagel-6 and Sequagel complete buffer reagent (National Diagnostics). RNA 
samples were mixed with an equal volume of sequencing STOP solution (Section 
2.3.4.14.) and heated to 90°C for 3 minutes immediately prior to loading. Gels were 
run in lx TBE (Table 2.1.5.) at 25mA for approximately 45 minutes. 
Transfer of RNA from Polyacrylamide Gels to Nylon Membrane. The RNA was 
transferred electrophoretically to Hybond-N nylon membrane at 60V for 60 minutes 
in 0.5x TBE (Table 2.1.5.). RNA was cross-linked to the membrane after transfer as 
described in Section 2.3.4.16. 
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Hybridisation of End-labelled Oligonucleotide Probes to Nylon Membranes. 
Oligonucleotides, end-labelled as described in Section 2.3.4.13., were hybridised to 
the membrane in SES1 buffer (2.3.4.16) at a temperature 5°C below the 
oligonucleotide annealing temperature (as calculated by 4(G + C) + 2(A + T)). 
Membranes were washed in SES3 buffer at the appropriate temperature. 
. SES3 Buffer: 5% (w/v) SDS 
1mM EDTA 
0.5M Sodium phosphate buffer, pH 7.2. 
2.3.5.4. In vitro Transcription. 
The description given below relates to the production of an RNA antisense to part of 
the pre-mRNA of the ACT] gene. This anti-sense RNA was used in the RNA 
protection assay described in Section 2.3.5.5. 
Preparation of DNA Template. RNase-free plasmid DNA (p283; Table 2.1.12.) was 
linearised by digestion with EcoRJ and an aliquot of the digested DNA analysed by 
agarose gel electrophoresis (Section 2.3.4.9.) to verify that digestion was complete. 
The cleaved  DNA was extracted as described in Section 2.3.1.3., precipitated as 
described in Section 2.3.1.4. and resuspended in sterile, distilled water. 
Transcription Reaction. The transcription reaction was prepared in an Eppendorf 
tube and incubated at 37°C for 45 minutes. 






• Transcription reaction mix: DNA template (-500ng) 	 2tl 





RNasin 1 tl 
[a-32P] UTP (-800Ci/mmol) 2pJ 
Sp6 RNA polymerase 2p1 
Sterile, distilled water 
Pur/lcation of in vitro transcribed RNA molecule. After the transcription reaction 
was complete, 20j.tl of STOP solution (Section 2.3.4.14.) was added and the reaction 
mix, heated to 90°C for 3 minutes and electrophoresed on a 6% (w/v) denaturing 
polyacrylamide gel as described in Section 2.3.5.3. The position of the RNA was 
determined by autoradiography and the band excised from the gel with a sterile 
scalpel blade. The RNA was eluted from the gel slice using the Micro-electroeluter 
(Amicon) apparatus. The RNA was electroeluted for 60 minutes at 200V in 
electroelution buffer (lx TBE, 0.1% (w/v) SDS). The RNA was concentrated by 
centrifugation for 25 minutes at 6000 rpm (Beckmann JA25.50 rotor) using a 
Centricon C-30 concentrator (Amicon). The RNA sample was then extracted as 
described in Section 2.3.1.3. 
2.3.5.5. RNase Protection Assay. 
Total RNA was prepared as described in Section 2.3.5.1. and the concentration 
determined spectroscopically (Section 2.3.1.). Eight micrograms of RNA were 
mixed with excess radiolabelled antisense RNA (Section 2.3.5.4.) and precipitated 
as described in Section 2.3.1.4. The RNA pellet was dissolved in 20p.l of 
hybridisation buffer and vortexed prior to 5 minutes incubation at 80°C. The 
samples were then allowed to cool slowly to 56°C, overnight. After this incubation 
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180tl of RNase solution was added to each tube, and incubated at 23°C for 30 
minutes. Ten microlitres of 10% (w/v) SDS was added to each tube, followed by 
1 jil of 20mg/mi Proteinase K solution. Each sample was vortexed for 10 seconds, 
and incubated at 37°C for 15 minutes. The RNA was then extracted from the 
samples (Section 2.3.1.3.), precipitated (Section 2.3.1.4.) and dried under vacuum. 
The pellets were resuspended in 4j.ii of sterile, distilled water, mixed with an equal 
volume of STOP solution (Section 2.3.4.14.) and heated to 90°C for 3 minutes 
before loading. RNA fragments were separated on 6% (w/v) polyacrylamide gels as 
described in Section 2.3.4.14. The gels were run in lx TBE buffer (Table 2.1.5.) for 
2 hours, dried at 80°C for one hour and visualised by autoradiography. 
• Hybridisation Buffer: 80% (v/v) formamide 
40mM PIPES, pH 6.7 
0.4M NaCl 
1mM EDTA. 
• RNase solution: 10mM Tris-HC1, pH 7.5 
5mM EDTA 
300mM NaCl 
200U/pJ RNase Ti (stock at 100,000U/ml) 
10tg/pi RNase A (stock at lOmg/ml). 
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2.3.6. Protein Methods. 
2.3.6.1. Crude Extraction of Total Cellular Protein from Yeast. 
Five millilitres of appropriate medium (Table 2.1.3.) were inoculated with a 
single colony of the yeast strain and incubated at the appropriate temperature. The 
cells were harvested by centrifugation at 3,500 rpm for 3 minutes (Mistral 1000 
centrifuge) and resuspended in 2001.il of lx SDS loading buffer (Section 2.3.6.3.). 
Fifty microlitres of glass beads were added, and the tubes vortexed for 60 seconds. 
The tubes were incubated at 96°C for 60 seconds and placed on ice for 60 seconds. 
These incubations were carried out three times and the lysates cleared by 
centrifugation at 14,000 rpm for 5 minutes. Samples were incubated at 96°C for 5 
minutes immediately prior to loading on SDS-PAGE gels (Section 2.3.6.3.). 
2.3.6.2. Large Scale Extraction of Total Cell Protein! Splicing Extract. 
Total cell protein preparations or splicing extracts from yeast cells were 
performed as described by Lin et al. (1985) 
Two litres of appropriate medium (Table 2.1.5.) were inoculated with a mid-
logarithmic phase culture of the selected yeast strain, and the culture grown 
overnight with constant shaking, at the appropriate temperature. Cells were 
harvested at an 0D600 of between 0.5 and 1.5 units by centrifugation at 5,000 rpm 
for 10 minutes at room temperature (Beckmann JLA 10.500 rotor). The cell pellet 
was resuspended in 40ml of 50mM potassium phosphate, pH 7.5 and transferred to 
a sterile 50m1 tube. Cells were pelleted at 3,500 rpm for 3 minutes (Mistral 1000 
centrifuge), the supernate discarded and the cells resuspended in 40ml of lyticase 
buffer. The cell suspension was transferred to a 250ml flask, 1 ml of lyticase solution 
containing 2,500 units of enzyme dissolved in water was added and incubated at 
23°C for 3 0-60 minutes with continuous slow shaking until 70-80% of the cells had 
formed spheroplasts, as determined microscopically. 
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Spheroplasts were harvested by centrifugation at 3,500 rpm for 5 minutes 
(Mistral 1000 centrifuge). The supernate was discarded and the spheroplasts were 
washed twice in 30m1 of 1.2M sorbitol and once in ice-cold SB-3 buffer; after each 
wash spheroplasts were pelleted by centrifugation at 3,500 rpm for 5 minutes 
(Mistral 1000 centrifuge). The spheroplast pellet was gently resuspended using a 
sealed sterile Pasteur pipette. After the wash with SB-3, the pellet was weighed, 
resuspended to approximately 1 g/mI in ice-cold Buffer A and transferred to a chilled 
Dounce homogeniser. Spheroplasts were lysed by 10-13 slow, rotating strokes of 
the tight fitting pestle, with the homogeniser maintained on ice. 
The post-homogeniser lysate was transferred to a chilled, sterile beaker and 1/9th 
volume of cold 2M KC1 was added, dropwise. The suspension was continuously 
stirred for 30 minutes at 4°C, transferred to a chilled 1 5m1 polycarbonate tube and 
centrifuged at 17,000 rpm for 15 minutes at 4°C (Beckmann JA25.50 rotor (pre-
cooled to 4°C)). Without disturbing the lipid layer, the supernate was transferred to a 
chilled UltraPlus polycarbonate tube (Nalgene) and centrifuged at 38,000 rpm for 60 
minutes at 4°C (Beckmann 70.1 Ti rotor (pre-cooled to 4°C)). 
The final supernate was transferred to dialysis tubing (Visking size 1-8/32", 12-
l4kDa cut off) and dialysed against two changes of 1.51 of ice-cold Buffer D at 4°C 
over a period of 3 hours. The extract was then transferred to pre-chilled Eppendorf 
tubes, centrifuged at 14,000 rpm for 10 minutes at 4°C and aliquoted into fresh pre-
chilled Eppendorfs. The aliquots were snap frozen on dry ice and stored at -70°C. 
Extracts were stored in 1 00-200d volumes and thawed slowly on ice prior to 
use. Extracts were never thawed and re-frozen more than three times. 
• Lyticase Buffer: 	1 .2M Sorbitol 
50mM Potassium phosphate buffer, pH 7.5 
30mM DTT. 
• SB-3 Buffer: 	1.2M Sorbitol 








. Buffer D: 	20mM HEPES-KOH, pH 7.9 
0.2mM EDTA 
50mM KC1 
20% (v/v) Glycerol 
0.5mM DTT. 
All solutions were prepared in advance and sterilised by autoclaving. DTT was 
prepared fresh and added to each solution immediately before use. 
2.3.6.3. SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE). 
All SDS-polyacrylamide gels were run using two 'sealed' 16 x 16 cm glass 
plates separated by 1.5mm spacers and using 14 well combs. The resolving gel 
solution was prepared, poured between the plates and overlaid with water-saturated 
butanol. The gel was allowed to set at room temperature, the butanol was washed 
off with sterile, distilled water and the stacking gel was poured. After 
polymerisation was complete, the seal was removed from the plates, the comb was 
gently taken out and the wells were washed with distilled water. The plates were 
firmly fixed in the "ATTO" electrophoresis apparatus and the chambers filled with 
lx protein gel rurming buffer. Protein extracts were mixed with an equal volume of 
2x SDS loading buffer, heated to 96°C for 5 minutes and centrifuged at 14,000 rpm 
for 60 seconds. Samples were loaded onto the gel, and run until the bromophenol 
blue dye-front had reached the bottom of the resolving gel. 
• Low Molecular Weight pre-stained protein standards: (Size range 2.85-43.0 kDa) 
were purchased from Gibco BRL. 
• Broad Range Molecular Weight pre-stained protein standards: (Size range 6.5-175 
kDa) were purchased from New England Biolabs. 
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10% Resolving gel: 1 0.5m1 30% (w/v) Acrylamide/ 0.8% (w/v) bis-acrylamide 
9.Oml 1.5M Tris-HCJ, pH 8.8 
11 .55m1 sterile, distilled water 
300p1 10% (w/v) SDS 
3001i1 10% (wlv) Aminonium persulphate (prepared fresh) 
15tl TEMED. 
• 15% Resolving gel: 1 5.75ml 30% (w/v) Acrylamide/ 0.8% (w/v) bis-acrylamide 
9.Oml 1.5M Tris-HC1, pH 8.8 
6.45ml sterile, distilled water 
300p1 10% (w/v) SDS 
300p1 10% (w/v) Ammonium persulphate (prepared fresh) 
100 jtl TEMED. 
• 4.8% Stacking gel: 1 .6ml 30% (w/v) Acrylamide/ 0.8% (w/v) bis-acrylamide 
1.3m1 1M Tris-HC1, pH 6.8 
7.4ml sterile, distilled water 
100 jil 10% (w/v) SDS 
1 OOpi 10% (wlv) Ammonium persulphate (prepared fresh) 
10p.1 TEMED. 
2x SDS loading buffer: 100mM Tris-HC1, pH 6.8 
200mM DTT (added fresh immediately before use) 
4% (w/v) SDS 
0.2% (w/v) Bromophenol blue 
20% (v/v) Glycerol. 
• 1 Ox Protein gel running buffer: 250mM Tris-Base 
2.5M Glycine 
1.0% (w/v) SDS. 
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2.3.6.4. Western Blotting. 
Electrophoretic Transfer of Proteins to PVDF Immobilon-P Membrane. Proteins 
were transferred electrophoretically from the SDS-polyacrylamide gel to 
Immobilon-P membrane (Millipore) using the Bio-Rad transfer system and 
following the manufacturers' instructions. All transfers were performed in lx 
Western transfer buffer at 100V for 90 minutes. Transfer was confirmed by Ponceau 
S staining of the membrane. 
• lOx Western Transfer Buffer: 1.5M Glycine 
200mM Tris-HC1, pH 8.3. 
Antibody Binding. Non-specific protein interactions were blocked by incubating the 
membrane for 60 minutes (at room temperature) in lOOml of blocking buffer (5% 
(w/v) dry milk in lx TBS-T (Table 2.1.5.)), with constant shaking. Primary 
antiserum (Table 2.1.13.) was diluted in 10 ml of fresh blocking buffer, applied to 
the membrane and incubated for 2 hours at room temperature, or overnight at 4°C, 
with constant shaking. The membrane was then washed three times in lx TBS-T 
(Table 2.1.5.) and once in lx TBS (Table 2.1.5.). Each wash was with lOOm! for 10 
minutes. Secondary antiserum (Table 2.1.13) was diluted in 15m1 of blocking 
buffer, applied to the membrane and incubated for 45 minutes at room temperature 
with constant shaking. The membrane was washed as before. 
Immunodetection with Alkaline Phosphatase. Five millilitres of NBT/BCIP stain 
solution were prepared and applied to the membrane. The assay was allowed to 
continue until the development was considered sufficient, and was then stopped by 
removing the stain solution and washing the membrane in sterile, distilled water. 
. NBT/BCIP Stain solution: 0.5ml 1M Tris, pH 9.5 
4.3 ml Sterile, distilled water 
125tl 4M NaC1 
50p.l 0.5M MgCl2 
33p1 NBT (Promega) 
16.5p1 BCIP (Promega). 
Immunodetection with Enhanced Chemiluminescence (ECL). Three millilitres of 
developer solution was prepared as described in the manufacturers' (Amersham) 
protocol, applied to the membrane and incubated for 60 seconds at room 
temperature. Care was taken to ensure the membrane was uniformly covered by the 
developer solution. After incubation the developer solution was removed and the 
membrane was placed in Saran wrap and exposed to photographic film. Exposure 
times were varied depending on the strength of the signal. 
Membrane Stripping and Re-probing. For membranes developed with the ECL 
system, the antibodies could be stripped and the membrane re-probed. Stripping was 
performed by submerging the membrane in SOml of ECL stripping buffer at 50°C 
for 30 minutes. The membrane was then washed three times in large volumes of lx 
TBS-T (Table 2.1.5.). The membrane was blocked, probed and developed as 
described above. 
ECL Stripping buffer: 62.5 mM Tris-HC1, pH 6.7 
2% (w/v) SDS 
100mM 3-mercaptoethano1. 
2.3.6.5. Co-immunoprecipitation of Proteins. 
All protein co-immunoprecipitations were performed from extracts prepared as 
described in Section 2.3.6.2. Extract (-500jig of protein) was made up to 50j.tl with 
lx IP buffer, mixed with antiserum (Table 2.1.13.) and incubated on ice for 60 
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minutes. During this incubation, Protein A-Sepharose (PAS) beads were swollen in 
NTN buffer, washed twice in NTN, and twice in lx IP buffer. PAS beads 
(10mg/sample) were suspended in 200t1 of lx IP buffer, added to the 
extract/antibody sample and incubated for 60 minutes at 4°C on a rotating wheel. 
The suspension was then washed three times with lx IP buffer and the pellet finally 
resuspended in 35jil of lx SDS loading buffer (Section 2.3.6.3.). Samples were 
vortexed, heated at 96°C for 5 minutes and the proteins analysed by SDS-PAGE 
(Section 2.3.6.3.) and Western Blotting (Section 2.3.6.4.). 
. NTN Buffer: 50mM Tris-HC1, pH 7.5 
150mM NaCl* 
0.1% (v/v) NP-40. 




* NaCl concentration was varied between 50-150mM depending on the stringency 
of the interaction under investigation. 
2.3.6.6. Co-immunoprecipitation of snRNAs. 
All protein co-immunoprecipitations were performed from extracts prepared as 
described in Section 2.3.6.2. PAS beads (10mg/sample) were swollen with NTN 
buffer for 15 minutes at room temperature, then washed three times in NTN buffer. 
The beads were resuspended in 150tl of NTN buffer, mixed with the antiserum 
(Table 2.1.13.) and incubated for 60 minutes at room temperature on a rotating 
wheel. One hundred microlitres of blocking buffer were added to each sample and 
the incubation continued for a further 60 minutes. The PAS beads were then washed 
three times in NTN buffer and once in lx IP buffer. Extract (-500g of protein) was 
made up to 50p.l with lx IP buffer, mixed with SOp! of 2x IP buffer, and lOO[d of lx 
IP buffer. The extract mixture was then added to the PAS beads and incubated on a 
rotating wheel for 2 hours at room temperature, or overnight at 4°C. The samples 
were then washed twice in NTN buffer and once in NT buffer. Fifty microlitres of 
proteinase K digestion mix was added to the beads and incubated at 37°C for 30 
minutes. 
The RNA was extracted from the sample by adding 1 OOpJ of sterile, distilled 
water, 100i.l of phenol: chloroform: IAA (25:24:1) and 0.5p1 of tRNA (20mg/mi) 
before vortexing for 10 seconds and centrifugation at 14,000 rpm for 2 minutes. One 
hundred microlitres of the aqueous phase was transferred to a fresh tube and the 
organic phase "back-extracted" with 1 00t1 of sterile, distilled water. The aqueous 
phases were pooled and precipitated with ethanol (Section 2.3.1.4). The pellet was 
dried under vacuum and resuspended in sterile, distilled water. The samples were 
mixed with STOP solution and analysed by denaturing polyacrylamide gel 
electrophoresis and Northern blotting (Section 2.3.5.3). 
• NTN Buffer: 50mM Tris-HC1, pH 7.5 
150mM NaCl* 
0.1% (v/v) NP-40. 
• NT Buffer: 50mM Tris-HC1, pH 7.5 
150mM NaCl*. 




• Blocking buffer: 0.2.ig/pi Glycogen (Boehringer Mannheim) 
0.2tg/pJ BSA (Boehringer Mannheim) 
0.2j.ig/t1 tRNA (Sigma). 
Proteinase K digestion mix: 50mM Tris-HC1, pH 7.5 
5mM EDTA 
1.4% (w/v) SDS 
2j.xg/p.l Proteinase K (Boehringer Mannheim). 
* NaCl concentration was varied between 50-150mM depending on the stringency 
of the interaction under investigation. 
2.4. Computer Analyses. 
Yeast database searches were performed on the Saccharomyces Genome 
Database (SGD) network (http://genome-www.stanford.edulSaccharomycesf ). 
Protein database searches were performed on the NCBI network server using the 
BLAST algorithm (Altschul etal., 1990); (http://www.ncbi.nlm.nih.gov/cgi-binl  
BLAST/nph-blast?Jform=O). 
Multiple protein sequence alignments were performed using the PILEUP 
program (Pearson and Lipman, 1988) in the GCG9 suite of sequence analysis 
programs (Devereux et al., 1984). 
Sequence identities and similarities were identified using the BOXSHADE 3.21 
server (http ://ulrec3 .unil.chlsoftware/B OX_form.html). 
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CHAPTER THREE. 
TWO-HYBRID SCREEN ANALYSIS OF 
SM-LIKE PROTEINS. 
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3.1 Introduction to the Yeast Two-Hybrid System. 
The two-hybrid system is a yeast-based genetic assay for detecting protein-
protein interactions (Fields and Song, 1989; Chien et al., 1991; Fromont-Racine et 
al., 1997; Brent and Finley, 1998 and references therein). 
The assay relies upon the modular nature of transcriptional activator proteins, 
which are composed of two domains, a DNA binding domain (DNA BD) and an 
activation domain (AD); (Brent and Ptashne, 1985). The DNA BD localises the 
activation domain to the promoter region, however, these two domains need not be 
covalently linked in order to function, since activity can be reconstituted through the 
interaction of any two proteins (Fields and Song, 1989). The application of the assay 
requires the construction of two chimeric proteins i) the "bait" protein consisting of 
the DNA BD fused to the protein of interest (X) and ii) the "prey" protein consisting 
of the activation domain fused to the protein (Y) for which the interaction with X is 
being investigated. These two chimeric proteins are expressed in cells containing 
one or more reporter genes which rely upon functional reconstitution of the 
transcriptional activator (and therefore interaction between X and Y) for their 
expression (see Figure 3.1.). 
The two-hybrid system can be used to assay directly if two proteins are capable 
of interacting, or alternatively, by creating a library of prey fusions, screens can be 
performed to identify novel interactions with the bait protein. 
Although the system can be used to assay the interaction between any two 
proteins (which need not be endogenous to the nucleus or to yeast), for yeast 
proteins involved in pre-mRNA splicing the assay is performed within their normal 
physiological compartment thereby circumventing any potential problems caused by 
differences in the nature of the environment of different sub-cellular locations. 
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Figure 3.1. Basis of the two-hybrid assay. (A) The bait hybrid binds to the 
Upstream Activating Sequence (UAS) but cannot activate transcription without the 
activation domain. (B) The prey hybrid cannot localise to the UAS and thus does 
not activate transcription. (C) Interaction between the bait and prey portions of the 
two hybrids in vivo, reconstitutes the activator protein function, thereby resulting in 
expression of the reporter gene(s). -- 
The two-hybrid systems also has a number of advantages over classical genetic 
procedures for identifying and characterising protein-protein interactions. The main 
advantage is the ability to study interactions for which no conditional mutants are 
available. Other approaches rely upon mutant phenotypes to select for suppressor or 
enhancer mutations in genes whose protein products interact, however, in the two- 
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hybrid assay the wild-type sequence can be used. This allows the interaction of 
proteins encoded by non-essential ORFs, or novel proteins for which conditional 
mutants are not yet available to be studied. Similarly, the system can be used to 
identify interactions with prey proteins which are encoded by non-essential ORFs. 
Thus, the two-hybrid assay can identify protein-protein interactions which would be 
missed by traditional genetic screens. 
Furthermore, the availability of the S. cerevisiae genome sequence (Cherry et al., 
1997 and SGD database (see Section 2.4.)) now allows all interacting factors 
isolated in screens to be identified. 
The two-hybrid assay has been used extensively in the work described in this 
thesis in two main ways i) to identify novel factors interacting with the protein of 
interest via screens of a genomic library and ii) to assay directly for interactions 
between two ôloned proteins (or fragments of proteins). 
The baits used are fusions to either the yeast Ga14 DNA BD or to the bacterial 
LexA DNA BD, which exploits another feature of transcriptional activators i.e. that 
the DNA BD and the activation domain need not be from the same parental protein, 
or even from the same organism. For all the tests presented here, the prey fusions 
are to the yeast Ga14 protein activation domain, with the HIS3 and LacZ genes used 
as reporters. 
Some bait fusions are capable of activating transcription of these genes even in 
the absence of interacting prey fusions however, by using the HIS3 reporter, any 
problems of such "auto-activation" can be overcome by adding the competitive 
inhibitor, 3-aminotriazole (3-AT). This chemical is added to the medium used, to a 
level that makes the strain auxotrophic for histidine (even in the presence of the 
auto-activating bait) thereby allowing the interactions of that bait protein to be 
studied. 
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In this study, two-hybrid screens were performed using the mating strategy, 
FRYL library and prey analysis described by Fromont-Racine et al. (1997). 
Modifications of the basic two-hybrid assay by these authors allow rapid and 
exhaustive screens of a yeast genomic library to be performed. The main advantages 
arise from the quality of the library and the way in which the results are analysed. 
The FRYL library comprises 5xl0 6 clones, with randomly generated genomic 
inserts (average size 700bp), and a fusion event predicted to occur (statistically) 
every four bases throughout the genome. This will produce an in-frame fusion on 
average every 24 bases throughout the genome, however Fromont-Racine et al. 
(1997) demonstrated that it is possible to select for and produce frame-shifted 
proteins from "out of frame fusions". The size of the library, and the frequency of 
fusion events allows a greater number of potential interactions to be screened, and 
one would expect to find a given ORF several times as independent clones. 
However, the probability that a given fusion will be selected depends upon both the 
length of the interaction domain, and on the position of that interacting domain 
along the coding sequence. 
From these considerations, all prey are classified into one of five categories 
(Figure 3.2., as defined by Fromont-Racine et al. (1997)). The four A categories 
correspond to fusions beginning within the sequence of an ORF, while the B 
category relates to fusions located in an intergenic region, on the anti-sense strand of 
an ORF, in a non-protein encoding region (rDNA, telomeric DNA, mitochondrial 
DNA) or in a Ty retrotransposon element. The Al category represents the most 
statistically significant interactions, with several fusions found as overlapping 
clones within a single ORF. As such, Al prey share a common region which may be 
used to aid the identification of the interaction domain within the protein. The three 
other A categories represent candidates found only as a single fusion within an 
ORF, even if the same fragment is found several times. The A2 category consists of 
fusions starting close to the initiating codon of an ORF, and within 150 bases of the 
in-frame stop codon located upstream of this ORF. These fusions therefore represent 
amino-terminal interacting domains, and are expected to be under-represented in the 
library due to the presence of the in-frame non-sense codons upstream of the ORF 
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which will interrupt translation. The A3 category represents candidates containing 
large coding inserts (greater than 1 000bp) and may represent prey with large 
interacting domain. This category will also be under represented since the average 
size of library inserts is 700bp. The A4 category represents all candidates in a 
coding sequence which do not fall into one of the other categories. 
The classification of prey found in a screen is only possible due to the 
reproducible experimental protocol which allows complete coverage of the library; 
1 5x1 06  interactions must be screened however the mating strategy typically allows 
exhaustive screens to be performed, with 20-60 million interactions tested. 
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Figure 3.2. C1assification of prey selected in a two-hybrid screen of a yeast 
genomic library. A fragment of a yeast chromosome is represented with a potential 
in frame non-sense codon (,) upstream of the initiation codon of a yeast ORF (open 
box). The putative interacting domain is shown (black box). Arrows indicate the 
position, the length and the orientation of the selected inserts. The categories of prey 
are defined on the right (see text for details). 
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Although both Ga14 and LexA baits have been used in this study, intrinsic 
differences exist between these systems, due to the yeast stains in which the bait 
plasmid is carried. For the Ga14 system, CG1945 cells are used (Table 2.1.7.). These 
cells have a double reporter system, containing both the HIS3 and LacZ coding 
sequences under the control of the GAL] upstream activator sequence (UAS). 
However flocculation problems have been encountered with these cells due to the 
presence of certain bait plasmids. To date no such problems have been experienced 
with the LexA system, and indeed the L40 cells (Table 2.1.7.) used generally give a 
higher mating efficiency than CG1945 cells. However, the L40 cells are not mutant 
for the GAL4 and GAL80 genes, and therefore when mated to Yl 87 cells (Table 
2.1.7.) expression of the LacZ gene (under GAL] UAS control) will be activated. 
Thus L40xY187 diploid cells have only a single reporter system (HIS3), although 
the -galactosidase activity can be used to determine if the mating has been 
successful. 
As part of the TAPIR network (Two-hybrid Analysis of Proteins Involved in 
RNA metabolism) this lab has performed two-hybrid screens with known splicing 
factors in order to identify novel proteins involved primarily in pre-mRNA splicing, 
and possibly to identify links with other cellular processes. 
At the outset of this work, Ussip was the only characterised U6 snRNA-
associated protein. Given its similarity to the Sm proteins, and the lack of other 
proteins identified as associating with U6 snRNA, Ussip was used as the starting 
bait protein for two-hybrid screens to identify novel U6 snRNA-associated proteins. 
During the course of the work, the completion of the S. cerevisiae genome 
sequencing project revealed a number of other hypothetical Sm-like proteins 
(Fromont Racine et al., 1997). As Sm-like proteins and putative splicing factors, 
these proteins and their ORFs were systematically analysed (see Chapters Seven and 
Eight). As part of these analyses, exhaustive two-hybrid screens of the FRYL library 
were performed, using these novel Sm-like proteins as baits. 
Before commencing a full two-hybrid screen, a number of checks were carried 
out on each bait construct. The fusion was always verified by sequencing the DNA 
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at the junction between the vector and the insert (in those cases for which the insert 
was generated by PCR, the whole fragment was sequenced). Where possible, the 
expression of a stable and functional fusion protein and the auto-activating 
properties of this fusion protein were also assayed. 
3.2. Pre-screen Checks of the Ga14:Ussl Fusion Protein. 
Crude extracts were prepared from CG1945 cells carrying the pAEM13 plasmid 
(pAS2Az:USS]) and analysed by Western blot. A single band of the size predicted 
for the Ga14:Ussl fusion protein i.e. approximately 40kDa was detected (Figure 
3.3A.) indicating that it is stably expressed in vivo. 
The functional capacity of the fusion protein was tested in MCY4, a yeast strain 
in which the sole copy of USSJ is under the control of the GALl promoter. Thus 
when plated on glucose medium, MCY4 cells fail to grow due to the depletion of 
Ussip (Cooper et al., 1995). MCY4 cells carrying pAEM13 were able to grow on 
glucose medium, while those with pAS2M alone were not (Figure 3.3B.). This 
suggests that the Ussi portion of the fusion protein is folded with the correct 
structure. 
To test the auto-activating potential of pAEM13, bait plasmid DNA (4g) and 
FRYL library DNA (4p.g) were co-transfonned into CG1945 x Y187 diploid cells. 
Over 3,000 diploids containing both vectors were screened, with only 3 able to 
support a two-hybrid interaction (as assayed by growth on YMM -LWII medium). 
Only one of these clones gave a positive result in a n-gal overlay assay. This clone 
was analysed with those of the full screen (no. 199, see Table 3.1.). Thus, pAEM13 
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Figure 3.3. Analysis of Ga14:Ussl fusion protein. (A) Ga14:Usslp is stably 
expressed. Crude cell extracts were prepared from CG1945 cells (lane 1) and from 
CG1945 cells carrying pAS2AA (lane 2) or pAEM13 (lane 3). Proteins were 
fractionated on a 12% SDS-polyacrylamide gel, electroblotted and probed with 
antibodies against the Ga14 DNA binding domain. Immunodetection was with 
alkaline phosphatase-conj ugated anti-rabbit antibodies. (B) Ga14 : Uss 1 p  is 
functional. Five independent transformants of MCY4 cells transformed with 
pAS2AA or pAEMI3 were suspended in galactose medium and spotted onto 
selective (-LW) galactose and glucose solid media. Plates were incubated at 30°C 
for 3 days. 
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3.3. Two-Hybrid Screen with pAEM13. 
A full two-hybrid screen with pAEM 13 was carried out as described in Section 
2.2.8. A total of 47 x 106  diploids were screened at a mating efficiency of 12.3%. 
Although the mating efficiency was relatively low, the number of diploids screened 
represents 3 libraries-worth of interactions, and the screen can be considered as 
saturating. The 3-gal overlay assay produced a total of 198 colonies displaying a 
"strong" blue colour after 24 hours. A further 108 colonies displayed a paler 
colouration and were not analysed further. Of the "strong blues", 9 clones failed to 
grow after re-streaking to fresh YMM -LWH medium, with a further 14 failing to 
reproduce the positive n-gal activity in a filter-lift assay. An example of this is 
shown in Figure 3.4., with clones 107 and 109 proving negative and being 
discarded. 
110 	102 
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Figure 3.4. Example of filterlift assay. -ga1 filterlifi assays were performed as 
described in Section 2.2.8.6. Colour was allowed to develop for 3 hours at 30°C 
before being stopped. Clone numbers are given around the perimeter of the filter. 
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The 175 clones which passed all three test criteria i.e. His+ and LacZ+ in overlay 
and filterlift assays, were again restreaked to fresh YMM -LWH medium. From 
these plates, the prey plasmids responsible for the two-hybrid interactions were 
rescued and plasmid DNA was prepared and sequenced. The ORF encoded by each 
interacting plasmid, and the nucleotide of the fusion were determined by using the 
BLAST search available at the SGD web site (see Section 2.4.). A total of 169 
clones were successfully sequenced, however 6 clones either failed to give any 
colonies after plasmid rescue, or failed to produce sequence data. Table 3.1. 
summarises the information obtained from this screen. 
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Table 3.1. Results of two-hybrid screen with pAEM13. The prey plasmid inserts are ordered by ORF number. All gene and ORF names are 
given as defined by the Saccharomyces Genome Database, SGD. Identical clones are those with the same start point and insert size. Anti 
relates to fusions which begin on the antisense (i.e. the non-coding DNA strand) of an ORF; Inter relates to fusions which begin in 
intergenic regions; Ribo represents ribosomal DNA; c, Crick DNA strand; w, Watson strand (as defined by SGD); Chr. nt., nucleotide 
position on the chromosome at which the fusion begins; nt from AUG, distance from the start of the coding sequence (A of the initiation 
(AUG) codon) to the point at which the fusion begins. Approximate insert size was determined by BamHI restriction digest and agarose gel 
electrophoresis except in those cases marked with an asterisk(*).  For these examples DNA sequencing revealed the exact end point of the 
fusion. The categories used are as described in Section 3.1. (defined by Fromont-Racine et al., 1997). 
Bait Clone Identical clones Gene  Chr Strandl Chr. nt. nt. from AUGI ORFsize Insert size Category 
Ga14-Uss1 48 51,56,57,59  YAR069c I c 224028 268 294 765* A4 
Ga14-Uss1 48 51,56,57,59 anti YHR216w VIIL c 550668  765 B 
Ga14-Uss1 1 8, 	123 inter YBR082c/YBRO83w _I - w 407213  595* B 
Ga14-Uss1 69  anti YBR097w _I - c 437981  800 B 
Ga14-Uss1 157  anti YBR133c 11 - w 504093  200 B 
Ga14-Uss1 42 44 anti YBR245c _I - w 780237  250 B 
Ga14-Ussl 34 139,158,172,193 anti VBR272c U w 746493  1260 B 
Ga14-Uss1 129  SNF5 YBR289w U w 780699 1076 2718 600 A4 
Ga14-Ussl 49 50,103,108,125 anti YCR067c III w 233119  834* B 
Ga14-Uss1 49 50,103,108,125 inter VCRX10wIYCRX011w III w 233119  834* B 
Ga14-Ussl 180  PATI YCR077c tO c 250299 1055 2394 900 A4 
Ga14-Ussl 5 10,177,181,189 PRPII YDL043c IV c 1 	376325 195 1 	801 1,400 A4 
Ga14-Ussl 89  GOPI I 	YDL145c IV c 196701 250 3606 500 A4 
Ga14-Ussl 96 100 anti YDL164c IV w 165984  1100 B 
Ga14-Uss1 23 162,175,182 anti YDR017c IV w 479337  413* B 
Ga14-Uss1 93  STN1 YDR082w LV w 611744 1264 1485 1700 Al 
Ga14-Uss1 78 88,90 STN1 YDR082w IV w 611789 1309 1485 283* Al 
Ga14-Uss1 97 107 STNI YDF3082w IV w 611798 1318 1485 2300 Al 
Ga14-Uss1 22  YDR289c IV c 1039333 212 1 	1230 250 A4 
Ga14-Uss1 99  YDR386w IV w 1246449 331 1899 987* A4 
GaI4-Uss1 150  YDR452w IV w 1363080 168 2025 350 Al 
Ga14-Uss1 144  YDR452w IV w 1363090 178 2025 600 Al 
Ga14-Ussl 132  YDR485c IV c 1425483 1801 2433 1600 Al 
Ga14-Ussl 138  YDR485c IV c 1425297 1987 2433 455* Al 
Ga14-Ussl 101  inter YDR502cIYDR503c IV c 1454935  150 B 
Ga14-Ussl 63  inter YDR502cIYDR503c IV c 1454938  300 1 	B 
Gal4-Ussl 29  anti YER077c V w 316566  600 B 
Ga14-Uss1 52  anti YER077c V w 316575  450 B 
Ga14-Uss1 135  YER124c V c 407660 1400 1722 200 A4 
GaI4-Uss1 199  XRNI YGLI73c VII C 177529 2586 4587 1655 A3 
Ga14-Uss1 118  anti YHL023c VIII w 60220  900 B 
GaI4-Uss1 166  anti YHR183w VIII C 471142  800 B 
Ga14-Uss1 26  anti YHR208w VIII 	I c 1 	517656  450 B 
Ga14-Uss1 11 13,15,58,61,68,80,92,113,114,126 anti YIL026c IX w 305222  566* B 
Ga14-Uss1 130,133,141,153,179 anti YIL026c IX w 305222  566* B 
Ga14-Ussl 190,196 anti YIL026c IX w 305222  566* B 
Ga14-Uss1 110 165,178  YIL029c LX c 300864 391 429 550 A4 
Ga14-Uss1 82  SCAI YIL099w LX w 178836 835 1650 200 A4 
GaI4-Uss1 81  anti YIR005w IX C 364975  450 B 
Ga14-Ussl 156  GZF3 YJL110c X c 210011 1262 1656 500 Al 
Ga14-Ussl 28  G2F3 YJL110c X c 210087 	1 1187 1656 450 Al 
Table 3.1. Results of two-hybrid screen with pAEM13. The prey plasmid inserts are ordered by ORF number. All gene and ORF names are 
given as defined by the Saccharomyces Genome Database, SGD. Identical clones are those with the same start point and insert size. Anti 
relates to fusions which begin on the antisense (i.e. the non-coding DNA strand) of an ORF; Inter relates to fusions which begin in 
intergenic regions; Ribo represents ribosomal DNA; c, Crick DNA strand; w, Watson strand (as defined by SGD); Chr. nt., nucleotide 
position on the chromosome at which the fusion begins; nt from AUG, distance from the start of the coding sequence (A of the initiation 
(AUG) codon) to the point at which the fusion begins. Approximate insert size was determined by BamHI restriction digest and agarose gel 
electrophoresis except in those cases marked with an asterisk(*).  For these examples DNA sequencing revealed the exact end point of the 
fusion. The categories used areas described in Section 3.1. (defined by Fromont-Racine et al., 1997). 
Bait Clone Identical clones Gene CFF Chr Strand I 	Chr. nt. nt. from AUG I ORF size Insert size Category 
Ga14-Ussl 4 6,168,195,197 FBP26 YJL155c X c 129911 340 1359 800 Al 
GaI4-Ussl 54 112 FBP26 YJL155c X c 129970 364 1359 1000 Al 
GaI4-Ussl 102  FBP26 YJLI55c X c 129977 371 1359 1200 Al 
Ga14-Ussl 20  FBP26 YJL155c X c 130001 430 _lj 1300 Al 
Ga14-Ussl 39  YJR022w X w 469405 -10 387 500 A2 
GaI4-Ussl 3  YJR138w X w 687268 3009 4755 286 A4 
Ga14-Ussl 37  STE6 YKL209c Xl C 43265 3031 3873 450 A4 
Ga14-Ussl 170  inter YKR027w/YKRO28w Xl w 493789  600 B 
Ga14-Ussl 169  anti YKRO45c Xl w 523472  300 B 
GaI4 -Ussl 131  YLL032c XII c 75052 1694 2478 500 A4 
GaI4-Ussl 155  SMD2 YLR275w XII w 694402 158 333+90 800 A4 
Ga14-Ussl 25 74,79,84  YLR386w XII w 894424 798 2643 1447 Al 
Ga14-Ussl 94  YLR386w XII w 1 	894432 806 2643 1439* Al 
GaI4-Ussl 40 41,73,106  YLR386w XII w 1 	894610 984 2643 1700 Al 
Ga14-Ussl 67 85,98 YLR386w XII w 894620 994 2643 1235 Al 
Ga14-Ussl 17 YLR386w XII w 894629 1003 2643 1226 Al 
Ga14-Ussl 43 71 YLR386w XII w 894644 1018 2643 1725 Al 
Ga14-Ussl 192 YLR386w XII w 894656 1030 2643 900 Al 
Ga14-Ussl 18 24,33,95,104,105 YLR386w XII w 894752 1126 2643 1579* Al 
Ga14-Ussl 70 YLR386w XII w 894757 1131 2643 1515* Al 
GaI4-Ussl 136  inter YLRWd6/RDN37-1 XII C 1 	450648  500 B 
GaI4-Ussl 12  anti YML074c XIII w 120867  500 B 
Ga14-Ussl 9 128,137 anti YMR032w XIII C 336632  269 B 
Ga14 -Ussl 134  inter YMR187c/YMR188c XIII w 636004  350 B 
GaI4-Ussl 121 YNL091w XIV w 455882 3475 1 	3723 300 A4 
GaI4-Ussl _86_ 87 PSU1 YNL118c XIV C 405314 249 2913 596 Al 
Ga14-Ussl _16  PSU1 YNL118c XIV c 405301 262 2913 583 Al 
GaI4-Ussl _19 45,91 PSU1 YNL118c XIV c 404905 658 2913 1000 Al 
GaI4-Ussl 21 30,31,36,64,75,76,77,83,111,119,120 PSUI YNL118c XIV C 404835 728 2913 393* Al 
Ga14-Ussl 55  PSUI YNL118c XIV c 404656 907 2913 750 A4 
Ga14-Ussl 161 167,194 anti YNLI56c XIV w 341268  879 B 
Ga14-Ussl 32  G?2 	1 YNL199c XIV c 266015 813 1605 500 A4 
GaI4-Ussl 173  anti YNL31lc/YBR272c XIV w 50564  400 B 
Ga14-Ussl 146  SIN3 YOL004w )(V w 318409 1471 4611 1200 A4 
GaI4-Ussl 38  DCPI VOL149w XV w 44922 -14 696 1300 A2 
GaI4-Ussl 2 35,149 anti YOR059c XV w 438729  643* B 
Ga14-Ussl 183  SLKI9 YOR195w XV w 713663 800 	1 2466 450 A4 
GaI4-Ussl 65 66 STEI3 YOR219c XV c 753746 1095 2793 200 A4 
Ga14-Ussl 191  anti YPL1l8w XVI 	I c 327579  500 B 
GaI4-Ussl 198  anti YPL118w XVI c 327580  500 B 
GaI4-Ussl 47 53,62,72 inter YPL203w/YPL202c XVI w 167986  383* B 
Ga14-Ussl 116  ribo -  800 B 
3.4. Analysis of Proteins Identified in Two-Hybrid Screen with 
pAEM13 (Ussip). 
The protein encoded by the YCR077c/PATJ ORF was identified once as an A4 
candidate for interaction with Uss ip, and was also identified in screens with the 
other Sm-like proteins (see Section 3.7. and Appendix I). See Chapter Four for the 
characterisation of the PAT] ORF, and its protein product. 
The protein encoded by the YDL043cIPRPJJ ORF was identified 5 times as an 
A4 candidate for interaction with Ussip. The Prpl 1 protein is a U2 snRNA 
associated protein (Wells and Ares, 1994), and its proposed interaction with Ussip 
is analysed in Section 6.2. 
The protein encoded by the YDR082w/STN] ORF was identified 6 times as an 
Al candidate for interaction with Ussip. The Stnl protein is 494 amino acids in 
length, with a predicted molecular weight of 57.5kDa. Stnlp has been implicated in 
the regulation of telomere size in association with Cdcl3p (Gradin et al., 1997). 
Analysis of the fragments of Stnlp identified in the two-hybrid screen revealed a 
domain of interaction located within a 55 amino acid portion of the C-terminus of 
the protein (Figure 3.5.). 
The protein encoded by the YDR386w ORF was identified once as an A4 
candidate for interaction with Ussip. It was also identified in two-hybrid screens 
with Prp24p (A. Colley pers. comm.) and with Prpl ip (Fromont-Racine et al., 
1997) and is discussed in Section 6.3. 
The protein encoded by the YDR485c ORF was identified twice as an Al 
candidate for interaction with Usslp. It was also identified in a two-hybrid screen 
with Prp9p (Fromont-Racine et al., 1997) and is discussed in Section 6.3. 
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Figure 3.5. Definition of the region of Stnlp required for the two-hybrid interaction 
with Ussip. (A) The fragments of STNJ identified from the FRYL library are 
shown, with the minimum region of overlap in black, and the nucleotide number 
(relative to the A of the initiation (AUG) codon) at the point of fusion quoted below 
each fragment. (B) The region of Stnlp containing the interaction domain is defined 
and its position and size within the protein sequence is indicated. Numbers represent 
amino acids relative to the initial methionine. 
The protein encoded by the YGL173c/XRNJ ORF was identified once as an A3 
candidate for interaction with Uss ip, in the auto-activation test carried out prior to 
the full screen. The Xml protein has 5' to 3' exonuclease activity, and functions in 
the mRNA decay pathway in S. cerevisiae (reviewed in Caponigro and Parker, 1996 
and references therein). This protein also has roles in the maturation of ribosomal 
RNA species (Venema and Tollervey, 1995) and is reported to have a cytoplasmic 
localisation (Heyer et al., 1995). 
The protein encoded by the YJL155c/FBP26 ORF was identified 9 times as an 
Al candidate for interaction with Usslp. The Fbp26 protein is 452 amino acids in 
length, with a predicted molecular weight of 52.6kDa, and has been shown to be a 
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fructose-2,6-bisphosphatase (Paravicini and Kretscbner, 1992). A domain of 
interaction with Ussip was identified by analysis of the fragments isolated in the 
screen (Figure 3.6.). 
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Figure 3.6. Definition of the region of Fbp26p required for the two-hybrid 
interaction with Ussip. (A) The fragments of FBP26 identified from the FRYL 
library are shown, with the minimum region of overlap in black, and the nucleotide 
number (relative to the A of the initiation (AUG) codon) at the point of fusion 
quoted below each fragment. (B) The region of Fbp26p containing the interaction 
domain is defined and its position and size within the protein sequence is indicated. 
Numbers represent amino acids relative to the initial methionine. 
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The protein encoded by the YJR022w ORF was identified once as an A2 
candidate for interaction with Ussip. The Yjr022 protein contains the Sm-motif, and 
was previously identified in a two-hybrid screen with the splicing factor Hsh49p 
(Fromont-Racine et al., 1997). This protein was characterised with the other Sm-like 
proteins, and shown to be associated with the U6 snRNA (see Chapter Eight). 
The protein encoded by the YJR138w ORF was identified once as an A4 
candidate for interaction with Ussip. The Yjr138 protein is a 1,584 amino acid 
protein, with a predicted molecular weight of 1 82kDa. No functional data are 
available for this protein, however it was also identified as a potential interacting 
factor in two hybrid screens with Smx4p (A. Colley and J. McCormack, pers. 
comm. (Appendix I) and Yerl46p (P. Legrain, pers. comm. (Appendix I)). 
The protein encoded by the YLR275wISMD2 ORF was identified once as an A4 
candidate for interaction with Ussip. The Smd2 protein is one of the canonical Sm 
proteins, associated with Ui, U2, U4 and US snRNAs (Neubauer et al., 1997). It 
was also identified in two-hybrid screens with Ydr378p (see Table 3.2) and with 
Yeri46p (Section 3.9. and P. Legrain, pers. comm. (Appendix I)). The prey fusion 
identified with Ussip begins in the intron region (158 nt from the A of the initiation 
(AUG) codon) but is able to read through (in frame) into the exon 2 sequence. This 
sequence contains both Sm-motifs of the Smd2 protein. 
The protein encoded by the YLR386w ORF was identified as the most 
statistically significant candidate for interaction with Uss ip. The Y1r3 86 protein was 
isolated 23 times as 9 different fragments in this screen. The characterisation of the 
YLR386w ORF and its encoded protein is described in Chapter Five. 
The protein encoded by the YNL091c ORF was identified once as an A4 
candidate for interaction with Ussip. The Yn1091 protein was also identified as a 
potential interacting factor in a two-hybrid screen with the Msl 1 protein (Fromont-
Racine etal., 1997), and is discussed in Section 6.3. 
The protein encoded by the YNL 11 8c/PSUJ ORF was identified 19 times as an 
Al candidate for interaction with Ussip. The Psul protein is 970 amino acids in 
length, with a predicted molecular weight of 108.7kDa, and is "an essential 
suppressor of the respiratory defect of a pet mutant" (SGD database). PSU] shows 
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synthetic lethality with the HRR25 gene, a protein kinase of the casein kinase I 
family (A.J. DeMaggio, pers. comm.). The Psul and Hrr25 proteins can be co-
immunoprecipitated and can interact in a two-hybrid assay, with Hrr25p reported to 
be capable of phosphorylating a GST-fusion protein of Psuip (A.J. DeMaggio, pers. 
comm.). Analysis of the fragments of Psuip identified in the two-hybrid screen with 
Ussip gave two potential regions of interaction (Figure 3.7.). The Psul protein was 
also identified as a potential interacting factor with Yb1026p (P. Legrain, pers. 
comm. (Appendix I)) and Yjr022p (Fromont-Racine et al., 1997). 
The protein encoded by the YOL149w/DCPJ ORF was identified once as an A2 
candidate for interaction with Uss ip. The Dcp 1 protein is required for the decapping 
of mRNA prior to 5' to 3' degradation, and has been demonstrated to be a 
phosphoprotein (Beelman et al., 1996; La Grandeur and Parker, 1998). The 
significance of this proposed interaction will be discussed in Section 3.11. 
A number of B candidate proteins identified in this screen were isolated as 
multiple clones. Due to the way the FRYL genomic library was constructed, it is 
possible to have prey clones containing more than one genomic fragment. In such 
cases, the more 3' fragment may be responsible for the two-hybrid interaction 
selected, and not the fragment at the 5' end i.e. the fragment sequenced initially. The 
multiple hit B candidates identified were therefore sequenced at the 3' end of their 
inserts, to ensure no potential interacting factors were missed. Of the 9 B candidate 
clones sequenced, all were found to contain only one genomic DNA fragment. Thus 
in each case, the peptide fortuitously expressed from the B-fragment is responsible 
for the two-hybrid interaction with Ussip. 
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Figure 3.7. Definition of the region of Psuip required for the two-hybrid interaction 
with Ussip. (A) The fragments of PSUJ identified from the FRYL library are 
shown, with the minimum region of overlap in black, and the nucleotide number 
(relative to the A of the initiation (AUG) codon) at the point of fusion quoted below 
each fragment. (B) The regions of Psuip containing the interaction domains are 
defined and their position and size within the protein sequence are indicated. 
Numbers represent amino acids relative to the initial methionine. 
.121 
3.5. Pre-screen Checks for Ydr378p Two-Hybrid Bait. 
The YDR378c open reading frame encodes one of the hypothetical Sm-like 
proteins identified by analysis of the S. cerevisiae genome (Fromont-Racine et al., 
1997). The coding sequence was cloned into the pAS2AA vector (see Table 2.1.12.) 
for use in a two-hybrid screen, and the construct (pAEM33) was verified by 
sequencing. However, when pAEM33 was transformed into CG1 945, the cells 
underwent severe flocculation before reaching the 0D 600 required for a screen to be 
performed (i.e. 0.8-1.2 0D600 units). The coding sequence was therefore re-cloned 
into the pBTM1 16 plasmid to produce a LexA fusion construct (pAEM34). The 
junction was verified by sequencing, but no antibodies were available to assay 
expression of the stable fusion protein. 
The functional ability of the fusion proteins expressed from pAEM34 (and 
pAEM33) was tested in AEMY19 cells, which are deleted for YDR378c and as a 
result have a temperature-sensitive phenotype (see Section 7.1.). pAEM34 was 
capable of supporting the growth of these cells at 3 7°C, suggesting that the Ydr378 
portion of the fusion protein is folded with the correct structure to produce a 
functional protein (Figure 3.8.). Although pAEM33 was unable to support growth at 
37°C, this construct did allow faster cell growth at 30°C. This was determined by 
larger colony size for cells carrying pAEM33 after two days incubation at 3 0°C, 
compared to cells carrying pAS2AA (data not shown). 
To test the auto-activating potential of pAEM34, a two-hybrid "mini-screen" was 
performed using the same protocol as for a full screen, but with only approximately 
one tenth of the library-containing cells. In this assay, 6.8 x 106  diploid cells were 
screened at a mating efficiency of 23%. Eleven colonies grew on YMM -LWH 
medium, but only 4 gave a positive result in a n-gal overlay assay. pAEM34 was not 
considered an auto-activating bait, and was used in a full two-hybrid screen. The 
four clones identified in the miniscreen (A, F, G and I) were analysed with those 





pAS2AA I pAEM33 
116 IpAEM34 
Figure 3.8. LexA:Ydr378p is functional. AEMY1 9 cells transformed with pAS2AA, 
pAEM33 pAS2M:YDR378c), pBTM1 16 or pAEM34 (pBTM1 16:YDR378c) were 
streaked onto solid YMM -HW medium and incubated at 30°C or 37°C for 3 days. 
3.6. Two-Hybrid Screen with pAEM34. 
A full two-hybrid screen with pAEM34 was performed as described in Section 
2.2.8., with the assistance of N. Gromak, an undergraduate student at Univ. of 
Edinburgh. A total of 30 x 106  diploids were screened at a mating efficiency of 
4 1.5%. The -ga1 overlay assay revealed a total of 102 colonies displaying a strong 
blue colour after 2 hours incubation at 30°C (NB. The differences between Ga14 and 
LexA bait screens with respect to n-gal assays (see Section 3.1.)). Of the blues, 15 
failed to grow after re-streaking to fresh YMM -LWH medium. From those which 
did grow, prey plasmid DNA was rescued and prepared for sequence analysis. A 
total of 79 clones were successfully sequenced (plus 3 of the 4 clones from the mini 
screen). Table 3.2. summarises the information obtained from the screen. 
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Table 3.2. Results of two-hybrid screen with pAEM34. The prey plasmid inserts are ordered by ORF number. All gene and ORF names are 
given as defined by the Saccharomyces Genome Database, SGD. Identical clones are those with the same start point and insert size. Anti 
relates to fusions which begin on the antisense (i.e. the non-coding DNA strand) of an ORF; Ribo represents ribosomal DNA; mito 
represents mitochondrial DNA; c, Crick DNA strand; w, Watson strand (as defined by SGD); Chr. nt., nucleotide position on the 
chromosome at which the fusion begins; nt from AUG, distance from the start of the coding sequence (A of the initiation (AUG) codon) to 
the point at which the fusion begins. Approximate insert size was determined by BamHI restriction digest and agarose gel electrophoresis. 
The categories used are as described in Section 3.1. (defined by Fromont Racine et al., 1997). 
Bait j Clone Identical clones J• 	Gene CFF Chr Strand I 	Chr. nt. nt. from AUG ORE size Insert size Category 
LexA-Ydr378 7 91 SNP3 YBL026w H w 170515 -67 285+131 462 A2 
LexA-Ydr378 45  YCLX1Oc III c 91873 35 312 1400 A3 
LexA-Vdr378 28 41,51,58,75,83 PAT1 YCR077c Ill c 251305 49 2394 2100 Al 
LexA-Ydr378 - 2_ 13,14,19,23,35,36,46,57,78,79,80,82,85,95,I  YCRO77c III c 250299 1055 2394 1100 Al 
LexA-Ydr378 _31  anti YDR255c IV w 966925  n/d B 
LexA-Ydr378 _l  USSI VER112w V w 387187 -41 564 700 Al 
LexA-Ydr378 _2  YER112w V w 387196 -32 564 600 Al 
LexA-Ydr378 _2 1_ 32  YGL251c VII c 28789 2272 3141 800 A4 
LexA-Ydr378 90  anti YHR068w VID c 232881  2000 B 
LexA-Ydr378 5 56,70,86,101 anti YIL118w D( c 140184  250 B 
LexA-Ydr378 55  VURI YJ1-139c X c 152109 588 1287 n/d A 
LexA-Ydr378 38 59,66,87,89,98  YJR022w X w 469374 -41 387 1500 Al 
LexA-Ydr378 6 9,11.27,33,34,49.63,74,100  YJR022w X w 469394 -21 387 450 Al 
LexA-Ydr378 20  YJR022w X w 469413 -2 387 700 Al 
LexA-Ydr378 52 61  YJR022w X w 469443 28 387 500 Al 
LexA-Ydr378 84  YJR022w X w 469444 29 387 400 Al 
LexA-Ydr378 73  YJR022w X w 469476 61 387 500 	- Al 
LexA-Vdr378 65  YJR022w X w 469479 64 387 400 Al 
LexA-Ydr378 24 77 anti YJR041c X w 513104  500 B 
LexA-Ydr378 54  anti YKL116c )(I w 221895  400 B 
LexA-Ydr378 62  anti YKL162c XI w 148735  400 B 
LexA-Ydr378 60  YLR053c X c 248295 130 327 500 A2 
LexA-Ydr378 17  YLR275w XII w 694402 24 333+90 800 Al 
LexA-Ydr378 43 71  YLR275w XII w 694407 29 333+90 600 Al 
LexA-Ydr378 50 53  VLR275w XII w 694514 136 333+90 600 Al 
LexA-Ydr378 30  USS2 VLR438c-A XII c 1014248 -77 270 450 A2 
LexA-Ydr378 96  YMR221C XIII C 714329 1135 1515 1000 A3 
LexA-Ydr378 12 68 PRP24 YMR268c XIII c 803884 337 1335 1100 A3 
LexA-Ydr378 F  YNL147w XIV w 350888 -51 324+120 463 A2 
LexA-Ydr378 67 G  YOR320c XV c 913878 1207 1476 1000 A3 
LexA-Ydr378 97  ribo  n/d B 
LexA-Ydr378 1  mito  900 B 
LexA-Ydr378 3  mito  700 B 
LexA-Ydr378 29  mito  n/d B 
LexA-Ydr378 8 44 mito -  400 B 
3.7. Analysis of Proteins Identified in Two-Hybrid Screen with 
pAEM34 (Ydr378p). 
The protein encoded by the YBL026w ORF was identified twice as an A2 
candidate for interaction with Ydr378p. The Yb1026 protein contains the Sm-motifs, 
and was characterised with the other Sm-like proteins, and shown to be associated 
with the U6 snRNA (see Chapters Seven and Eight). 
The protein encoded by the YCR077c/PATJ ORF was identified 22 times as an 
Al candidate for interaction with Ydr3 78p. The characterisation of the PA Ti ORF 
and its protein product are presented in Chapter Four. 
The protein encoded by the YER1 12w/USS1 ORF was identified twice as an Al 
candidate for interaction with Ydr378p. This gives an indication that the Ydr378 
protein may be complexed with Usslp, and may also be associated with the U6 
snRNA. These proposals were confirmed by biochemical analysis (see Chapter 
Eight). 
The protein encoded by the YJR022w ORF was identified as the most 
statistically significant candidate for interaction with Ydr378p. The Yjr022 protein 
was found 21 times as 7 different fragments in this screen. This protein contains the 
Sm-motif, and associates with the U6 snRNA (see Chapter Eight). Analysis of the 
fragments of Yjr022p isolated in the screen revealed that both Sm-domains were 
probably required for the two-hybrid interaction with Ydr378p (Figure 3.9.). Further 
analyses of the interactions between the Sm-like proteins is presented in Chapter 
Eight. 
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Figure 3.9. Definition of the region of Yjr022p required for the two-hybrid 
interaction with Ydr378p. (A) The fragments of YJR022w identified from the FRYL 
library are shown, with the minimum region of overlap in black, and the nucleotide 
number (relative to the A of the initiation (AUG) codon) at the point of fusion 
quoted below each fragment. (B) The region of Yjr022p containing the interaction 
domain is defined and its position and size within the protein sequence is indicated. 
The positions of the Sm-motifs within the protein sequence are indicated. Numbers 
represent amino acids relative to the initial methionine. 
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The protein encoded by the YLR275w/SMD2 ORF was identified 5 times as an 
Al candidate for interaction with Ydr378p. The Smd2 protein is one of the 
canonical Sm proteins, associated with Ui, U2, U4 and U5 snRNAs (Neubauer et 
al., 1997). It was also identified in two-hybrid screens with Ussip (see Table 3.1) 
and with Yerl46p (Section 3.9. and P. Legrain, pers. comm. (Appendix I)). 
The protein encoded by the YLR438c-AIUSS2 ORF (Smx4p) was identified once 
as an A2 candidate for interaction with Ydr378p. The Smx4 protein contains the 
Sm-motifs, and associates with U6 snRNA (Séraphin, 1995). Further 
characterisation of this ORF and its protein product is presented in Chapters Seven 
and Eight. 
The protein encoded by the YMR268c/PRP24 ORF was identified twice as an 
A3 candidate for interaction with Ydr378p. The Prp24 protein associates with the 
U6 snRNA (Jandrositz and Gutbrie, 1995; Vidal, 1998) and has been proposed to 
play a role in the re-annealing of the U4 and U6 snRNPs after completion of the 
splicing reaction (Raghunathan and Guthrie, 1998). The proposed interaction of 
Prp24p with Ydr378p also suggests that Ydr378p may be associated with the U6 
snRNA. 
The protein encoded by the YNL 147w ORF was identified once as an A2 
candidate for interaction with Ydr378p. The Ynl147 protein contains the Sm-motifs, 
and was characterised with the other Sm-like proteins, and shown to be associated 
with the U6 snRNA (see Chapters Seven and Eight). 
The protein encoded by the YOR320c ORF was identified twice as an A3 
candidate for interaction with Ydr378p. The Yor320 protein is 491 amino acids in 
length, with a predicted molecular weight of 57.6kDa. No functional data are 
available for this protein, however it was also identified as a potential interacting 
factor in two-hybrid screens with the Sm-like proteins Spb8p and Yeri46p (P. 
Legrain, pers. comm. (Appendix I)). 
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3.8. Pre-screen Checks of the LexA:Yer146 Fusion Protein. 
The YER146w coding sequence was sub-cloned into pBTM1 16 from pAEM70, 
a prey plasmid isolated in a screen with the Yjr022 protein (pers. comm., Pierre 
Legrain). The bait construct, pAEM53, was verified by sequencing; the fusion at the 
3' end lacks the STOP codon of YER146w, thereby allowing read-through from 
YER146w sequence into the "terminator" region of the plasmid. This produces an 
11 amino acid C-terminal extension to the fusion protein. 
No antibodies were available to check if the fusion protein is stably expressed, 
and due to the Trp+ prototrophy of the YER146w deletion strain (AEMY9), the 
functional capacity of the fusion could not be checked. 
3.9. Two-Hybrid Mini-Screen with pAEM53. 
A two-hybrid "mini-screen" was performed with pAEM53 as bait. From a 
mating efficiency of 27%, 1 x 106  diploids were screened. Positive two-hybrid 
interactions were assayed by growth on YMM -LWH medium. After two days 
incubation at 30°C, 12 colonies were visible. This number increased to 27 after 3 
days and to 38 after 4 days. Since 3 days is the usual time point at which colonies 
are overlaid in this assay, a full screening of the library would yield over 400 
"positive interactions". This bait is therefore considered to be mildly auto-
activating. 
The 12 colonies visible after 2 days were re-streaked and shown to produce a 
positive result in a f3-gal assay. These clones were analysed, as before, to determine 
the identity of the inserts. Of the 12 clones, one failed to yield informative sequence. 
The data obtained from the others is presented in Table 3.3. 
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Table 3.3. Results of two-hybrid mini-screen with pAEM53. The prey plasmid inserts are ordered by ORF number. All gene and ORF 
names are given as defined by the Saccharomyces Genome Database, SGD. Anti relates to fusions which begin on the antisense (i.e. the 
non-coding DNA strand) of an ORF; Inter relates to fusions which begin in intergenic regions; c, Crick DNA strand; w, Watson strand (as 
defined by SGD); Cbr. nt., nucleotide position on the chromosome at which the fusion begins; nt from AUG, distance from the start of the 
coding sequence (A of the initiation (AUG) codon) to the point at which the fusion begins. Approximate insert size was determined by 
BamHI restriction digest and agarose gel electrophoresis. The categories used are as described in Section 3.1. (defined by Fromont Racine et 
al., 1997).  
Bait 'Clone' Gene I 	CFF Chr I 	Strand I 	Chr. nt. I 	nt. from AUG j ORF size I 	Insert size Category 
LexA-Yer146 9 FOBI YDR11Ow IV w 677505 1365 1701 1000 A4 
LexA-Yer146 6 GCD1I YER025w V w 205276 26 1584 800 A2 
LexA-Yer146 3 anti YGRI50c VII w 790912  900 B 
..exA-Yer146 11  YJL124c X c 187396 -52 519 800 A2 
LexA-Yer146 2 SHM2 YLR058c Al c 258256 1146 1410 400 A4 
LexA-Yer146 1 	4 SMD2 YLR275w XII w 694402 24 333+90 1000 A2 
LexA-Yer146 5 inter YOR121c/YOR122c XV c 552176  3500 B 
LexA-Yer146 12 inter YPL202c/YPL203w XVI w 167595  n/d B 
LexA-Yer146 10  YPR184w XVI w 904107 2086 4611 1000 A4 
Although the bait is mildly auto-activating, two proteins containing Sm-motifs 
were identified, Smd2p and Spb8p. This would suggest that the bait fusion protein 
may be folded correctly, and able to select meaningful interactions. Due to time 
constraints, the full screen with pAEM53 was performed by A. Brunet, L. Decourty 
and M. Fromont-Racine in the lab of P. Legrain. The results are presented in 
Appendix I. 
3.10. Sm-Like Bait Proteins. 
As part of the systematic analysis of the Sm-like proteins, other two-hybrid baits 
were also constructed (see Table 2.1.12.), with the screens performed by other 
members of the TAPIR network (in either this lab (Edinburgh) or in that of P. 
Legrain (Paris)). The details of the baits and the workers responsible for the screens 
are given in Table 3.4. 
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Table 3.4. 
Details of Two-Hybrid Screens with Sm-Like Proteins. 
Bait namea  ORF cloned System Performed by... 	 Results 
pAEM13 USS] Gal4 A. Mayes (Edin.) Table 3.1. 
pAEM17 USS2 Ga14 J. McCormack and A. Appendix I 
Colley (Edin.) 
pAEM34 YDR378c LexA A. 	Mayes 	and 	N. Table 3.2. 
Gromak (Edin.) 
pAEM53 YER146w LexA A. Mayes (Edin.) b Table 3.3. 
A. Brunet, L. Decourty Appendix I 
and M. Fromont-Racine 
(Paris) 
pAEM56 SPB8 LexA A. Brunet, L. Decourty Appendix I 
and M. Fromont-Racine 
(Paris) 
pAEM59 YNL147w LexA A. 	Brunet 	and 	M. Appendix I 
Fromont-Racine 
(Paris) 
nla YBL026w Ga14 A. 	Brunet 	and 	M. Appendix I 
Fromont-Racine 
(Paris) 
n/a YJR022w Ga14 M. Fromont-Racine and Fromont-Racine 
J-C Rain (Paris). et al., 1997 
n/a YJR022w LexA M. Fromont-Racine and Appendix I 
J-C Rain (Paris). 
a 




This Section deals with the data from the three screens described in this Chapter. 
A discussion of the results of the other two-hybrid screens (done as part of the 
TAPIR collaboration) performed with the Sm-like protein bait fusions (constructed 
as part of this study) and how they relate to the screens performed here, will be 
discussed in Chapter Nine. 
Examination of the data-sets obtained in each of the two-hybrid screening 
experiments performed here highlights some interesting variation within the system. 
For example, although the Ga14:Ussl fusion protein bait did not significantly 
autoactivate when tested by co-transformation, a high proportion of the potentially 
interacting factors identified were either in the A4 or B category (as defined by 
Fromont-Racine et al. (1997)). This implies a lack of specificity for the interactions 
formed by this bait protein, and is in contrast to the results obtained with the 
LexA:Ydr378 bait fusion protein. In the screen performed with this fusion, very few 
A4 or B category prey were identified. The specificity of this latter screen is 
emphasised by the isolation of only a small number of potentially interacting 
proteins, by the fact that many of these are in the (statistically more significant) Al, 
A2 and A3 categories, and that many of these were identified as multiple "hits" of 
the same prey fragment. The differences between these screens is highlighted in 
Figure 3.10. in which the results are presented graphically. 
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Figure 3.10. Distribution profiles of prey found in two-hybrid screens. All prey 
selected with the bait indicated are represented according to the classification given 
in Section 3.1. (defined by Fromont-Racine et al., 1997). Subdivisions within a 
category reflect the number of prey falling within the same genomic locus. (A) 
Screen performed with Ga14:Usslp. (B) Screen performed with LexA:Ydr378p. 
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These differences may reflect that the screen performed with Ga14:Usslp as bait 
utilises yeast operator sequences (GAL4) for the binding of the DNA binding 
domain of the bait protein, whilst the screen with LexA:Ydr378 uses bacterial 
sequences. Thus, it could be envisaged that the "yeast sequences in yeast nucleus" 
situation of the Ga14 system may give greater background problems than the 
"bacterial sequences in yeast nucleus" situation of the LexA system, due to aspecific 
associations of yeast DNA binding proteins to the yeast GAL4 operator sequences. 
Alternatively, the reporter gene constructs in the different yeast strains used in 
these experiments (CG1945 for Ga14 system, L40 for LexA system) are likely to 
have different activation thresholds, producing differences between the two systems. 
In addition, the variable behaviour of different bait proteins in the two-hybrid 
system is an intrinsic property of the particular fusion (Fromont-Racine et al., 
1997). This point is reinforced by the LexA:Yerl46 bait fusion protein, which has a 
mild autoactivating capacity. For a screen to be performed effectively with this 
protein, therefore, 3-AT must be added to the medium used, in order to increase the 
selective pressure for expression from the HIS3 reporter. 
Despite the range of apparently aspecific interacting proteins identified in the 
screen performed with Ussip as bait, a comparison of the data-set achieved (Table 
3.1.) with those from the screens with Ydr378p (Table 3.2.) and Yerl46p (Table 
3.3.) allowed a map of potential interactions to be drawn (Figure 3.11.). By 
comparing the data-sets, factors proposed to be interacting proteins in multiple 
screens can be highlighted, thereby increasing their statistical significance above 
that determined from a single screen in isolation. 
An example of such a case is Patip which was identified once as an A4 candidate 
in the screen with Uss 1 p  as bait, but 22 times as an Al candidate (2 different 
fusions) in the screen with Ydr378p. Subsequently, Patip has also been identified in 
screens with the other Sm-like proteins (Appendix I) and has been characterised 
biochemically (see Chapter Four). 
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Figure 3.11. Interaction map from two-hybrid screens. A protein linkage map was 
drawn based on the data obtained from the two-hybrid screens described in this 
Chapter. Arrows run from bait proteins to prey proteins. Ovals represent proteins 
with Sm motifs. Red colouration represents proteins used as baits. Green 
colouration represents proteins involved in pre-mRNA splicing. Blue colouration 
represents proteins involved in mRNA degradation. Black colouration represents 
proteins with no obvious connection to RNA processing. 
As with Patlp, the significance of the proposed interactions with Yjr022p (A2 
with Usslp; Al with Ydr378p) and Smd2p (A4 with Ussip; Al with Ydr378p; A2 
with Yer146p) was increased by their identification in multiple independent screens. 
These proteins have and not been identified in screens with other unrelated proteins 
(Fromont-Racine et al., 1997; J. Beggs, pers. comm.) indicating that these are not 
common non-specific prey. Yjr022p has subsequently been characterised as a 
member of the family of Sm-like proteins which associate with U6 snRNA and with 
Usslp (see Chapter Eight). 
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Fromont-Racine et al. (1997) identified a reciprocal interaction between Yjr022p 
and Hsh49p, a U2 snRNA-associated protein (Gozani et al., 1996), indicating links 
between the U2 and U6 snRNPs. The proposed interaction between Ussip and 
Prpl ip also suggests this link, and is discussed in more detail in Chapter Six. 
Encouragingly, these screens identified several candidates for biologically 
relevant interactions. Most striking is the ability of the Sm-like proteins used as 
baits to interact with the other Sm-like proteins (as prey); (Figure 8.3.). That only a 
uni-directional interaction was identified between Ydr378p and Ussip may occur 
due to a number of possibilities; assuming that the proposed interaction is real, as 
reinforced by the data from direct mating experiments (Section 8.6.) and co-
immunoprecipitations (Section 8.4.), it may be that no prey fusions containing the 
region of Ydr378p necessary for the proposed interaction were present in the screen 
with Ussip. Given the number of diploids screened (47 x 106)  however, this is 
thought to be unlikely. More likely is that either the Ydr378p prey fusions were not 
folded in an interaction-compatible way or that the potentially interacting clones 
were amongst the 108 prey blues discarded after the overlay assay. 
The identification of interactions between the Sm-like proteins has led to the 
proposal that a protein complex, analogous to the canonical Sm protein complex, 
may form between these proteins. The existence of such a complex is examined 
further in Chapter Eight. 
The two-hybrid screen data also allow the tentative prediction that if such a 
complex were to form, it may associate with the U6 snRNA. This prediction is 
based on the interactions between the bait proteins and Ussip, Smx4p and Prp24p, 
which are all associated with U6 snRNA (Cooper et al., 1995; Séraphin, 1995; 
Jandrositz and Guthrie, 1995; Vidal, 1998). It has subsequently been demonstrated 
that the Sm-like proteins identified in the screens described here do indeed associate 
with U6 snRNA (Section 8.3.). 
Thus, the two-hybrid screens have provided valuable evidence for novel contacts 
within the splicing machinery, which has led to the characterisation of the proteins 
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involved (Chapters Seven and Eight). In addition, the data have led to predictions of 
the existence of multi-molecular complexes involving these proteins. 
The two-hybrid screens have also revealed potential links between the Sm-like 
proteins and other RNA processing events. The screen performed with Ussip as bait 
identified Dcplp and Xrnlp as potential interactors, while the miniscreen with 
Yer146p identified Spb8p. Each of these three proteins has previously been shown 
to be involved in the decapping andlor subsequent degradation of mRNA (Beelman 
et al., 1996; Caponigro and Parker, 1996; La Grandeur and Parker, 1998; Boeck et 
al., 1998). Xrnlp was also identified as a potential interacting protein in two-hybrid 
screens with Yjr022p (Fromont-Racine et al., 1997) and with Yb1026p (Appendix 
I). Here again the comparison of data-sets from different screens has increased the 
significance of each of these interactions above their individual standing. Whether 
the proposed connection with the mRNA degradation pathway would involve a 
subset of the Sm-like proteins, all the Sm-like proteins, a U6 snRNP particle, or 
indeed the entire splicing machinery, is not known and is beyond the scope of 
prediction from these preliminary data. It does however, provide exciting clues as to 
potential cross-talk between different RNA processing pathways. 
The identification of other processes potentially involving the Sm-like proteins, 
also provides new avenues to pursue in the characterisation of novel proteins 
identified by the two-hybrid screens. For example, the Pati, Psul, Yjr138 and 
Yor320 proteins were all identified in multiple two-hybrid screens using Sm-like 
proteins as bait (Table 3.1., Table 3.2. and Appendix I). The function of these 
proteins, or the details of their interactions with the Sm-like proteins is not known, 
however, given the two-hybrid data obtained here it is intriguing to propose that 
these proteins may play a role in either pre-mRNA splicing and/or in mRNA 
decapping and degradation. 
Thus, through the systematic approach of exhaustive two-hybrid screening 
undertaken here (and in the TAPIR network) novel proteins associated with 
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components of the splicing machinery have been identified, as well as potential new 
links to other cellular processes. 
Further genetic and biochemical analyses of these interactions and links must be 
undertaken in order to determine whether the proposals, based solely on two-hybrid 
data, are valid. 
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CHAPTER FOUR, 
CHARACTERISATION OF YCR077c/PATJ 
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4.1. Introduction. 
Two-hybrid screens using the Sm-like proteins as baits identified the product of 
the YCR077c open reading frame as a potential interacting factor (see Chapter 
Three and Appendix I). The YCR077c ORF is 2,391 nucleotides in length, encoding 
a 797 amino acid protein with predicted molecular mass 88.4kDa. Searches of 
protein databases revealed only one protein with significant homology to Ycr077p. 
This is an 82.9kDa hypothetical protein displaying 27.3% identity and 36.3% 
similarity to Ycr077p and was identified via the S. pombe genome sequencing 
project (Figure 4.1.). The similarity to Ycr077p is distributed throughout the entire 
sequence. No functional data are available for this protein. 
Rodriguez-Cousino et al. (1995) published the sequence of the YCR077c ORF, 
and performed a partial gene deletion. From this it was concluded that the gene was 
not essential for cell viability although the disruption did produce a slow growth 
phenotype. Cell fractionation and immunoblotting studies suggested a cytoplasmic 
localisation for the protein, although no function was proposed by these authors. 
Wang et al. (1996) demonstrated by two-hybrid analysis and 
immunoprecipitation that the Ycr077 protein associated with Topoisomerase II, and 
based on these observations, the gene was renamed PAT] (for Erotein Associated 
with lopoisomerase II). These authors also performed a gene disruption, removing 
a larger portion of the ORF than Rodriguez-Cousino et al.. The gene was again 
found to be dispensable for cell viability although this disruption produced a more 
severe growth defect than that seen previously. It was demonstrated that the 
disruption increased cell size and the frequency of chromosome fragmentation. The 
disruption of PAT] also decreased cell viability and the ability to produce viable 
spores. Fidelity of chromosome segregation was also affected at both mitosis and 
meiosis. 
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Figure 4.1. Sequence alignment of Ycr077p and putative homologue. (A) Proposed homologue from S. pombe was identified by BLAST 
searches of the NCBI nr peptide sequence database (Section 2.4.). Sequences were aligned using the PILEUP program of the GCG9 suite of 
sequence analysis programs, with identities and similarities highlighted using BOXSHADE 3.21 (Section 2.4.). White on black represents 
identity between the sequences, black on grey represents conservation of the nature of the amino acid at that site. Accepted conservative 
groupings were M=I=L=V, K=R=H, F=Y=W, S=T, E=D, A=G and Q=N. The accession numbers of the proteins are as follows S. 
cerevisiae, P25644; S. pombe, AL021839. 
S.cerevisiae 	1 f. 	 LESARD,GPLp'__S KGY EHEL EN'Y 	' 	DNV.Q 	TI'__'1GNPHSS 	S...GNAIGGG 
S.pombe 1 t. 41T DDL NQLN AG'EI 4 VSAGS[, RI'__'SGTTAQA AQLEDEQYQXQ 
S.cerevisiae 82 	 ............ AAGPL' K 	E LSTAPPANPSQSTPAPAPQQM 	LQPLM 
S.pombe 86 QNXFPVKPSjSULPQVSLNASQFPSREPAS INKLS' Q A 	JENIVEKP 	 PE.LV  
S.cerevisiae 156 DIRQR]MQQQPMNFHAMH... 
S.pornbe 170 
S.cerevisiae 236 GM.NTSPGPVVGPKNLQSGRRKRDSPE s .. .RR QIiAVi. . . .jLKYSC P1PRI D 	TY 
S.pombe 255 MQPULVQMPYPQNMYNSVAPPALVN FQQ 'LXQNQN DERQULJDHNLMAQCMeI_vI'RS' S AI 
— 	 S.cerevisiae 312 N' 	FQ K Q . GIT 	SNKGLXARAEH GHLG YKIAt'R . 	 sKLKDQQAr.GNssQDNK 
S.pornbe 340 S' R 	S 	. 	RKP EEASHFXQT 	GP NNURR 	. .KATQLSLELG. ........ 
S. cerevisiac 397 QANTV 	lSSTLNsN RQ QIPQQPSSDPDALKDVTDSLTNVjL 	G STGS i:AAVASKQRflRSSYANNGNGATN N 
Spombe4l4 	I AVN TVRT QL NVKOP 	 TEP N LNNP GPSTKKDVLHAIEKV1YjD 	LL D 
S.cerevjsiae482 KSGKFILE XE VYE LDLEANRNGQQDST 	EALHI1D YDVN__1MI.OFD TKIMI NP DQK?ijK  QK] 
Sponthe47o FEQLRKAST ET DQQ DTWKTTSEKLESIWKLYXNESkEA KTRPI_IXXflHP 	1RILL 	PH SEF1Q1JS KV&J 
S.cerevisiae 567 FNELSH Q 	LSKTTPKPT TQ KjDLQQMI KI[Vi]FSNSNPXE MGBLL . 	RNNVSIi.I TTt1?111NL[1L 
S.po,nbe555 VYNFDS D J.RGDVNGELP DVSESSUTQF PP .TI.ELDLET NNPS' JNRTUAV1X IQI44eISF[F GM 
S.cerevisiae 652 
S.pombe 639 	 . 	 .......... 
S.cerevisiae 737 VRDEIFAT NEAETQKKEKE SVPQRSQE DTELKSIIYNKEKLYQDLNLPLNVMGLVYRDGEISELK 
S.pombe7ll T S K R A P S E .AVVR:SNVNLP NAMGLDARQ SA ------------------------------------ 
None of these published data suggested an obvious role for Patip in the splicing 
pathway, indeed the cytoplasmic localisation reported by Rodriguez-Cousino et al. 
would argue against it. However, this proposed localisation contradicts the 
association seen with Topoisomerase II, which is a nuclear, DNA-associated 
protein. Thus, due to such ambiguities in the literature, no firm conclusions could be 
drawn as to the function (or even the localisation) of Patip. 
Given that the Pati protein was identified in independent two-hybrid screens, 
using Sm-like proteins as baits, it was analysed for an association with small RNAs 
and its proposed physical association with the Sm-like proteins was studied. The 
stability of the snRNAs and the efficiency of splicing were also assayed in the strain 
disrupted at the PA Ti locus. 
4.2. Disruption of YCR077c/PATJ confers temperature 
sensitivity to haploid cells. 
The strain disrupted for PA Ti (PW5 OAPat 1) and its parental strain (PW50) were 
obtained from the lab of Dr Ian Hickson (Wang et al., 1996). Both strains were 
tested for nutritional auxotrophy, and found to be as documented. As part of these 
checks, the slow growth phenotype described in the literature was examined at a 
range of temperatures. When the two strains were tested for growth on solid media, 
it was found that the disruption of PAT] confers a severe thermo-sensitivity to 
PW50iPat1 at 3 7°C, whilst the parental strain displayed no such temperature-
sensitive phenotype (Figure 4.2A.). This phenotype was not reported by Wang et al. 
1996. Neither strain displayed a cold-sensitive phenotype when tested at 14°C (data 
not shown). To examine the temperature sensitivity, the growth rate of PW50iPat1 
was monitored following a shift to the restrictive temperature (Figure 4.213.). For the 
first 5 hours, the doubling times of the cells remained very similar to those of cells 
grown at 30°C. Thereafter, the growth rate at 37°C began to slow, until at around 13 
hours after the shift the cells appeared to have stopped dividing. In contrast, the cells 
at 30°C continued to grow as before, doubling approximately every 132 minutes. 
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Figure 4.2. Disruption of PAT] produces a temperature-sensitive phenotype. (A) 
Single colonies of haploid strains PW50 or PW50APat1 were streaked onto solid 
YPDA medium and incubated for 3 days at 30 °C or 37°C. (B) A culture of 
PW50APat1 was grown to mid-log phase in liquid YPDA at 30 °C. Cells were 
harvested and resuspended in pre-warmed medium (at either 30 °C or 3 7°C) to an 
0D600  of approximately 0.1. Samples were removed at 2 hour intervals (up to 14 
hours) and the 0D 600 measured. Cultures were diluted with pre-warmed medium, as 
appropriate, to keep all 0D 600 readings below 0.8, thereby maintaining the cells in 
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4.3. Patip is not Required for the Stability of the Spliceosomal 
snRNAs. 
Several of the Sm-like proteins (including Uss ip) proposed to interact with 
Patip, have been shown to be required for the stability of the U6 snRNA in vivo 
(Chapter Seven and Cooper et al., 1995). This phenotype suggests a physical 
association, or an association of function, between these proteins and the U6 
snRNA. The stability of the spliceosomal snRNAs was therefore investigated to 
ascertain if such a phenotype was produced by the absence of the Pati protein in 
vivo. 
Total RNA was isolated at various times from PW50 and PW50APat1 cells 
grown at 30°C or 37°C. Northern blot analysis was used to assay the levels of the 
spliceosomal snRNAs in the isolates. No difference exists between the spliceosomal 
snRNA levels in PW50 and PW50APat1 cells grown at 30°C (Figure 4.3A, compare 
lanes 1 and 6) suggesting that the slow growth phenotype of PW50APat1 is not 
caused by alteration to the levels of these snIRNAs. Similarly, the levels do not 
change when PW50APat1 cells are grown at 37°C (compare lanes 7-8 with 9-10). 
Thus, the primary defect causing the arrest of PW50APat1 cell division at 37°C is 
not due to an alteration of the steady-state levels of the spliceosomal snRNAs. 
The effects of Patlp depletion on the levels of other small RNA species in 
PW50tPat1 cells was also investigated. The levels of the RNAs from RNase MRP, 
RNase P and 5S rRNA were all examined and it was demonstrated that there is no 
effect on the levels of any of these small RNA species when PW50APat1 cells are 
grown at 37°C (Figure 4.3B, lanes 9-10). 
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Figure 4.3. Effect of PA Ti disruption on the levels of small RNAs. (A) Total RNA 
was extracted form PW50 or PW50APat1 cells grown at 30°C or 37°C for various 
lengths of time. The RNA (5jig/lane) was separated on a denaturing 6% w/v 
polyacrylamide gel, electroblotted and probed with radiolabelled oligonucleotides 
complementary to the spliceosomal snRNAs. The positions of Ui, U2, U4, U5 L , 
U5 5 and U6 snRNAs are indicated. (B) The membrane described above was 
successively stripped and reprobed with radiolabelled oligonucleotides specific for 
MRP RNA, P RNA and 5S rRNA. ____ 
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4.4. Effect of Ussip or U6 snRNA Over-Production in 
PW5OAPat1. 
The two-hybrid data together with the non-essential nature of the PA Ti gene and 
the temperature sensitivity of the PW50APat1 strain suggest that the protein may be 
involved in a multimeric complex. It is proposed that at 30°C in the absence of 
Pat 1 p  the complex retains it structure but only some of its functional capabilities, 
producing the slow growth phenotype in PW50APat1 cells. At increased 
temperatures, the structure of the proposed complex may be destabilised leading to a 
loss of function, and the arrest of cell growth. The two-hybrid data from screens 
with Sm-like proteins suggests that these proteins may form part of the proposed 
complex, for example the screen with pAEM 13 suggested a molecular interaction 
between Ussip and Patip. If Ussip is involved in a complex with Patip, this may 
include U6 snRNA and over producing Ussip (or U6 snRNA) could potentially 
stabilise the complex, thereby by-passing the need for Patip and suppressing the 
phenotype seen at 37°C. 
To investigate this possibility, the ability of over-expression of the USSJ gene 
(carried on either a centromeric (pRS3 16) or a high-copy number (YEp24) plasmid) 
to support growth of PW50APat1 cells at 37°C was tested. It was demonstrated that 
Ussip, on either plasmid tested, was unable to suppress the defect seen in these cells 
at 37°C (Figure 4.4.). Similarly, over-production of U6 snRNA (from pYX172 
(high-copy number plasmid)) could not suppress the arrest of cell growth seen at 















Figure 4.4. Over-production of Ussip, or of U6 snRNA catmot rescue PW50APatI 
cells grown at 37°C. Five individual transformants of PW50APat1 cells canying 
pRS3I6, pAEM12, YEp24, YEp24-USSI or pYX172 were suspended in selective 
media (YMM -LU) and spotted onto solid, selective media. Plates were incubated at 
30°C or 37°C for 3 days. The relevant properties of each plasmid are indicated on 
the right. 
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4.5. PW50APat1 Cells do not Display a Splicing Defect, in 
vivo. 
The temperature sensitivity of PW50APat1 cells grown at 37°C suggests the 
disruption of a major cellular process(es). In order to determine if the arrest in cell 
growth is due to a primary defect in the splicing pathway, the levels of actin pre-
mRNA and mRNA were studied in these cells. RNase protection experiments with 
total RNA extracted from PW50APat1 cells revealed that the levels of both species 
of actin remained constant, regardless of whether the cells were grown at 30°C or 
for 6 hours at 37°C (Figure 4.5A, compare lanes 3 and 4). It was also shown that the 
PW50APat1 cells do not have a splicing defect per Se, since the levels of both RNA 
species are the same as those seen in PW50 cells (Figure 4.5A, compare lanes 1-2 
with 3-4). Samples from DJY36 cells grown at 23°C, or for 2 hours at 37°C were 
also assayed to show the profile expected for a temperature-sensitive splicing 
mutant (prp2-1). These results were confirmed by Northern analysis of the RP28 
transcript (data not shown). From these experiments it was concluded that the 
disruption of PA Ti did not produce a splicing defect in PW50APat1 cells. 
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Figure 4.5. PW50EPat1 cells do not show a splicing defect. Total RNA was 
extracted from PW50 or PW50APat1 cells grown continuously at 30°C, or for 6 
hours at 3 7°C, and was assayed by RNase protection. RNA was also extracted from 
DJY36 (prp2-1) cells grown continuously at 23°C or for 2 hours at 37°C, as a 
positive control for a splicing defect. Total cellular RNA (4ig) was mixed with 
excess radiolabelled "reverse actin" prior to digestion with RNases A and Ti (see 
Section 2.3.5.5.). Samples were analysed on a 6% w/v denaturing, polyacrylamide 
gel and visualised by autoradiography. Pre-mRNA, exon 2 and exon 1 are shown. 
Due to differences in the abundance of the RNA species, the pre-mRNA section for 
PW50 and PW50Patl is from a longer exposure of the gel than exon 1 and exon 2. 
(B) Schematic representation of the radiolabelled probe used, and the RNA species 
protected. i) ACT] pre-mRNA; ii) radiolabelled RNA probe; iii) fragment protected 
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4.6. Spliceosomal snRNAs do not Co-immunoprecipitate with 
the Pati Protein. 
Disruption of the PAT] locus does not affect the stability of the spliceosomal 
snRNAs nor does it cause a splicing defect. However, these results do not 
necessarily preclude the Pati protein from associating with components of snRNPs 
or of the spliceosome. 
In order to examine the possibility of such physical associations, the antiserum 
described by Rodriguez-Cousino et al. (1995) was used for immunoprecipitation 
experiments. As reported, the antibodies recognised a single band of approximately 
1 OOkDa in the extract from PW50 cells, but no corresponding band in the extract 
from PW50APat1 cells (Figure 4.6A.). 
Total cell extract prepared from PW50 cells grown at 3 0°C, was used for 
immunoprecipitations with the polyclonal antiserum, and the RNA species co-
immunoprecipitating were examined by Northern analysis. Although demonstrated 
to be present in the extracts, none of the spliceosomal snRNAs could be 
immunoprecipitated with this antiserum under the conditions tested (Figure 4.613.). 
The membrane was successively stripped and reprobed for the small RNAs of 
RNase MRP, RNase P and 5S rRNA. Again, although present in the extract, none of 
these small RNA species could be co-immunoprecipitated with Patip (Figure 4.6C). 
Thus Patip would appear to have no RNA binding capacity for those RNA 
species tested. However, the possibility cannot be excluded that, under less stringent 
salt conditions than the 150mM used in these experiments, Patip could bind to or 
associate with a small RNA. 
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Figure 4.6. Patip does not associate with the spliceosomal snRNAs. (A) 
Identification of Patip. Total cell extracts were made from PW50 or PW50Pat1 
cells, and 50pg of protein were separated by 10% SDS-PAGE, and electroblotted. 
Immunodetection was performed using anti-Patip antiserum and alkaline 
phosphatase conjugated anti-rabbit antiserum. (B) snRNA precipitations. Total cell 
extract (500tg of protein) from PW50 cells was incubated with Protein-A 
Sepharose-bound antibodies against Patip (lane 3) or with Protein-A Sepharose 
(PAS) alone (lane 2). Incubation and washes were carried out in the presence of 
150mM salt. RNAs were separated on 6% denaturing polyacrylamide gels, 
electroblotted and probed with radiolabelled oligonucleotides specific for the 
spliceosomal snRNAs. Lane 1 shows deproteinised total RNA from the same 
extract. The identity of each RNA is shown on the left. (C) Other small RNAs. The 
membrane from (B) above was successively stripped and reprobed with 
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4.7. Co-immunoprecipitation of the Pati protein and Sm-like 
proteins. 
Patip was identified here by its ability to interact genetically with the Sm-like 
proteins in the two-hybrid assay. In order to confirm this proposed interaction 
biochemically, experiments were carried out to examine if Patip and the Sm-like 
proteins could be co-immunoprecipitated. Antiserum against Patlp was used to 
immunoprecipitate proteins from either wild-type (PW50) extracts, or from extracts 
made from strains expressing HA-tagged fusions of the Sm-like proteins (Chapter 
Eight). When the precipitated proteins were analysed by Western blotting, it was 
revealed that 7 of the 8 Sm-like proteins could be co-immunoprecipitated with the 
antiserum raised against Patip (Figure 4.7A.). The precipitation of Spb8p and 
Yjr022p was seen to be particularly strong, with Yb1026p, Yer146p Ydr378p, 
Yn1147p and Usslp all giving a weaker signal. This may reflect a weaker, or a more 
transient association between these proteins and Patip (compared to that of Spb8p 
and Yjr022p). Only Smx4p was not found to co-immunoprecipitate with antiserum 
against Patlp. 
The reciprocal set of experiments were also carried out, using antiserum against 
the HA-epitope, or against Ussip for the immunoprecipitations, and the anti-Patip 
antiserum for immuno-detection. Figure 4.7B. shows that Patip could be co-
immunoprecipitated from extracts containing HA-tagged versions of Spb8p, 
Yb1026p, Ydr378p or Yn1147c (lanes 1,2,5 and 6) and also with anti-Ussip 
antiserum (lane 9). No Patip signal could be detected from extracts containing HA-
tagged Smx4p, Yer146p or Yjr022p (lanes 3,4 and 7). To distinguish if this lack of 
signal was due to a lack of association, or whether the Sm-like protein had failed to 
precipitate in these samples, the membrane was stripped and reprobed with anti-HA 
antiserum (Figure 43C.). This confirmed that in all cases, the Sm-like proteins were 
immunoprecipitated and that the lack of signal for the Pati protein (with Smx4p, 
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Yer146p or Yjr022p) was due to the absence of a molecular association between 
Patip and these Sm-like proteins under these experimental conditions. 
The apparent co-precipitation of the Ga14 activation domain with Patip, and its 
implications will be discussed in Section 4.8. 
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Figure 4.7. Co-immunoprecipitation of Patip and Sm-like proteins. (A) Splicing 
extracts from strains expressing HA-tagged Sm-like proteins (lanes 1-7), Ga14AD-
HAp (lane 8) or from PW50 cells (lane 9) were subjected to immunoprecipitation 
with antiserum raised against the N-terminal region of Patip. Incubation and washes 
were done at 150mM salt. Precipitated proteins were separated on a 10% SDS-
polyacrylamide gel and electroblotted. Antiserum against the HA-epitope (lanes 1-
8) or against Ussip (lane 9), was used for immunodetection in conjunction with the 
relevant HRP-conjugated secondary antibody. Visualisation was carried out by 
ECL. The position of the full-length, Sm-like proteins co-immunoprecipitated is 
shown by an asterisk (*). (B) The extracts used in (A) above were subjected to 
immunoprecipitation with antiserum against the HA-epitope (lanes 1-8), or against 
Ussip (lane 9). Precipitated proteins were fractionated and blotted as before. The 
membrane was probed sequentially with anti-Patip antiserum and HRP-conjugated 
secondary antibody and visualised by ECL.(C) Membrane from (B) was stripped 
and reprobed with anti-HA antiserum and HRP-conjugated secondary antibodies. 
All panels, extracts were HA-Spb8p from AEMY28; Yb1026-HA from AEMY33; 
HA-Smx4 from AEMY31; HA-Yer146 from AEMY29; HA-Ydr378 from 
AEMY19 [pAEM61]; HA-Yn1147 from AEMY22 [pAEM62]; HA-Yjr022 from 
LMA4-2A; Ga14AD-HA from AEMY9 [pACTIIst]; PW50 from PW50 cells. 
Extracts expressing proteins tagged to the Ga14 activation domain are marked with a 
dollar sign ($). 
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4.8. Discussion. 
The Pati protein encoded by YCR077c, was identified in all the two-hybrid 
screens with the Sm-like proteins as baits (Chapter Three and Appendix I). This 
protein had previously been identified (Rodriguez-Cousino et al., 1995; Wang et al., 
1996) and shown to be associated with topoisomerase II (Wang et al., 1996). 
However, the available literature gave conflicting reports as to the phenotypic effect 
of disruption of this ORF, and on the localisation of the protein. More recently, 
subcellular fractionation and immunoblotting has shown the Patl protein to be 
found in both the nucleus and cytoplasm in approximately equal amounts (F. Wyers, 
pers. comm.). No information has previously been presented to suggest a link 
between Patip and pre-mRNA splicing, or any other RNA processing pathway. 
The specificity of the interaction between Patip and the U6-associated Sm-like 
proteins (see Chapter Eight) but not with the canonical Sm proteins, is emphasised 
by comparison with the two-hybrid screens performed with the seven canonical Sm 
proteins as baits. None of these screens identified Patip as a potentially interacting 
protein (Fromont-Racine et al., 1997; P. Legrain, pers. comm.). 
Biochemical analysis of the Pati protein, and of the temperature-sensitive cells 
produced by disruption of the ORF revealed no snRNA association and no splicing 
defect. Similarly, over-production of Ussip, or U6 snRNA, could not rescue the 
temperature-sensitive phenotype of these cells, and the protein was shown not to be 
required for the stability of a range of small RNA species. These results suggest that 
Patip may not be involved in pre-mRNA splicing. 
However, the cells used in these experiments, PW50APat1 (Wang et al., 1996), 
which carry a disruption of the PAT] ORF, still contain a portion of the 3' end of the 
coding sequence. The possibility exists that this region may be fortuitously 
expressed, producing a 100 amino acid polypeptide capable of restoring (some of) 
the functional activity of Patlp. The region of Patip involved in the interaction with 
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the Sm-like proteins (as determined from the two-hybrid screens) is deleted in these 
cells, and as such any interaction with the Sm-like proteins e.g. in a protein 
complex, would need to be indirect, and would seem unlikely to occur in these cells 
The lack of a splicing effect in the temperature-sensitive cells disrupted at the 
PAT] locus would strongly suggest that the protein is not involved in the splicing 
pathway. However, the splicing of only two intron-containing genes was assayed, 
and the possibility that only a subset of genes may require Patip for their efficient 
splicing cannot be formally excluded at this point. A precedent for such activity 
exists, for example the Slu7 and Prpl 8 proteins are only required for the splicing of 
genes in which the distance from the branch point to the 5' splice site is greater than 
11 nucleotides (Brys and Schwer, 1996; Zhang and Schwer, 1997). 
The interaction between the Sm-like proteins and Patip suggested by the two-
hybrid screens was confirmed by co-immunoprecipitation (Section 4.7.). Of the 
proteins tested, only Smx4p could not be precipitated by antibodies raised against 
the Pati protein. However, it would appear that the Pati protein may have an 
affinity for the Ga14 activation domain (see Figure 4.7., lane 8 in both A and B). 
Given this, Patip may have fortuitously co-immunoprecipitated the Yer146 and 
Yjr022 proteins, due to the presence of the Ga14 activation domain in the fusion 
proteins used. An affinity for the Ga14 activation domain could also explain the 
powerful auto-activation properties of the full-length Pati protein as a two-hybrid 
bait (C-H. Chua and I. Dix, pers. comm.) since all prey fusions will be localised to 
the promoter region, irrespective of the fusion protein they encode. Howev&r, from 
this it would be expected that in the reciprocal co-immunoprecipitation experiment 
with anti-HA antibodies the Pati protein should be co-immunoprecipitated. Figure 
43B., lanes 4 and 7 hOwever, show that this is not the case. An alternative 
explanation for the co-precipitation is that the antibodies against the Pati protein 
cross-react with the Ga14 activation domain, however this does not account for the 
co-precipitation of Patlp with the Ga14 activation domain using the anti-HA 
antibodies (Figure 4.7B, lane 8). Whatever the true reason, further experiments 
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would be required to confirm the validity of the co-immunoprecipitation of Yer146p 
and Yjr022p with anti-Patip antibodies. 
As none of the other Sm-like proteins is fused to the Ga14 activation domain, the 
co-immunoprecipitation results with these proteins may be considered to be reliable. 
The possibility that the Pati protein recognises the HA epitope and not the actual 
Sm-like proteins can be discounted since HA-Smx4p cannot be co-
immunoprecipitated with Patlp in either orientation of the experiment. The HA-
Smx4 protein is however precipitable with anti-HA antibodies (Figure 43C., lane 
3). 
Thus, Spb8p, Ussip, Yb1026p, Ydr378p and Yn1147p all revealed reciprocal co-
immunoprecipitations with Pat ip, and it seems likely therefore that these proteins 
may form a complex, although it cannot be determined from these experiments 
whether all of the Sm-like proteins proposed as part of this complex, would interact 
with Patip simultaneously. 
A two-hybrid screen with a N-terminally deleted form of Patip as bait (to 
overcome the auto-activation) failed to identify any of the Sm-like proteins as 
potentially interacting factors (C-H. Chua and I. Dix, pers. comm.). However, Psuip 
was identified as an Al category prey for a potential interaction. This protein was 
also identified in screens with Uss 1 p  (Table 3.1.), Yj r022p (Fromont-Racine et al., 
1997) and Yb1026p (Appendix I), and as such may form part of the proposed 
complex with the Pati and Sm-like proteins. 
The function of this proposed complex is unknown, although its involvement in 
the splicing reaction per se would seem unlikely from the biochemical data 
discussed above. The strength of the co-immunoprecipitation of Patip and Spb8p 
has led to the hypothesis that the complex may be involved in mRNA decapping 
and degradation, since the Spb8 protein has already been demonstrated to play a role 
in this activity (Boeck et al., 1998). Such a proposal would also allow for the 
interactions of Usslp with Dcplp and Xrnlp (Table 3.1.), and Yb1026p with Xrnlp 
(Appendix I). The associations with Psuip, which is known to be phosphorylated 
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(by Hrr25p (A.J. DeMaggio, pers. comm.) also implies that the proposed complex 
may be involved in an active or regulated process, indeed Dcplp is also known to be 
a phosphoprotein (LeGrandeur and Parker, 1998). 
The phenotype produced by the disruption of the PAT] ORF, upon closer 
examination, is not inconsistent with that expected for cells defective in mRNA 
decapping and degradation (R. Parker, pers. comm.). Thus it remains possible that 
the Patip, together with the Sm-like proteins and possibly Psuip, may form a 
complex which is involved in the mRNA degradation pathway. 
This proposal could be examined in vivo using the conditional strains and assay 
systems already available (Hatfield et al., 1996). Similarly, synthetic lethal and/or 
suppression studies could be used to genetically analyse the proposed links between 
the proteins involved. Synthetic lethality may prove to be the more powerful 
approach given that several of the core proteins are dispensable for cell growth 
(Chapter Seven), as are Pat 1 p  (Rodriguez-Cousino et al., 1995; Wang et al., 1996), 
Dcplp (Beelman et al., 1996) and Psuip (A.J. DeMaggio, pers. comm.). The 
physical interactions between each of the proteins potentially involved in the 
proposed complex could be analysed biochemically by co-immunoprecipitation, 
and/or by in vitro transcription and translation experiments. 
Thus, the two-hybrid screening experiments have identified novel links between 
the Sm-like proteins and previously identified proteins (Patip and Psuip), and have 
opened up many new avenues for research into the function of these proteins. 
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CHAPTER FIvE, 
CHARACTERISATION OF YLR386w 
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5.1. Sequence Analysis of the Y1r386 Protein. 
The hypothetical protein Ylr386p was identified in the pAEM13 two-hybrid 
screen as the most statistically significant candidate for interaction with Uss 1 p  (see 
Table 3.1.). A total of 23 clones encoding 9 independent fragments of the protein 
were isolated. The YLR386w ORF is 2,640 nucleotides in length, and encodes a 
protein of 880 amino acids with a predicted molecular weight of 99.7kDa. No 
functional data are available for this protein in any database searched. 
The protein sequence, as shown in Figure 5.1A, contains no recognised motifs, 
although there is a proposed trans-membrane domain between residues 426 and 442. 
A putative di-basic, nuclear localisation signal may also be present between residues 
311 to 323. The complete amino acid composition for the protein is shown in Figure 
5.113, and reveals a high proportion of leucine residues; 14.2% of the total amino 
acids. Many of the leucines are found as di-leucine pairs at 15 locations scattered 
throughout the protein sequence (Figure 5.1A). The potential significance of these 
di-leucine pairs will be discussed later (see Section 5.8.). Thus, examination of the 
sequence of the Y1r386 protein gave no clues as to the role of this protein, or its 
involvement in the splicing pathway. 
Protein database searches with the Y1r3 86p sequence revealed two putative 
homologues, from S. pombe and from C. elegans. Alignment of these sequences 
revealed two main domains of homology, one at the N-terminus, and the other 
toward the C-terminus (Figure 5.2A). As with Ylr386p, no functional data were 
available for either of these proteins. Searches of databases containing EST 
sequences identified a number of fragments (from a range of organisms) with 
extensive sequence similarities to Y1r3 86p (Figure 5 .2B). Interestingly, these 
regions of similarity fall within the domains previously identified with the S. pombe 
and C. elegans sequences. 
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Figure 5.1. Sequence analysis of Y1r3 86p. (A) Predicted amino acid sequence of the 
Y1r386 protein. The proposed trans-membrane domain is underlined, with the 
putative nuclear localisation signal double underlined. Di-leucine pairs are shown in 
italics. Standard amino acid abbreviations apply. (B) The amino acid composition of 
Y1r3 86p is given as the number of residues of each present (n) and as the percentage 
of the total residues (n(%)). 
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LI Amino Acid n n(%) 
A ala alanine 46 5.2 
C cys cysteine 13 1.5 
D asp aspartic acid 59 6.7 
E glu glutamic acid 56 6.4 
F phe phenylalanine 34 3.9 
G gly glycine 31 3.5 
H his histidine 15 1.7 
I ile isoleucine 68 7.7 
K lys lysine 56 6.4 
L ieu leucine 125 14.2 
M met methionine 20 2.3 
N asn asparagine 56 6.4 
P pro proline 31 3.5 
Q gin glutainine 36 4.1 
R arg arginine 37 4.2 
S ser serine 81 9.2 
T thr threonine 40 4.5 
V val valine 43 4.9 
W trp tryptophan 5 0.6 
Y tyr tyrosine 28 3.2 
Figure 5.2. Sequence alignment of Y1r386p and putative homologues. (A) Proposed 
homologues from S. pombe and C. elegans were identified by BLAST searches of 
the NCBI nr peptide sequence database (Section 2.4.). Sequences were aligned 
using the PILEUP program of the GCG9 suite of sequence analysis programs, with 
identities and similarities highlighted using BOXSHADE 3.21 (Section 2.4.). White 
on black represents identity between all three sequences, black on grey represents 
conservation of the nature of the amino acid at that site. Accepted conservative 
groupings were M=I=L=V, K=R=H, F=Y=W, S=T, E=D, A=G and Q=N. The 
accession numbers of the proteins are as follows S. cerevisiae, S51473; S. pombe, 
Z95397; C. elegans, Z75712. (B) Schematic representation of EST sequences 
sharing homology with Y1r386p. Each dumbbell represents an EST encoding a 
peptide with similarity to the Y1r386 protein. S. c., Saccharomyces cerevisiae; D. 
m., Drosophila melanogaster; M. m., Mus musculus; H. s., Homo sapiens. Sequence 
accession numbers (a) AA439067, (b) AA439873, (c) AA517424, (d) W97985, (e) 
AA497446, (f) AA036005 and(g) AA346222. 
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In order to define the region of Y1r386p responsible for the interaction with 
Uss ip, the C-terminal encoding regions of the two-hybrid prey were sequenced and 
mapped. An alignment of the fusions reveals a defined minimum region of overlap 
between amino acids 377 to 743 (see Figure 5.3). However, the region actually 
required for the interaction is likely to be smaller than this, since the 3' end of the 
fusion beginning at nucleotide 1,030 (relative to the AUG) was identified as being 
from the non-coding strand of the MSN2 gene. This gene if found on chromosome 
XIII and is unlinked to YLR386w. This arrangement found in this clone is likely to 
have resulted from the ligation of two separate genomic DNA fragments into the 
pACTIIst vector during the construction of the library. The precise length of 
YLR3 86w sequence in this clone was not determined, since only the extremities of 
the fusion were sequenced, however as the total insert size is only approximately 
1 ,000bp, this would still reduce the minimum region of the interaction even if it was 
all YLR386w sequence within the fusion. Thus the minimum region is likely to be 
substantially smaller than the 366 amino acids depicted in Figure 5.3. 
When the minimum region as defined above was used to search protein 
databases, only the proteins previously identified as homologues were found. No 
clues were therefore given as to any potential motifs in this region which could help 
suggest a function for this protein, however the region does contain the conserved 
domain at the C-terminus identified in Figure 5.2. 
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Figure 5.3. Definition of the minimum region of Y1r386p required for the two-
hybrid interaction with Ussip. The fragments of YLR386w identified from the 
FRYL library are shown in yellow, with the minimum region of overlap in red, and 
the nucleotide number (relative to the A of the initiating AUG) at the point of fusion 
quoted below each fragment. The blue bar represents sequence from the MSN2 
gene. The region of Y1r386p containing the interaction domain is defined and its 
position and size within the protein sequence is represented by the bottomost bar. 
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5.2. Potential Interactions of Y1r386p with Known Splicing 
Factors. 
Given the range of Y1r3 86p fragments available from the pAEM 13 screen, direct 
mating experiments were carried out to determine if this protein can also potentially 
interact with other splicing factors. Although no other two-hybrid screens with 
splicing factors have identified Y1r386p (Fromont-Racine et al., 1997 and J.D. 
Beggs, pers. comm.), the use of fragments in the directed assay could reveal some 
previously unseen interactions. 
Each of the Y1r3 86p fragments was tested for interaction against a range of baits, 
predominantly encoding proteins known to be associated with the U2 or U6 
snRNAs. In the majority of cases, no positive interactions were seen, as witnessed 
by a failure to grow on selective medium (YMM -LWH + 5mM 3-AT) or to go blue 
in a -galactosidase filter-lift assay (Figure 5.4). In two cases however positive 
interactions were identified 1) between Uss1p and the Y1r386p fragments, and ii) 
between Prp9p and a subset of the Y1r386p fragments. 
Full length Ussip, and Ussli\p, show no observable difference in the strength of 
interaction with Y1r386p, suggesting that only the N-terminal portion of Ussl 
(present in Uss lAp) is required for the interaction with Y1r3 86p. As neither Uss 1-A, 
nor Ussl-B, which encode fusions of only the Smi or Sm2 domains respectively, 
supported a two-hybrid interaction with the Y1r386p fragments, both Sm domains 
would appear to be necessary for the interaction. The observation that Smx4p did 
not interact with any of the Y1r3 86p fragments indicates that the interaction with 
Ussip was specific, and not simply due to the common fold of the Sm-like proteins. 
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Figure 5.4. Directed two-hybrid experiments with Y1r386p fragments. 
Fragments of Y1r386p were tested for two -hybrid interactions with a number of 
bait fusions in a direct mating assay (Section 2.2.9.). Diploid cells were grown 
on solid selective medium (YMM -LWH + 5mM 3-AT) for 3 days. The filter 
shown is from a 3-galactosidase filter-lift assay that was stopped after 2 hours 
incubation at 301C. The bait vectors used are described in Table 2.1.12.; 
Vector, pAS2A; Ussip, pAEM13; Usslp, pAEM15; Ussl-A, pAEM29; 
Ussl-B, pAEM30; Smx4p, pAEM17; Prp24p, pAEM23. Prp9p, Prpl ip and 
Prp2lp are all in pAS2AA (Table2.1.12.); (Fromont-Racine etal., 1997). 
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When the three fragments of Y1r3 86p interacting with Prp9p were examined, it 
was seen that these are the fusions which were used to define the C-terminal 
boundary of the minimal interaction domain. Thus, these fragments represent the 
most C-terminally truncated fusions of the protein, and indeed the strongest 
interaction was with the smallest fragment (encoded by the clone described above, 
whose fusion begins 1,030 nucleotides from the AUG). For those fragments which 
do not support a two-hybrid interaction with Prp9p, it is thought that the folding of 
the C-terminal portion of the protein probably interferes with the interaction 
domain. How this may relate to the wild-type situation will be discussed later (see 
Section 5.8.). At this stage it cannot be concluded whether the interaction seen with 
the fusion beginning at nucleotide 1,030 is due to the fragment of Y1r386p, or the 
peptide produced from the fragment of the MSN2 gene. 
The prey fusions beginning 798 and 1,129 nucleotides from the AUG were also 
tested against baits encoding the splicing factors Slu7p, Prpl8p, Prpl6p, Prp2p and 
against fragments of Prp8p. In all cases no positive two-hybrid interactions were 
identified (data not shown). 
5.3. Cloning of YLR386w by Gap Repair. 
In order to examine the role of the Y1r386 protein in more detail, the full-length 
ORF was cloned, with its own upstream sequence, using the gap repair strategy 
outlined in Figure 5.5. Subsequently, the gene was transferred from this centromeric 
construct (pAEM42) on an EcoRI cassette, to a high-copy number plasmid to 
produce pAEM44. 
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Figure 5.5. Schematic representation of the cloning of YLR3 86w. (a) A 61 7nt 
fragment of YLR386w (encoding 531nt of the 5' untranslated region (UTR) and 
86nt of the coding sequence) was generated by PCR using genomic DNA as a 
template, and primers V5579 and V5580. The fragment was blunt cloned directly 
into pBluescript at the unique EcoRV site of the polylinker, to generate pAEM39. 
The insert was sequenced, with no PCR-introduced errors found. (b) C-YLR386w, 
the region of YLR386w encoding the carboxy-terminus of the protein was isolated 
from the two-hybrid prey fusion starting 984 nucleotides from the AUG, as a 
HindIII/XhoI fragment. (c) C-YLR386w was cloned into pAEM39 between the 
Hindlil and XlioI sites of the polylinker to generate pAEM40. (d) A NotIIXhoI 
fragment encompassing both the 5' UTR region and C-YLR386w was isolated and 
cloned into pRS316 (e) at these sites, to generate pAEM41. (f) pAEM41 thus 
contains the 5' UTR and C-terminal encoding regions of YLR386w and was 
linearised between these regions with ClaI and Hindill to generate a gapped vector, 
which was gel purified. (g) This linear DNA was transformed into W303, and 
clones were selected for their ability to grow on solid medium lacking uracil, 
indicating that the vector had been successfully gap-repaired with the YLR386w 
ORF. (h) The repaired vector, pAEM42, containing the 5' UTR and the entire 
YLR386w coding sequence was rescued and verified by restriction analysis. 
Restriction sites; C, ClaI; E, EcoRI; H, Hindill; N, NotI; X, XhoL 
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5.4. Disruption of YLR386w at its Chromosomal Locus. 
As a first step in the characterisation of the Y1r3 86 protein, the YLR3 86w coding 
sequence was disrupted at its chromosomal locus. This was done by replacing a 
823bp ClaI-SalJ fragment of YLR386w (from nt 9 to 832) with the HIS3 gene 
(isolated from the Ylpi vector) to produce plasmid pAEM43. The plasmid was 
linearised and homologous recombination used to transfer this disrupted copy of the 
ORF to the genome in W303 cells, thereby creating strain AEMY3. The integration 
was confirmed by Southern analysis (Figure 5.6A). The AEMY3 diploid strain was 
sporulated and tetrads dissected. All four spores from any single ascus were found 
to be viable (Figure 5.613), although in all cases two of the spores displayed a slower 
growth phenotype, which segregated with histidine prototrophy (Figure 5.6C). If 
YLR386w is essential for cell viability, it is possible that the expression of around 
1,800bp from the 3' end of the gene, not deleted in AEMY3, could partially rescue 
the growth defect in haploid cells carrying the disruption i.e. AEMY3n cells. 
However, the lack of an upstream promoter sequence, and the presence of stop 
codons at the end of the HIS3 fragment inserted into the ORF, should prevent the 
fortuitous expression of this C-terminal portion of Y1r386p. 
The AEMY3n cells were assayed for growth on solid medium at a range of 
temperatures between 14°C and 3 7°C. No arrest of cell growth was seen at any of 
the temperatures tested, although the slower growth rate was exacerbated at 37°C 
(data not shown). When the rate of growth was analysed in liquid media at 30°C or 
37°C, AEMY3n cells were seen to double in 168 minutes at 30°C and 327 minutes 
at 37°C (Figure 5.7A). This compares to W303 haploid cells which double in 86 
minutes at 30°C and 94 minutes at 37°C. 
The specificity of the gene disruption, and the successful expression of 
YLR386w from pAEM42 were demonstrated by the ability of pAEM42 to rescue 
the slow-growth phenotype of AEMY3n (Figure 5.713). 
Thus, YLR386w is regarded as non-essential for the viability of cells, although 
disruption of the ORF does cause a severe growth defect. 
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Figure 5.6. Analysis of disrupted YLR386w. (A) Southern analysis of AEMY3. 
Genomic DNA was prepared from AEMY3 and from W303, and digested with 
restriction enzymes BamHI and EcoRV. Fragments were separated on a 1% wlv 
agarose gel, blotted and probed with a radiolabelled fragment of the 5' UTR of 
YLR386w. Lane 1, W303; Lane 2, AEMY3. (B) Tetrad analysis of AEMY3. 
Dissected tetrads were grown on solid YPDA medium at 23°C for 6 days. (C) The 
spores shown in (B) were tested for histidine auxotrophy on solid medium (YMM - 
H). + indicates cells able to grow on medium lacking histidine; - indicates cells 
unable to grow on the same medium. 
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Figure 5.7. Growth analysis of AEMY3n. (A) Haploid cells disrupted for 
YLR386w (AEMY3n), or wild type at this locus (W303n) were grown to mid-log 
phase in liquid minimal media at 3 0°C. Cells were harvested and resuspended in 
pre-warmed media (at either 30°C or 3 7°C) to an 0D 600 of approximately 0.1. 
Samples were removed at 2 hour intervals (up to 14 hours) and the 0D 600 measured. 
Cultures were diluted with pre-warmed media, as appropriate, to keep all 0D 600 
readings below 0.8, maintaining the cells in mid-log phase. (B) The growth of 
AEMY3n cells carrying pRS3 16, or pAEM42 was followed at 3 0°C. All cultures 
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5.5. Disruption of YLR386w has no Effect on the Levels of 
Spliceosomal snRNAs. 
The effect of the disruption of YLR386w on the steady state levels of the 
spliceosomal snRNAs was examined. Total RNA, isolated from AEMY3n or 
W303n cells grown at 23°C, 30°C or 37°C was assayed by Northern analysis. Five 
micrograms of RNA was loaded for each sample. No change in the steady state 
levels of the snRNAs was observed between disrupted and parental cells (Figure 
5.8., compare lanes 1-3 with 4-6), or between cells grown at 23°C, 30°C or 37°C 
(Figure 5.8., compare lanes 1 and 4, 2 and 5, 3 and 6). Thus, disruption of 
YLR386w does not effect the stability of the spliceosomal snRNAs, and the slow 
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Figure 5.8. Disruption of YLR386w does not affect the spliceosomal snRNA levels. 
Total RNA was extracted from W303n (lanes 1-3) or from AEMY3n (lanes 4-6) 
grown continuously at 23°C, 30°C or 37°C. The RNA (51g/lane) was separated on a 
denaturing 6% w/v polyacrylamide gel, electroblotted and probed with radiolabelled 
oligonucleotides specific for the spliceosomal snRNAs. The positions of Ui, U2, 
U4, U5L, U5 5 and U6 snRNAs are indicated. - 
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5.6. Potential Genetic Interactions of YLR3 86w. 
Two-hybrid data suggested links between Y1r386p and both Ussip and Prp9p. In 
order to examine these interactions, genetic complementation experiments were 
carried out. The ability of Y1r386p (when over produced from a centromeric or a 
high-copy number plasmid) to complement MCY4 or Cy103 (prp9-1 temperature-
sensitive strain; Chapon and Legrain, 1992) was tested. Y1r386p produced from 
either plasmid was unable to rescue the growth of MCY4 cells grown on glucose 
medium (Figure 5.9A.). Thus, over-producing the Y1r386 protein is not sufficient to 
by-pass the requirement for Ussip. Similarly, neither Ylr386p-producing plasmid 
could suppress the temperature-sensitive phenotype of Cy103 at 37°C (Figure 5.913), 
suggesting that YLR386w and PRP9 do not interact genetically. 
The effect of over-producing the Y1r3 86 protein in a prpl 1-1 temperature-
sensitive strain (A635); (Legrain and Rosbash, 1989) was also examined, since 
Prpl ip has links with both Ussip (two-hybrid data, see Section 6.2.) and with 
Prp9p (both U2 snRNP proteins). The growth defect of A635 at 37°C could not be 
suppressed by the over production of the Y1r386 protein (Figure 5.9C.), and thus it 
was concluded YLR386w does not interact genetically with PRPJJ in this assay. 
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Figure 5.9. Genetic complementation studies with Y1r386p. (A) 3 individual 
transformants of MCY4 carrying pRS316, pAEM12, pAEM42, YEplac195 or 
pAEM44 were resuspended and spotted onto galactose (YMGa1 -U) or glucose 
(YMM -U) medium. Plates were incubated at 30°C for 4 days. (B) 3 individual 
transformants of Cy 103 carrying YCp50, pPL 12, pRS3 16, pAEM42, YEplac 195 or 
pAEM44 were resuspended and spotted onto YMM -U medium. Plates were 
incubated at 23°C or 37°C for 4 days. (C) 3 individual transformants of A635 
carrying YEp13, C379, pRS316, pAEM42, YEplac195 or pAEM44 were 
resuspended and spotted onto selective medium (YMM -L for YEp13 and C379, 
YMM -U for pRS3 16, pAEM42, YEplac 195 or pAEM44). Plates were incubated at 
23°C or 37°C for 4 days. For all panels, the relevant features of each plasmid are 














































5.7. Two-Hybrid Screen with Y1686p. 
To this point, the only evidence of the involvement of Y1r386p in the splicing 
pathway was the two-hybrid interactions identified with Ussip, and Prp9p. In order 
to gain further clues as to the function of the Y1r386 protein, a two-hybrid screen 
was performed to identify the proteins with which it may interact. 
The full-length ORF was cloned into the pBTM1 16 two-hybrid bait vector, and 
used to screen the FRYL genomic library. A total of 22.8 million diploids were 
screened at a mating efficiency of 50%. This identified 95 clones which passed both 
selective criteria (the ability to grow on medium lacking histidine, and a positive J3-
galactosidase assay). Sequence data were obtained for all but 12 of these clones, and 
are presented in Table 5.1. Eight of the clones were empty prey vectors and are not 
included in the Table 5.1. 
The only Al candidate protein identified in this screen was Y1r386p i.e. the 
protein used as bait. A total of 9 clones were found to contain fragments of this 
protein, present as four different fusions. No splicing, or other RNA processing 
proteins were found, indeed those proteins which were identified appear to have no 
shared features, or common function. 
IVII] 
Table 5.1. Results of two-hybrid screen with Y1r386p as bait. The prey plasmid inserts are ordered by ORF number. All gene and ORF 
names are given as defined by the Saccharomyces Genome Database, SGD. Identical clones are those with the same start point and insert 
size. Anti relates to fusions which begin on the antisense (i.e. the non-coding DNA strand) of an ORF; Inter relates to fusions which begin in 
intergenic regions; Ribo represents ribosomal DNA; Mito represents mitochondrial DNA; TY represents DNA from TY elements; c, Crick 
DNA strand; w, Watson strand (as defined by SGD); Cbr. nt., nucleotide position on the chromosome at which the fusion begins; nt from 
AUG, distance from the start of the coding sequence (A of the initiation (AUG) codon) to the point at which the fusion begins. Approximate 
insert size was determined by BamHI restriction digest and agarose gel electrophoresis. The categories used are as described in Section 3.1. 
(defined by Fromont-Racine et al., 1997).  
Bait 	j Clone Ident. clones Gene OF Chr Strand J 	Chr. nt. nt. from AUG ORFse Insert size Category 
LexA-Y1r386 87  anti 'IBR055c u w 346461  550 B 
LexA-Y1r386 55  anti YBR184w 11 c 597435  800 B 
LexA-Y1r386 2  FUSI YCL027w UI w 72999 1231 1539 350 A4 
LexA-Y1r386 30 50,79,92 inter YDL047w/YDLO48c IV c 368872  900 B 
LesA-Y1r386 9 78 inter YDL110c/YDLI1Ic IV w 264353  700 B 
LexA-Y1r386 82 ____________ inter YDLI35c/YOL136w IV c 218595  600 B 
LexA-Y1r386 31  anti YDR248c IV w 958114  200 B 
LexA-Y1r386 10  anti YDR331w IV c 1129709  500 B 
LesA-Y1r386 46  inter YDR419w/YDR420w IV c 1305797  350 B 
LexA-V1r386 1 17  VDR466w IV w 1397010 1855 2969 1250 A3 
LexA-Y1r386 3  YGL066w VII w 378267 660 1974 1100 A3 
LexA-Y1r386 8  anti YGL083c VII c 353105  700 B 
LexA-Y1r386 20 48 inter YGR05ICIYGR052w VU w 593307  300 B 
LexA-Y1r386 7  ADE3 YGR204w VU w 908079 2151 2840 700 A4 
LexA-Y1r386 35  YGR241c VII c 976591 -15 1706 1800 A2 
LexA-Y1r386 89  anti YIL085c w 201341  1300 B 
LexA-Y1r386 44  YIL145c D( C 76511 880 1038 500 A4 
LexA-Y1r386 22 27,34,60,90 CCEI YKL011c XI c 419926 931 1061 750. A4 
LesA-Y1r386 43  YLL029w XII w 81707 247 2250 1200 A4 
LexA-Y1r386 Il 21,25,62,74  YLR093c XII c 326563 706 755 1100 A4 
LexA-Y1r386 58 69  YLR301w XII w 730909 84 735 500 A2 
LexA-Y1r386 6 12,37,67  YLR386w XII w 894424 797 2643 1500 Al 
LexA-Y1r386 32 40,41  YLR386w XII w 894620 993 2643 1300 Al 
LexA-Y1r386 88  YLR386w XII w 894621 995 2643 1100 Al 
LexA-Ytr386 4  YLR386w XII w 894659 1,032 2643 300 Al 
LexA-Y1r386 68  inter YLR441c/YLR442c XII c 1019131  350 B 
LexA-Y1r386 45  CLUI YMR012w XIII w 291965 832 3834 450 A4 
LexA-YIr386 38 47 inter YMR027w/YMR028w XIU c 327367  300 B 
LexA-YIr386 52  anti YMR307w XIU C 888379  600 B 
LexA-Y1r386 73  YNL323w XIV w 32958 1015 1245 700 A4 
LexA-Y1r386 72  YNL325c XIV c 29702 2305 2640 350 A4 
LesA-Y1r386 76  anti YOL066c XV w 1 	203683  600 B 
LexA-Y1r386 54  anti YOL066c XI.' w 203731  1100 B 
LexA-Ytr386 13  inter 'IOR075wIYOR076c Xv w 469293  500 
LexA-Y1r386 56  inter YOR103c/YORI04w XV w 517040  600 
LexA-YIr386 94  inter YPLI70w/YPL169c Xvi c 228707  350 B- 
LexA-Y1r386 16 77,95  YPR029c Xvi c 625920 1042 2498 400 A 
LesA-YIr386 53  inter YPRI94cIYPRI95c Xvi c 927605  700 - - 
LexA-Y1r386 51  mito  200 
LexA-Y1r386 61  ribo  900 - 
LexA-YIr386 64 91 ribo  600 B- 
LexA-YIr386 15 2357,93 TV  900 
LexA-Y1r386 19 24,86 IV  1600 
LexA-VIr386 36 39 TV  300 
LexA-Y1r386 63  IV ___________________ - _______ ____________  200 
5.8. Discussion. 
The protein encoded by the YLR386w ORF was isolated as the most statistically 
significant interaction in the pAEM1 3 two-hybrid screen with the Ga14 DNA 
binding domain:Uss 1 fusion protein as bait. Twenty-three of the 169 potentially 
interacting prey fusions encoded Ylr386p fragments. 
Direct mating experiments revealed that the interaction is specific for the N-
terminal half of Uss ip, and that both Sm-motifs are required for the interaction. 
This specificity was confirmed by the two-hybrid screens performed with the other 
Sm-like proteins as baits, none of which identified Y1r386p as an interacting protein 
(see Chapter Three and Appendix I). Indeed no two-hybrid screens performed with 
splicing factors, either in this lab, or in the lab of P. Legrain have identified Y1r386p 
as an interacting factor (Fromont-Racine et al., 1997; J. Beggs, pers. comm.; P. 
Legrain, pers. comm.). This could indicate that the interaction with Ussip is a false-
positive, however the statistical significance of the interaction, both in terms of the 
number of independent fusions isolated and the frequency of their isolation would 
argue against this. Given the large size of Y1r386p (880 amino acids with a 
predicted molecular weight of 99.7kDa) it would also seem unlikely from the multi-
molecular complexes containing Usslp, that only the Ussl protein was able to 
interact with Ylr386p. Indeed, if the interaction is with a snRNP-associated Ussi 
protein, it could be expected that a number of other snRNP-associated proteins 
might interact with Y1r386p. To date, two-hybrid screens have failed to identify any 
such interactions, however direct matings did reveal a potential interaction with 
Prp9p. This will be discussed in more detail later. 
An intriguing possibility from the screen results is that the interaction between 
Ussip and Ylr386p involves a non-snRNP associated form of Usslp. RNA-free 
protein complexes have been shown to form between human canonical Sm proteins 
e.g. between B and D3 or Dl and D2 (Lehmeier et al., 1994; Raker et al., 1996). If 
such complexes also assemble in the case of the Sm-like proteins, it could be in one 
of these forms that Uss 1 p  interacts with Y1r3 86p. The two-hybrid screen with Uss 1 p 
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as bait also identified a number of proteins (some partially characterised and some 
novel) which have no reported snRNP-associations or connections to the splicing 
pathway. The possibility exists that these proteins may be involved in cellular 
processes in conjunction with Ussip and Ylr386p. It was hoped that the two-hybrid 
screen with Y1r386p would possibly identify some of these proteins, however the 
data set achieved did not provide significant new interaction data other than 
suggesting a homeotypic interaction for this protein. The other "positive" clones 
encoded mainly B category interactors, together with a selection of single fusion A 
category candidates. Such a profile suggests potential problems with the bait fusion 
protein, and that alternative approaches may be more informative about the 
interactions of this protein. 
No functional data are available for the Y1r386 protein although structural 
homologues exist in a range of species (see Figure 5.2A and B). Two main areas of 
conservation exist, one at the N-terminus, the other towards the C-terminus. When 
the region of Y1r3 86p required for the interaction with Uss 1 p  was delineated, it was 
found to lie in this second conserved region, allowing the intriguing suggestion that 
this may represent a conserved protein-protein interaction domain. Whether such an 
interaction exists in other organisms is not known. 
The minimal region required for the interaction was found to be within a region 
300 amino acids in length (the exact length is not known since the clone encoding 
the smallest Y1r386p fragment has part of the MSN2 gene 3' to the YLR386w 
sequence). This suggests that either the limits of the two-hybrid screening have not 
allowed the smallest region of interaction to be identified, or that a large fragment of 
the protein is required for the interaction. Given that the average size of insert in the 
FRYL library is approximately 700bp, the fact that all the Y1r386p fragments 
isolated were greater than 1 000bp in length would agree with the second of these 
proposals i.e. that a large fragment is required for the interaction. 
It is possible however, that while residues well separated in the sequence of 
Y1r386p may be required for the interaction with Ussip, these amino acids could be 
brought into close proximity by secondary and tertiary folding of the polypeptide 
chain. In order to investigate the specific residues required for the interaction, 
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mutation of the minimal region and a reverse two-hybrid strategy could be 
employed (Vidal et al., 1996a; 1996b). Such techniques are used to seek mutations 
in one protein (Y1r386p) which will disrupt the interaction with another protein 
(Ussip). In this case however, the large size of the region which would be required 
to be mutagenised, and the amount of work involved in the cloning and analysis of 
the products of that mutagenesis meant that the constraints of time prevented such a 
strategy from being adopted. 
The proposed interaction between Y1r386p and Prp9p was seen to be dependent 
on the length of the fragment of Y1r386p present in the two-hybrid prey construct. 
Those clones containing the C-terminal region of Y1r386p could not sustain the 
interaction with Prp9p. A number of possibilities exits to explain such a 
phenomenon. For example, the C-terminal region, when present in the truncated 
version of the protein, may fold in such a way as to interfere with the Prp9p 
interaction site. Alternatively, in the full-length protein, the C-terminus may mask 
the Prp9p interaction site until a conformational change is produced in the protein to 
allow the interaction. Similarly, in the wild-type situation another protein may 
sequester the C-terminal region of Y1r386p thereby allowing Prp9p to interact. Due 
to the relatively high levels of expression of the two-hybrid fusion proteins (as 
driven from the ADHJ promoter) there may be insufficient sequestering protein to 
prevent the C-terminus of Y1r386p blocking the Prp9p interaction site under these 
conditions. In a similar way, it may be that to interact with a full-length Ylr386p, 
Prp9p must be associated with another protein(s). If there are insufficient levels of 
this extra protein(s) then the interaction will not be seen with the C-term of Ylr3 86p 
present. While these suggestions are by no means exhaustive, they do provide 
possibilities to explain the available data. 
The caveat to this interaction is the auto-activating properties of Prp9p as a Ga14 
DNA-binding domain fusion. Thus, it may be that the fragments of Ylr386p which 
appear to interact with Prp9p do so by aiding the auto-activation, overcoming the 
selective pressure applied by 3-AT in the medium in these experiments. 
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That the proposed interaction of Prp9p with Y1r386p may not be physiological is 
supported by the lack of a reciprocal interaction from the two-hybrid screen using 
Ylr386p as bait. However, given the limitations of this screen already discussed, this 
result may not be significant. Similarly, the inability of over production of Y1r386p 
to suppress the temperature-sensitive phenotype of Cy103 (prp9-1) cells may be 
misleading in arguing against the interaction of Y1r386p and Prp9p. Genetic 
suppression of this form may be allele-specific, and it is possible that Y1r386p could 
suppress other conditional alleles of PRP9, although the constraints of time 
prevented such experiments from being conducted. 
It is also noted at this time that the interaction seen between Prp9p and the prey 
fusion containing a portion of the MSN2 gene, may be due to the peptide produced 
from this recombinant double fusion, and not solely due to the Y1r386p fragment. 
The cellular function of Y1r386p remains unknown, although its evolutionary 
conservation would suggest it to be important. Disruption of the ORF produced a 
slow growth phenotype in haploid cells, indicating that although the protein is 
important, it is not essential for cell survival. The exacerbation of the slow growth 
phenotype at 37°C may suggest that Y1r386p is normally part of a molecular 
complex. Such a complex could be capable of maintaining (some) functional 
activity at 3 0°C, but this may be reduced further at 3 7°C, due to thermal instability 
producing the exacerbated phenotype seen. It remains a possibility that the fragment 
of YLR386w still present in the disrupted strain could produce a protein fragment 
capable of supplying some of the function of Y1r386p and producing the slow 
growth phenotype. However, as discussed in Section 5.4. this is thought to be 
unlikely. 
Northern analysis was performed in order to determine if the slow growth 
phenotype was due to an alteration in the steady-state levels of the spliceosomal 
snRNAs. These experiments revealed no difference in the snRNA levels between 
parental cells and cells disrupted for YLR386w, at all temperatures tested. This 
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result does not preclude the possibility that Y1r386p associates with spliceosomal 
snRNAs, or indeed the spliceosome, only that it is not essential for snRNA stability. 
Thus, the functional role of Y1r386p, and the associations it forms remain largely 
mysterious. The analyses of the amino acid sequence revealed no functional motifs, 
however they did present a number of interesting possibilities. The high proportion 
of leucine residues prompted an extensive search for a "leucine-rich repeat": a short 
sequence motif present in a number of proteins all thought to be involved in protein-
protein interactions, including the human U2 snRNP A' protein (Kobe and 
Deisenhofer, 1994). Close examination of the Y1r386p sequence failed to detect a 
leucine-rich repeat. Similarly, analysis of the primary sequence failed to detect any 
leucine-zippers. These are sequence motifs containing a leucine residue every 
seventh amino acid in helical regions, and have been proposed to play roles in 
protein dimerisation and in DNA-binding (Landschulz et al., 1988; Dang et al., 
1991). 
The sequence of Y1r386p was however found to contain a number of di-leucine 
pairs; 15 in total. Previously it has been reported that di-leucine pairs can act as a 
sorting signal for membrane-associated proteins (Trowbridge et al., 1993; 
Kirchhausen etal., 1997; Rapoport et al., 1998). This information, together with the 
proposed trans-membrane domain in Y1r386p and the high proportion of 
hydrophobic residues all suggest that Y1r386p could indeed be a membrane-
associated protein. 
If this were the case, a number of observations made about this protein may need 
to be re-assessed. For example, the two-hybrid interactions seen with this protein, in 
particular those with Ussip and Prp9p, may only be possible due to the nuclear 
localisation of the fusion proteins in this system. Under physiological conditions, 
Y1r386p may not be present in the nucleus, and as such would be unable to interact 
with Ussip or Prp9p. Such compartmentalisation considerations may also go some 
way to explaining the poor two-hybrid screen results obtained with Y1r386p as bait. 
If Ylr3 86p is a membrane-associated protein, its retention in the nucleus may 
produce folding problems due to differences between the aqueous environment of 
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the nucleus, and the environment in which the protein is normally located i.e. 
spanning a membrane. In this way, the interactions identified may not be 
physiological, although given that many membrane proteins, particularly those 
forming channels or part of signal transduction pathways form multimer complexes, 
it may be that the homeotypic interactions of Y1r386p identified in the two-hybrid 
screen may be physiological. 
Thus while Y1r386p was the most statistically significant prey found by Ussip, it 
may reflect an unrealistic situation produced only by the compartmentalisation of 
the fusion proteins imposed by the experimental conditions. 
Although the localisation of Ussip has until now been thought be nuclear, this 
has never been proven. The associations of Ussip with cytosolic proteins, proposed 
by the two-hybrid screen, and the physical association of the protein with Spb8p 
(see Chapter Eight) which is involved in mRNA decapping (Boeck et al., 1998), 
suggests that Ussip may not be restricted to the nucleus. It is intriguing to propose 
that Ylr386p is a membrane-associated protein and that the interaction with Ussip is 
physiological. Under these circumstances, Ylr386p could act as a membrane anchor 
for Ussip, and in turn for protein or snRNP complexes. Alternatively, Y1r386p 
could be part of a nuclear pore complex involved in the nucleo-cytoplasmic 
shuttling of Ussip and/or macro-molecular complexes containing this and other 
proteins (or RNA). Further analyses will be needed to determine the validity of such 
predictions. 
In order to examine the functional role of Y1r386p, its subcellular localisation 
should first be established. The possibility also exists to perform synthetic lethal 
experiments with the gene disrupted haploid cells in order to identify other proteins 
with which Y1r386p may functionally interact. Further work could also be done to 
examine biochemically the proposed interactions of this protein, especially those 
with Ussip and potentially with the other Sm-like proteins and U6 snRNA. 
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CHAPTER Six. 
LINKS BETWEEN U2 AND U6 SNRNA- 
AsSOCIATED PROTEINS. 
199 
6.1. Two-Hybrid Screens Reveal Potential Links Between the 
U2 and U6 snRNPs. 
A comparison of the data sets from two-hybrid screens with U2 snRNA-
associated proteins (Fromont-Racine et al., 1997 and P. Legrain, pers. comm.) and 
U6 snRNA-associated proteins (Chapter Three, Chapter Eight and Appendix I) 
reveals a number of proteins found in common. Thus, a linkage map was drawn to 
show how these proteins interact with one another (Figure 6.1). The only direct 
links between proteins known to be U2- or U6-associated are Prpl ip with Ussip 
and Hsh49p with Yjr022p (Fromont-Racine et al., 1997). 
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Figure 6.1. Protein links between U2 and U6 snRNPs proposed by two-hybrid screens. A protein linkage map was derived from a subset of 
the results of the two-hybrid screens described in Chapter Three, in Appendix I and in Fromont-Racine et al. (1997). Arrows run from bait 
proteins to prey proteins. Green hexagons represent U2 snRNA-associated proteins; Red colouration represents U6 snRNA-associated 
proteins; Ovals represent proteins with Sm motifs; Blue rectangles represent other proteins identified in two-hybrid screens with U2 and U6 
snRNA-associated proteins. 







6.2. Investigation of the Proposed Interaction Between Prpl ip 
and Ussip. 
In the two-hybrid screen using Ussip as bait, five clones encoding Prpl ip 
fragments were identified. DNA sequencing of these prey plasmids revealed that the 
inserts in all five clones began within the PRPJJ ORF, 195 nucleotides from the A 
of the initiating methionine codon. However, the 3' end of the insert was from the 
ROXJ gene (Figure 6.2) which is on chromosome XVI and is not linked to PRPJJ. 
This arrangement is likely to have resulted from the ligation of two separate 
genomic DNA fragments into the pACTIIst vector during construction of the 
library. Translation of the prey insert produces a 160 amino acid fragment of 
Prp lip, with a 13 residue C-terminal tag encoded by the two-hybrid prey library 
adaptor and the ROX] sequence. This Prpl lp fragment encodes the Zn-finger 
binding motif, implicated in nucleic acid binding (residues 67-92 of Prp lip)  (Chang 
etal., 1988; Evans and Hollenberg, 1988). 
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Figure 6.2. Schematic representation of the Prpi 1 protein fragment identified as 
potentially interacting with Ussip. (a) PRP11 open reading frame with the AUG 
and STOP codons indicated. (b) Two-hybrid prey insert identified in Ussip screen, 
showing the PRPJJ and ROX] coding sequences (joined by a two-hybrid library 
linker). (c) Translation of the two-hybrid prey insert, giving the amino acid 
positions within Prpl ip. The hatched area represents the Zn-finger. The white area 
is the non-Prpl ip sequence produced from this fragment. Prpl iF, fragment of 
Prpi 1 identified. 
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In order to examine if the proposed Usslp-Prpl ip interaction also occurred in 
the reciprocal two-hybrid orientation, the DNA insert from pAEM74 (i.e. the prey 
piasmid encoding a fragment of Prpl ip described above) was subcloned into the 
pAS2AA bait vector (Table 2.1.12.). Direct matings with this construct (pAEM31) 
gave no positive two-hybrid interactions with Ussip, or with UsslAp (Figure 6.3). 
This fragment of Prpl ip as bait also failed to support the interaction with Prp2lp 
seen with the full-length Prp 11 protein. However, an interaction was seen between 
the fragment of Prpl ip and the full-length Prpl 1 protein. This interaction was seen 
in both two-hybrid orientations. 
With Ussip as bait, the interaction was demonstrated with the same Prpl ip 
fragment as prey, but not with the full-length Prpl ip prey fusion (Figure 6.3). The 
N-terminal portion of Ussi containing both Sm domains, UsslAp, did however 
support the interaction with the full-length Prpl ip fusion, and with the Prpl ip 
fragment. Indeed, the interaction between the fragments of Ussip and Prpi ip 
appeared to be stronger than with either as a full-length protein. This was 
determined by the rate of cell growth on selective medium, and by the relative time 
required to give a positive result (blue colour) for the -ga1actosidase assay (data not 
shown). Both Sm domains are required for these interactions since neither Uss 1 -Ap 













Figure 6.3. Directed two-hybrid matings with U2 and U6 snRNA-associated 
proteins. Open reading frames encoding U2 and U6 snRNA-associated 
proteins, cloned as bait and prey fusions were transformed into their respective 
yeast host strains. Strains were then mated on YPDA medium and the growth 
of diploid cells assayed by replica-plating to selective medium (YMM -LWH + 
5mM 3-AT). Plate was incubated at 301C for 3 days and a —galactosidase 
filter-lift assay performed. The reaction was stopped after 5 hours incubation at 
301C. Baits are encoded by pAS2AA derived plasmids. Bait plasmids used 
were: Gal4BDp, pAS2AA; Ussip, pAEM13; UsslAp, pAEM15; Ussl-A, 
pAEM29; Ussl-B, pAEM30; Smx4p, pAEM17; Prp24p, pAEM23; Prp9p, 
pAS2EA:PRP9; Prpl ip, pAS2EA:PRP11; Prp1 lFp, pAEM3 1; Prp2lp, 
pAS2EA:PRP21. Preys are encoded by pACTIIst derived plasmids. Prey 
plasmids used were: Ga14AD, pACTIIst; Ussip, pAEM14; Uss1ip, pAEM16; 
Smx4p, pAEM18; Prp24p, pAEM7; Prp9p, pACTIIst:PRP9; Prpl ip, 
pACTIIst:PRPJJ; Prpl lFp, pAEM74; Prp2lp, pACTIIst:PRP21. Prp9p, 
Prpl ip and Prp21p encoding plasmids were obtained from P. Legrain. 
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The proposed interaction between Ussip and Prpl ip was examined genetically 
by testing the over-expression of each protein in cells containing a conditional allele 
of USS] or PRPJ 1. The ability of Uss 1 p  to suppress the temperature-sensitive 
phenotype of A635 cells (prpll-1 (Legrain and Rosbash, 1989)) was tested, 
together with the ability of over-expression of Prpl ip to rescue the growth of 
MCY4 cells on glucose medium. Ussip, produced from any of the plasmids tested, 
could not support the growth of A635 cells at 37°C (Figure 6.4A and B). The same 
was true for Uss lAp. The Prpl ip fragment identified in the two-hybrid screen with 
Ussip, was also unable to suppress the temperature-sensitive phenotype in these 
cells (Figure 6.4A). Similarly, MCY4 cells producing Prpl ip, or the Prpl ip 
fragment, could not grow on glucose medium (Figure 6.4C). Thus, Prpl ip and 
Ussip would appear not to interact genetically under the conditions tested. 
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Figure 6.4. Genetic complementation studies with Ussip and Prpl ip. (A) 3 
individual transformants of A635 (prp]1-1) carrying YEp13, C379, pACTIIst, 
pACTIIst:PRPJJ, pAEM74, pAEM14, pAEM16, pRS316 or pAEM12 were 
resuspended and spotted onto selective medium, as appropriate (YMM -L or YMM 
-U). Plates were incubated at 23°C, or 37°C for 3 days. (B) A635 cells were 
transformed with pAEM2, pAEM4, pAEM5, pFL45S, pUSS1-2, pMC9, YEp13 or 
C379 and plated directly onto YPDA. Plates were incubated at 37°C for 4 days, and 
the colonies counted. (C) 3 individual transformants of MCY4 carrying pAS2AA, 
pAEM13, pAS2AA:PRPJJ or pAEM31 were resuspended and spotted onto 
Galactose (YMGa1 -W) or Glucose (YMM -W) medium. Plates were incubated at 
30°C for 3 days. For (A) and (C), the relevant properties of each plasmid are 
indicated on the right. 
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6.3. Proteins Found at the Proposed Interface Between U2 and 
U6 snRNA-associated Proteins. 
The Ydr386 Protein. The protein encoded by YDR386w was identified in 
independent two-hybrid screens with Prpllp (Fromont-Racine et al., 1997), Prp24p 
(A. Colley, pers. comm.) and Ussip (Chapter Three) as baits. It is a 632 amino acid 
protein of predicted molecular weight 72.3kDa. Deletion of the YDR386w coding 
sequence gave no growth phenotype, indicating that the gene is inessential for cell 
viability (Fromont-Racine et al., 1997). Structural homologues of Ydr386p exist in 
S. pombe (acc. no. Z97052), A. thaliana (AL022198) and C. elegans (U80437) 
although no recognised motifs are present, and the function of these proteins is 
unknown. Analysis of the fragments of Ydr386p identified in the two-hybrid screens 
gave no clues as to specific regions of interaction with each of the bait proteins 
since each prey fragment contained a relatively large portion of the protein in 
common (Figure 6.5A). 
The Ydr485 Protein. The protein encoded by YDR485c was identified as an Al 
interacting protein in independent two-hybrid screens using Prp9p (Fromont-Racine 
et al., 1997), and Uss lp (Chapter Three) as baits. It is an 810 amino acid protein of 
predicted molecular weight 92kDa. No recognised motifs are present in the amino 
acid sequence, and while the function of this protein remains unknown, the protein 
does have sequence similarity to the human YL-1 protein (D43642). The YL-1 
protein is a candidate for a transformation suppressor gene, with a nuclear 
localisation and the ability to bind DNA (Horikawa et al., 1995). These authors 
proposed a role for this protein in transcriptional regulation. Analysis of the 
fragments of Ydr485p identified in the two-hybrid screens suggests that Prp9p may 
interact with the N-terminal region of the protein, while Ussip would appear to 
associate with a distinct, C-terminal portion (Figure 6.513). 
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The Yn1091 Protein. The protein encoded by YNL091c was identified as an A4 
interacting protein in independent two-hybrid screens using Msllp (Fromont-Racine 
etal., 1997), and Ussip (Chapter Three) as baits. It is a 1,240 amino acid protein of 
predicted molecular weight 141.5kDa. No recognised motifs are present in the 
amino acid sequence, and no close structural homologues were identified in protein 
database searches. Ussip and Msllp both identified the same fragment of the 
Yn1091 protein i.e. the 82 amino acids at the C-terminus of the protein (Figure 
6.5 C). 
Each of the remaining six proteins at the U2-U6 interface was identified in 
independent two-hybrid screens performed by other members of this lab (Smx4p) or 
in the lab of P. Legrain (Cusip, Hsh49p, Prp2lp, Spb8p, Yb1026p and Yjr022p). 
These proteins will be discussed in Section 6.5. The Sm-like protein-encoding baits 
used for these screens were constructed as part of this work (see Table 2.1.12. for 
details). 
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Figure 6.5. Domains of interaction of proteins at the U2-U6 interface. In each case 
the numbers given are for amino acids, and the baits used to identify the fragments 
are indicated. (A) Fragments of the Ydr3 86 protein identified in two-hybrid screens. 
(B) Fragments of the Ydr485 protein identified in two-hybrid screens. (C) 
Fragments of the Yn109 1 protein identified in two-hybrid screens. 
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6.4. Potential Interactions Between Ussip and Prp9p. 
Links between Ussip and Prp9p have been suggested by the identification of 
Ydr485p in two-hybrid screens with both proteins (see Section 6.3.) and also by the 
direct mating experiments with Ylr3 86p fragments (see Section 5.2.). MCY4 and 
Cy103 (prp9-1 (Chapon and Legrain, 1992)) cells were used to examine this 
proposed interaction genetically. The ability of Ussip, when over produced, to 
support the growth of Cy103 cells at 30°C was tested. None of the Ussip-encoding 
plasmids used supported the growth of these cells at 30°C (Figure 6.6A). 
Prp9p over-production in MCY4 cells was similarly tested on glucose medium. 
While Prp9p produced from its endogenous promoter sequence (encoded by either a 
centromeric or a high copy number plasmid) could not support the growth of MCY4 
cells on glucose medium, the two-hybrid bait fusion (Ga14BD:Prp9p) produced 
from the constitutive ADH 1 promoter was able to rescue the growth defect of these 
cells (Figure 6.6B). 
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Figure 6.6. Genetic complementation studies with Ussip and Prp9p. (A) 3 
individual transformants of Cy103 (prp9-1) carrying YCp50, pPL12, YEplac195, 
pAEM36, pAS2AA, pAS2AE:PRP9, pAEM2, pAEM4, pAEM5, pFL45S, pUSS1-2 
or pMC9 were resuspended and spotted onto selective medium, as appropriate 
(YMM -U, YMM -w or YMM -H). Plates were incubated at 23°C or 30°C for 3 
days. (B) 3 individual transformants of MCY4 carrying pRS316, pAEM12, YCp50, 
pPL12, YEplac195, pAEM36, pAS2M or pAS2AA:PRP9 were resuspended and 
spotted onto Galactose (YMGa1 -U or YMGa1 -W) or Glucose (YMM -U or YMM - 
W) medium. Plates were incubated at 30°C for 3 days. For both panels, the relevant 
properties of each plasmid are indicated on the right. 
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The U2 and U6 snRNA molecules are known to interact with one another (and 
with pre-mRNA) during the splicing reaction, and as such have been proposed to 
form (part of) the catalytic centre of the spliceosome (reviewed in Madhani and 
Guthrie, 1994; Ares and Weisner, 1995; Nilsen, 1998). Despite the extensive 
characterisation of the RNA-RNA contacts involved in the spliceosome, very few 
data have been presented for interactions between proteins of the U2 and U6 
snRNPs. Indeed, to date, the only published report is of an allele-specific genetic 
interaction between mutants of PRP21 and PRP24 (Vaidya et al., 1996). 
Yjr022p (U6-associated) and Hsh49p (U2-associated) have also been shown to 
interact by two-hybrid analysis (Fromont-Racine et al., 1997) however, it was only 
during the course of this work that the U6 snRNA-association of Yjr022p was 
demonstrated (Section 8.3.). In the future other examples of proteins already 
reported to be involved in interactions may be characterised as having an snRNA 
association, and the list of proteinaceous links between the U2 and U6 snRNPs may 
grow. 
Through two-hybrid screening, novel links have been proposed for interactions 
between U2 and U6 snRNA-associated proteins, with a direct link identified 
between Prpl ip and Ussip, in the screen with Ussip as bait (Chapter Three). When 
this interaction was examined by direct mating, it was found to be strongest when 
UsslAp and the fragment of Prpl ip identified in the screen (Prpl lFp) were 
combined. The full-length proteins failed to support a two-hybrid interaction, which 
may reflect steric hindrance of the interacting domains in the fusion proteins. The 
two proteins also failed to interact when the orientation of the two-hybrid constructs 
were reversed i.e. with Prpl ip as bait and Ussip as prey. This was true even when 
the truncated versions of the proteins were used (Figure 6.3.). Uni-directional two-
hybrid interactions are not uncommon (reviewed in Brent and Finley, 1997) 
although they reduce confidence that the observed interaction is physiological. It 
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cannot be ruled out that in this situation the Prpl ip fragment has auto-activating 
properties, as a weak interaction was seen with the pAS2AA plasmid. However, in 
tests of the Prp up fragment against a range of other baits no interactions were seen, 
suggesting that the association with Ussip was specific. 
The proposed interaction of Ussip with Prpl ip was further examined 
genetically, however it was discovered that over-production of Ussip could not 
suppress the temperature-sensitive phenotype of prpll-1 cells, and that Prpl ip 
could not support the growth of MCY4 cells on glucose-containing medium (Figure 
6.4.). This type of suppression analysis is however intrinsically function specific 
and as such it is possible for two proteins to interact but not to show suppression by 
over-production as described here. 
Despite the lack of suppression in these experiments, the data presented here are 
the first tentative suggestion that Ussip (and indeed other U6 snRNA-associated 
proteins) may be present in the spliceosome. Previous, immunological studies failed 
to detect Ussip in the spliceosome (M. Cooper, pers. comm.) although this may 
have reflected that the protein was buried in the structure of the spliceosome, and as 
such, inaccessible to the antiserum used. 
Figure 6.1. shows the network of potential interactions between other U2 and U6 
snRNP proteins identified by two-hybrid screening (Chapter Three; Appendix I; 
Fromont-Racine et al., 1997). The identification of a given protein in independent 
two-hybrid screens with different baits (proposed to be involved in splicing) 
increases the statistical significance of that protein with respect to its potential role 
or link with the splicing pathway. 
This is particularly true for example, in the case of Ydr3 86p which was identified 
in three screens, or Ydr485p which was an Al candidate in screens with Ussip and 
Prp9p as baits. In the absence of additional functional data, the categorisation of the 
prey (Al, A2 etc.) and an examination of the domains of interaction, should allow 
reasoned decisions to be taken as to which proteins are (statistically) more likely to 
be involved in splicing, and as such should be characterised first. For example, 
Ydr485p which (as several clones) revealed separate interaction domains with 
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Ussip and Prp9p should be studied before Yn1091p, which was identified as only an 
A4 prey with Uss ip and Msl 1 p  (with both proteins identifying the same region of 
interaction). 
Although the U2-U6 interface presented here contains nine proteins, it is unlikely 
that all of these interactions will represent physiologically relevant associations. For 
example, Bas 1 p  is known to be a transcription factor involved in the basal activation 
of histidine and adenine biosynthetic genes (Daignan-Fomier and Fink, 1992) whilst 
Atcip is known to bind to an actin binding protein (The Yeast Proteome Handbook, 
1998). It is difficult to envisage a situation in which these proteins would be present 
in the spliceo some. 
The protein encoded by the YNR053c ORF was identified in four screens with 
U2 or U6 snRNA-associated proteins (Figure 6.1.) and also with Smblp (Fromont-
Racine et al., 1997). No functional data are available for this protein, although it is 
reported to contain an ATP/GTP binding-site motif, and shows strong similarity to 
human breast tumour autoantigen (The Yeast Proteome Handbook, 1998). 
The Pet127 protein was identified in three independent screens (Figure 6.1.) and 
has previously been reported to be a membrane-associated protein involved in the 
stability and processing of mitochondrial RNAs (Weisenberger and Fox, 1997). 
The Pet309a protein was identified in three independent screens (Figure 6.1.) and 
has also been previously described. It is the product of a nuclear gene and is 
required for the translation and stability of mitochondrial COX] mRNA (Manthey 
and McEwen, 1995). 
The protein encoded by the HEX3 gene was also identified in three screens with 
U2 or U6 snRNA-associated proteins, and has been reported to be "involved in 
hexose metabolism" (The Yeast Proteome Handbook, 1998) although no further 
functional details are available for this protein. 
Although none of these proteins has an obvious role in nuclear pre-mRNA 
splicing, each should be analysed with respect to the splicing pathway and to 
snRNA association, in order to examine the validity of their placement at the U2-U6 
interface. 
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Although Ussip and Prp9p did not interact directly in the two-hybrid assay 
(Chapter Three; Figure 6.3.; Fromont-Racine et al., 1997), both proteins identified 
Ydr485 as a potential interacting factor, and both are capable of interactions with 
fragments of Y1r386p (Section 5.2.). A direct link between Ussip and Prp9p was 
examined genetically in MCY4 and prp9-1 cells. It was found that over-production 
of Uss 1 p  could not suppress the temperature-sensitive phenotype of the prp9-1 cells, 
and that Prp9p when produced from its own promoter could not support the growth 
of MCY4 cells on glucose medium (Figure 6.6.). However, when Prp9p was 
produced as a fusion protein with the Ga14 DNA binding domain, from the two-
hybrid bait vector, it was found to be capable of supporting the growth of MCY4 on 
glucose. This may represent a physiological interaction, although an alternative 
explanation also exists. Due to the constitutively high level of expression from the 
ADHJ promoter in the two-hybrid bait plasmid, it is possible that enough Ga14 
BD:Prp9p is produce to allow binding to the Gall promoter controlling the 
production of Ussip. Given the auto-activating properties of the fusion protein 
(Fromont-Racine etal., 1997), it is possible that it may then be capable of activating 
transcription of USS], even although the cells are on glucose medium. 
Alternatively, the bait fusion may be auto-activating due to non-specific protein-
protein interactions and by analogy could potentially (non-specifically) stabilise a 
complex lacking Ussip in MCY4 cells on glucose-containing medium. In this way 
these cells would also be able to grow. 
In order to distinguish between these possibilities, Western analysis of the 
proteins present in the MCY4 cells carrying the Prp9p bait plasmid could be 
performed. The presence of Ussip would confirm the first proposal, while its 
absence would support the second. Constraints of time prevented this analysis from 
being carried out. 
Alternatively, MCY4 cells could be transformed with other auto-activating Ga14 
bait fusions to determine if they too are capable of supporting the growth of these 
cells on glucose medium. 
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Thus, these two-hybrid data suggest links between proteins of the U2 and U6 
snRNPs, and by extrapolation that U6-associated proteins may be present in the 
spliceosome. Further analyses are now required to determine which of the proposed 
interactions are physiological. These analyses should include deletion of the novel 
ORFs involved, production of conditional alleles of those ORFs that are essential 
and their characterisation to determine if they play a role in pre-mRNA splicing. 
The proteins should also be tagged and examined for an association with the 
spliceosomal snRNAs and with the proteins of the U2 and U6 snRNPs. The 
availability of conditional and non-lethal mutations in a range of U2 and U6 
snRNA-associated proteins will also allow genetic suppression or synthetic lethal 
experiments to be performed to examine the proposed links between these proteins. 
An interesting observation from the work presented in this Chapter is the two-
hybrid interaction between Prp24p (bait) and Ussip (prey); (Figure 6.3.). As both 
these proteins are U6 snRNA-associated, this is perhaps an "expected" interaction 
however it was not identified in either of the two-hybrid screens performed with 
Ussip (Chapter Three) or Prp24p (A. Colley, pers. comm.) as baits. What is 
particularly interesting is that Prp24p does not interact with Uss lAp, indicating the 
need for the C-terminal region of Ussip. To date, such an interaction is unique since 
all other constructs are capable of interaction with Uss lAp. The interaction of Uss 1 p 
with Prp24p was suggested previously since the over-expression of Ussip 
exacerbated the temperature-sensitive phenotype of prp24-1 cells (Cooper, 1995). 
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CHAPTER SEVEN. 
CHARACTERISATION OF THE ORFs 
ENCODING SM-LIKE PROTEINS. 
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7.1. Introduction. 
The exhaustive two-hybrid screens performed with the Sm-like proteins 
produced a network of potential interactions which suggest that these proteins may 
be associated with one another (see Chapter Eight). Of the genes encoding non-
canonical Sm-like proteins in S. cerevisiae only USS] has been characterised 
(Cooper et al., 1995). Although Smx4p was shown to be U6-associated (Séraphin, 
1995) no additional work with this protein or its open reading frame (USS2) has 
been reperted. Mutations have been reported in the SPB8 locus, with the protein 
reported to be involved in mRNA decapping, however no information is available 
on any associations made by the protein (Boeck et al., 1998). As the first step in the 
systematic, biochemical analysis of the novel Sm-like proteins, the ORFs encoding 
these proteins were characterised. 
7.2. Deletion of the Open Reading Frames Encoding Sm-Like 
Proteins. 
In order to characterise each of the open reading frames encoding Sm-like 
proteins, targeted gene deletions were carried out. The coding sequence from the 
AUG to the STOP codon for each gene was precisely deleted at its chromosomal 
locus, and replaced with either the HIS3 or TRP1 gene as a marker. The deletions 
were carried out in diploid cells, with the integration of the marker confirmed by 
Southern analysis (Figure 7.1.). These cells were then sporulated and the tetrads 
dissected onto solid YPDA medium at 23°C. Viable spores were scored for the 
appropriate auxotrophic markers by re-streaking to selective media. Due to 
problems with sporulation, and thereafter with spore viability, all strains were 
analysed in this way, to ensure that those showing a 2:2 segregation of 
viable:inviable spores did indeed represent disruption of an essential ORF. 
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Figure 7.1. Deletion of open reading frames encoding Sm-like proteins. A 
schematic representation of the Sm-like protein-encoding locus in the wild-type 
(WT) and the deleted (Del) situations is given, together with the DNA fragment 
used to make the probe. Genomic DNA was extracted from BMA38, BMA64 or 
from the diploid cells heterozygous for the deletion of the Sm-like protein-encoding 
ORF. DNA was digested by the restriction enzymes shown, the fragments were 
separated on 1% w/v agarose gels, and blotted to Hybond-N membrane 
(Amersham). Blots were probed with radiolabelled DNA fragments and visualised 
by autoradiography. Black arrows give the position of the fragment from the 
undeleted locus. White arrows give the position of the fragment from the deleted 
locus. B, BamHI; E, EcoRI; N, NcoI;; 5, Sail; Sc, ScaT; V, EcoRV; X, )i7ioI. 
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Each deletion analysis was performed in two genetic backgrounds BMA38 or 
BMA64 and JDY6 (Table 2.1.7.), with the same results obtained in each strain. 
Three of the ORFs which were tested were found to be dispensable for cell 
growth; SPB8, YDR378c and YNL147w (Figure 7.2A.). Analysis of the spores on 
solid medium revealed a slow growth phenotype for those cells carrying the 
selectable marker, and therefore the ORF deletion. That these haploid cells were 
indeed deleted for their respective ORF was verified by Southern analysis (Figure 
7.2B. and data not shown). When the growth of the ORF-deleted haploid cells was 
examined at a range of temperatures, they displayed a slow-growth phenotype at 
23°C and 3 0°C, with the cells unable to grow at 3 7°C, indicating a severe thermo-
sensitive defect (Figure 7.2C.). 
Each of the remaining ORFs encoding Sm-like proteins, YBL026w, YER146w 
and USS2, was found to be essential for cell viability, with all viable spores scoring 
negative for the presence of the selectable marker and therefore the ORF deletion 
(data not shown). The heterozygous, gene-deleted diploids were transformed with 
two-hybrid prey plasmids expressing the corresponding genes (Table 2.1.12.), and 
sporulated. For YBL026w and YER146w, the haploid progeny carrying the 
chromosomal deletion and the prey plasmid were viable, but displayed a slow-
growth phenotype at 23°C (Figure 7.3A.). When tested at a range of temperatures, 
these strains (AEMY29 for YER146w; AEMY30 for YBL026w) displayed the same 
profile as the three non-essential genes described above, i.e. slow growth at 23°C 
and 3 0°C, with no growth at 37°C (Figure 7.3B.). 
For USS2, the two-hybrid prey fusion did not complement the gene deletion, with 
the only viable spores produced being wild-type in this case (data not shown). Yeast 
strain AEMY3 1 was produced by transforming a PGALJ-USS2 construct (pAEM64 
(see Table 2.1.12.)) into AEMY26 followed by random sporulation. Spores were 
plated on galactose medium selecting for the gene deletion and for the plasmid. The 
viable spores were then assayed for their inability to grow on glucose medium 
(Figure 7.4A.), with the disruption at the USS2 locus in these cells verified by 
Southern analysis (Figure 7.4B.). The specific complementation by pAEM64 with 
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galactose but not with glucose as the carbon source confirmed the essential nature of 
the USS2 gene. 
A diploid strain with YJR022w deleted by the same procedure as the other ORFs, 
was obtained from the lab of P. Legrain. The two-hybrid prey fusion (pAEM71) 
rescued the growth defect caused by the deletion at all temperatures (Figure 7.5.). 
However, YJR022w overlaps an uncharacterised ORF on the other strand 
(YJR023c) which was also disrupted by the knockout deletion. The insert in the 
pAEM71 construct also contains the YJR023c coding sequence, however, the ability 
of a prey fusion encoding only Yjr022p, but not Yjr023p, to complement the growth 
defect caused by the deletion confirmed that Yjr022p is essential (data not shown). 
Smxlp was not analysed in this study since the available evidence suggested no 
involvement with any RNA species or with the splicing machinery (Séraphin, 
1995). 
Thus for all six ORFs deleted in this study (SPB8, USS2, YBL026w, YDR378c, 
YER146w, and YNL147w) a strain displaying a conditional growth phenotype was 
available, either temperature-sensitive or carbon source dependent (summarised in 
Figure 7.6.). 
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Figure 7.2. Analysis of non-essential Sm-like protein-encoding open reading 
frames. (A) Deletion of YDR378c, YNL147w or SPB8 confers a slow-growth 
phenotype to haploid cells. Cells from the heterozygous diploid strains AEMY12 
(tsYDR3 78c), AEMY 15 (AYNL 147w) and AEMY 18 (ó.SPB8) were sporulated, and 
the haploid progeny propagated on YPDA at 23°C. These haploid cells were 
resuspended and ten-fold serial dilutions plated onto either YPDA or selective 
medium (YMM -H for AEMY12 and AEMY15, YMM -w for AEMY18). Plates 
were incubated at 23°C for 3 days. DEL, haploid cells deleted for Sm-like protein-
encoding ORF; WT, haploid cells not deleted for Sm-like protein-encoding ORF. 
(B) Southern analysis confirms that slow-growing cells are deleted for the Sm-like 
protein-encoding ORF. Genomic DNA was extracted from AEMY12, AEMY19 
(slow-growing haploid cells derived from AEMY12 i.e. DEL from Figure 7.2A.) or 
BMA38a (WT from Figure 7.2A.) and digested with restriction enzymes Sail and 
NcoI. DNA fragments were separated and analysed as described in Figure 7.1. Black 
arrow gives the position of the fragment from the undeleted locus. White arrow 
gives the position of the fragment from the deleted locus. (C) Deletion of YDR378c, 
YNL147w or SPB8 confers a temperature-sensitive phenotype to haploid cells. Ten-
fold serial dilutions of the haploid cells described in Figure 7.2A. were spotted onto 
YPDA and incubated at 23°C, 30°C or 37°C for 3 days. 
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Figure 7.3. Analysis of strains deleted for YBL026w or YER146w. (A) Growth of 
haploid cells deleted for YBL026w or YER146w can be rescued by two-hybrid prey 
plasmids expressing the respective ORFs. Cells from the heterozygous diploid 
strains AEMY9 (LiYER 146w) or AEMY23 (AYBL026w) were transformed with the 
two-hybrid prey plasmid encoding the respective ORF (pAEM70 and pAEM55) and 
sporulated. Haploid progeny were propagated on YPDA at 23°C. These haploid 
cells were resuspended and ten-fold serial dilutions plated onto either YPDA, or 
selective medium (YMM -LW for AEMY9 [pAEM70]; YMM -HL for AEMY23 
[pAEM55]. Plates were incubated at 23°C for 3 days. DEL, haploid cells deleted for 
Sm-like protein-encoding ORF; WT, haploid cells not deleted for Sm-like protein-
encoding ORF. (B) Haploid cells deleted for YBL026w or YER146w, carrying the 
two-hybrid prey plasmid encoding the respective ORF are temperature-sensitive. 
Ten-fold serial dilutions of the haploid cells described in Figure 7.3A. were spotted 
onto YPDA and incubated at 23°C. 30°C or 37°C for 3 days. 
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Figure 7.4. Analysis ofAEMY31. (A) The growth of haploid cells deleted for USS2 
can be rescued by pAEM68. Cells from the heterozygous diploid strain AEMY26 
(LiUSS2) were transformed with pAEM68 and sporulated. Haploid progeny were 
propagated on YMGa1 -UW at 23°C. Six independent progeny were picked, 
resuspended and ten-fold serial dilutions plated onto either YMGa1 -UW (Galactose) 
or YMM -UW (Glucose) and incubated at 23°C for 4 days. (B) AEMY3 I cells are 
deleted for USS2 but carry pAEM68. Genomic DNA was extracted from BMA64a, 
AEMY26 or AEMY3 1 cells (haploids described in Figure 7.4A.) and digested with 
restriction enzyme EcoRl. DNA fragments were separated and analysed as 
described in Figure 7.1. Black arrow gives the position of the fragment from the 
wild-type locus. White arrow gives the position of the fragment from the deleted 
locus. Grey arrow gives the position of the fragment from pAEM68. 
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Figure 7.5. The growth defect caused by deletion of YJR022w is complemented by 
pAEM71 at all temperatures. Cells from the heterozygous diploid strain LMA4 
(AYJR022w) were transformed with pAEM71 and sporulated, with the haploid 
progeny propagated on YPDA at 23°C. Four of these haploid progeny were 
resuspended and ten-fold serial dilutions plated onto YMM -LW and incubated at 
23°C, 30°C or 37°C for 3 days. 
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at 37°C 	 at 37°C 	 strain 
ORF STRAIN 	ORF STRAIN 	ORF STRAIN 
YDR378c AEMY19 YER146w AEMY29 USS2 AEMY31 
YNL147c AEMY22 	YBL026w AEMY30 
SPB8 AEMY24 
Figure 7.6. Summary of conditional strains. Schematic representation of the 
strategy used to produce the conditional strains, and the strain names for each of the 
haploid progeny used in subsequent experiments. 
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7.3. Analysis of the Growth of the Conditional Strains. 
The growth rate of each of the conditional strains was monitored in liquid media. 
For the temperature-sensitive strains, cells were pre-grown at 23°C, with the growth 
rate subsequently monitored at 23°C, 37°C, and for a selection of strains at 30°C 
(Figure 7.7.). In all cases, for those temperatures at which the cells are viable, the 
growth rate was slower than for the corresponding parental strain. The severity of 
the growth defect was variable from strain to strain, as was the point after the shift 
at which the cells stopped dividing. 
For AEMY3 1, cells were pre-grown in galactose medium at 30°C, and shifted to 
glucose medium (Figure 7.7.). The profile of growth arrest was different from that 
of the temperature-sensitive stains, possibly reflecting the need to turn over the 
Smx4 protein after repression of transcription in this strain, compared to the more 
rapid effect of heat treatment on the other strains. 
Significantly, for all of the conditional strains, cells grown for 12 hours (and in 
most cases also for 24 hours) under the restrictive conditions (3 7°C or in glucose 
medium) are still viable (Figure 7.8.). 
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Figure 7.7. Growth curve analysis of the conditional strains. Cells were grown to 
mid-logarithmic phase, harvested, washed and resuspended in the appropriate (pre-
warmed) media. 0D 600 was followed, with dilutions made, where necessary, to 
maintain the cells in logarithmic growth. The doubling times in minutes are quoted 
to the right of each line. x-axis, time in hours after shift to the experimental 
conditions; y-axis, 0D 600 values. Diamonds, growth at 23°C; squares, growth at 
30°C; triangles, growth at 37°C; crosses, growth at 30°C in galactose media; circles, 
growth at 30°C in glucose media. The Sm-like protein deleted is given for each 
curve. Strain AEMY32 carries the pAEM71 plasmid and is isogenic to AEMY31 






























Figure 7.8. Cells from the conditional strains remain viable after arrest of growth. 
Cells were grown to mid-logarithmic phase under "permissive" conditions 
(23°C or in galactose medium), harvested, washed and then resuspended in the 
appropriate pre-warmed media (37°C or glucose medium). Samples were removed 
12 hours after the shift to the restrictive conditions, and ten-fold serial dilutions 
were spotted onto YPDA or YPGa1A (for AEMY3 1) medium. Plates were incubated 
at 23°C for 3 days. N-R, cells grown for 12 hours under the "permissive" conditions. 
Samples were removed 24 hours after the shift to the restrictive conditions and 
analysed as described in Figure 7.8A. N-R, cells grown for 24 hours under the 
"permissive" conditions. 
M 
_1 	-; 	_4 




















7.4. Analysis of Small RNAs in the Conditional Strains. 
When Uss ip was depleted in vivo a concomitant reduction in the level of U6 
snRNA was observed (Cooper et al., 1995). The stability of the spliceosomal 
snRNAs was therefore analysed in each of the conditional strains described above. 
Cells were grown under the restrictive conditions for various times, and the RNA 
levels analysed by Northern blotting. No difference was observed in the levels of the 
spliceosomal snRNAs extracted from AEMY24 or AEMY29, compared to those 
from the parental strain when the cells were grown at 37°C (Figure 7.9A.). Thus 
neither Spb8p nor Yer146p seems to be necessary for the stability of any of the 
spliceosornal snRNAs. For each of the other conditional strains, a decrease in the 
level of U6 snRNA was observed upon a switch to the restrictive conditions. 
Although the kinetics of U6 decline are slower for AEMY3 1, this strain has the 
lowest levels of U6 after 24 hours at the restrictive conditions (Figure 7.9A.). In 
AEMYI9, AEMY22 and AEMY30 cells U6 snRNA was still detectable 24 hours 
after the shift to the restrictive conditions, although it was then more than 12 hours 
since any cell division had taken place. Each of these strains was pre-grown at 23°C 
and although the cells can grow at this temperature, the levels of U6 snRNA in 
AEMY19, AEMY22 and AEMY30 were already low (compared to wild-type cells) 
before the temperature shift to 37°C (Figure 7.9A.). From this it was concluded that 
Yb1026p, Ydr378p, Yn1147p and Smx4p are all needed to maintain the stability of 
the U6 snRNA in vivo. 
A decrease in the in vivo level of US L snRNA was also seen for AEMY30 and 
AEMY3 I under conditions restrictive for cell growth. The significance of this 
reduction remains unclear. 
In order to address the specificity of these effects on spliceosomal RNAs, the 
levels of a number of other small RNA species were examined. RNase P is a 
ribonucleoprotein involved in the processing of tRNA and contains a polymerase 
(rpol) III transcribed RNA component, P RNA (Lee et al., 1991); RNase MRP is a 
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ribonucleoprotein involved in rRNA processing (Tollervey, 1996); 5S rRNA is an 
rpol III transcribed ribosomal RNA component (Szymanski et al., 1998). No effect 
was seen on the level of any of these RNA species in most of the conditional strains, 
the exception being AEMY30 (Figure 7.913.). In these cells, the level of pre-P RNA 
(the precursor form of P RNA) fell sharply at the restrictive temperature. A slight 
decrease was also seen in P RNA, MRP RNA and 5S rRNA levels after 24 hours at 
the restrictive temperature, possibly due to the grossly disrupted physiology of these 
cells (as witnessed by the rapid arrest of cell growth at 4 hours (see Figure 7.7.)) and 
not to the loss of any specific function of Yb1026p. The maintenance of wild-type 
levels of P RNA and 5S rRNA in strains in which the level of U6 snRNA declines, 
indicates that this decline is not due to a general effect on all rpol III transcripts, but 
is specific for U6 snRNA. 
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Figure 7.9. Effect of in vivo inactivation or depletion of Sm-like proteins on the stability of small snRNAs. (A) Total RNA was extracted 
from cells of the conditional strains grown under the restrictive conditions for various lengths of time. RNAs were separated on 6% 
denaturing polyacrylarnide gels, electroblotted and probed with radiolabelled oligonucleotides specific for the spliceosomal snRNAs. (B) 
The membrane described above was successively stripped and reprobed with radiolabelled oligonucleotides specific for P RNA, MRP RNA 
and 5S rRNA. 
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7.5. Effect of U6 snRNA Over-production in the Conditional 
Strains. 
Over-production of U6 snRNA partially complements the growth and splicing 
defects caused by in vivo depletion of the Ussi protein (Cooper, 1995). Given the 
reduction in the U6 snRNA levels seen for some of the conditional strains, the effect 
of over producing U6 snRNA was assayed. The analyses were carried out on solid 
media for all strains, and subsequently in liquid culture for those strains displaying a 
partial complementation phenotype. Over-producing U6 snRNA had no discernible 
effect on the growth of AEMY24, AEMY29 or AEMY30 at 30°C or at 37°C. 
(Figure 7.10.). This may reflect the fact that AEMY24 and AEMY29 cells did not 
show a reduction in the levels of U6 snRNA at the restrictive temperature (Figure 
7.9A.), whilst AEMY30 cells have a more severely disrupted physiology. The 
growth defect in strains AEMYI9 and AEMY31 could be partially suppressed by 
over-production of U6 snRNA (Figure 7.10A. and 7.10B.). For AEMY19 a 
doubling time of 134 minutes was observed when over producing U6 snRNA, 
compared to 214 minutes with vector alone and 121 minutes for BMA38cz cells at 
30°C (Figure 7.1 OC.). The complementation was not strong enough however to 
allow AEMY19 cells to grow at 37°C. When grown in selective glucose medium, 
AEMY31 cells over producing U6 snRNA doubled in 309 minutes, compared to 
222 minutes for BMA64 haploid cells grown under the same conditions (Figure 
7.10D.). The best complementation was for strain AEMY22, in which over -
production of U6 snRNA could suppress the growth defect observed at 3 7°C, the 
(previously) restrictive temperature (Figure 7.1 OA.). Thus in strains AEMY 19, 
AEMY22 and AEMY3 I, the over-production of U6 snRNA can, to some extent, 
compensate for the loss of proteins Yn1147p, Ydr378p and Smx4p, respectively. 
This suggests that in these cells, at least part of the physiological function 
performed by these proteins is directly related to U6 snRNA. 
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Figure 7.10. Effect on growth of over-production of U6 snRNA in conditional 
strains. (A) Ten-fold serial dilutions of each conditional strain transformed with 
either vector (YEp24) or with U6 (carried on a high-copy number plasmid 
(pYX 117)) were spotted out on selective media and incubated at 30°C or 37°C for 3 
days. (B) Ten-fold serial dilutions of AEMY31 transformed with either vector 
(YEp13) or with U6 (carried on a high-copy number plasmid (pYX172) were 
spotted out on selective galactose or glucose media and incubated at 30°C for 3 
days. (C) 0D 600 values were followed for AEMY19, AEMY19 [YEp24], AEMY19 
[pYIXi 17] and BMA38u cells grown at 30°C. Dilutions were performed where 
appropriate to maintain the cells in logarithmic growth. (D) AEMY3I [YEpI3], 
AEMY3I [pYX172] or AEMY32 [pYX172] cells were grown to mid-logarithmic 
phase in galactose medium, harvested, washed and resuspended in glucose medium 
at 23°C. 0D 600 values were followed, with dilutions made where appropriate to 








A 	I 100 	10 10 10 -4' 	
37°C 











B 	I  GALACTOSE 	GLUCOSE 0 	- 	 I 	() 	-1 	) 	_ 	-41 
	
10 10 10 10 10 10 10 
\ECTOR 
AEMY31 	 U6 
0.011 




—e—AEMYI9 IpYXI 171 
RMA3 S 
001 
0 I 2 3 4 5 6 7 8 9 JO II 12 131415161718 





7.6. Analysis of pre-mRNA Splicing in the Conditional 
Strains. 
In order to determine whether the in viva depletion of the Sm-like proteins causes 
a defect in pre-mRNA splicing (as seen for Ussip) RNase protection assays were 
performed, looking specifically at the effect on the ACT] transcript. Total RNA was 
assayed from cells grown under the permissive conditions, or for up to 6 hours 
under conditions restrictive for cell growth. AEMY22 and AEMY30 cells displayed 
partial splicing defects in their RNA profiles at 37°C (Figure 7.1 1A., lanes 8 and 4 
respectively). AEMY22 showed an increased level of pre-mRNA, but no significant 
decrease in mRNA levels, while AEMY30 showed some pre-mRNA accumulation, 
but very low levels of rnRNA. Neither strain has the defined profile expected of a 
strong splicing mutant. Compare these two strains to DJY36, aprp2-] mutant strain, 
which showed accumulation of pre-mRNA, and concomitant decrease in the mRNA 
levels after only 2 hours at 37°C (Figure 7.1IA., lane 18). Compared to their 
parental strains, AEMY 19 and AEMY24 cells appear to show an accumulation of 
pre-mRNA at 23°C, but not at 37°C (Figure 7.1 IA., lanes 5-6 and 11-12). This may 
indicate that these cells have a defect in the splicing pathway per se and as such it is 
visible in this assay at 23°C, but not exacerbated at 37°C (see discussion). AEMY29 
cells have the same RNA profile at 23°C and 37°C (Figure 7.1 IA., lanes 13-14), 
which is comparable to that of its parental strain (BMA64), indicating that these 
cells do not have a splicing defect. 
Northern analysis of the RP28 transcript confirmed the results of the RNase 
protection assay, for each of the strains tested (Figure 7.1 1C.). 
Thus none of the conditional strains have a "classical" splicing defect under 
those conditions restrictive for cell growth. 
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Figure 7.11. Assays for in vivo pre-mRNA splicing in conditional strains. (A) 
RNase protection assay. Total RNA was extracted from cells grown for various 
lengths of time under the restrictive conditions. RNase protection analysis was 
carried out and the RNA fragments produced were separated on denaturing 6% w/v 
polyacrylamide gels and visualised by autoradiography. The RNA species relating 
to "protected" pre-mRNA, exon 2 and exon 1 are shown. The multiple bands seen 
for exon I and exon 2 are thought to be due to "breathing" at the ends of the RNA 
duplex formed. Hrs at rest., Hours for which the cells were grown under the 
restrictive conditions (37°C or glucose medium). (B) Schematic representation of 
the radiolabelled probe used, and the RNA species protected. i) ACT] pre-mRNA; 
ii) Radiolabelled RNA probe used for this experiment; iii) Species protected by 
unspliced ACT] pre-mRNA; iv) Species protected by spliced ACT] mRNA. (C) 
Northern blot analysis. Total RNA was extracted from cells grown for various 
lengths of time under the restrictive conditions. RNA was separated on denaturing 
1.2% w/v agarose gel and blotted to Hybond-N (Amersham). The blot was probed 
with a radiolabelled fragment of DNA encoding exon 2 of RP28. The positions of 
pre-mRNA and rnRNA are indicated. 
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Searches of the completed S. cerevisiae genome database identified 16 putative 
open reading frames encoding proteins containing Sm motifs (Fromont-Racine et 
al., 1997). In this Chapter the ORFs for seven of these proteins have been studied, 
and it is apparent that each may have different properties. As such each ORF, and in 
turn each protein, should not be regarded simply as an alternative member of an Sm-
like super-family. 
The clearest indication of the differences between them comes from the gene 
deletion analysis. Four of the uncharacterised ORFs (YBL026w, YER146w, 
YJR022w and USS2) are essential for cell viability, whilst the remaining three 
ORFs (SPB8, YDR378c and YNL147w) are non-essential. The essential nature of 
YER146w contradicts published data obtained from genetic footprinting of 
chromosome V by Tyl insertional mutagenesis (Smith et al., 1996). However, it is 
possible that the Ty insertion permitted the production of a modified, but functional 
protein. Although no ORFs are annotated in the SGD database as overlapping 
YER146w, a close examination and conceptual translation of the DNA from this 
region reveals the existence of a potential 145 amino acid encoding ORF on the 
opposite strand, which would overlap with YER146w. The deletion analysis 
described here would also disrupt this putative ORF, however since pAEM70 
(which encodes only YER146w) can complement the deletion, it was concluded that 
YER146w is indeed essential for cell viability. At present, the possibility that the 
temperature-sensitive phenotype of AEMY29 cells may be due to disruption of the 
putative ORF cannot be formally excluded. However, an examination of the 5' and 
3' regions of the ORF reveals no good matches to the consensus sequences expected 
for yeast gene promoters or terminators. Thus, whether this sequence represents a 
bonafide ORF remains to be determined. 
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The non-essential nature of three Sm-like protein-encoding ORFs analysed in 
this work suggests that either the function of the protein is not essential (at least at 
some temperatures), or that another member of the Sm motif-containing protein 
family may be able to substitute for that function. Such substitutions could also 
explain why eight Sm-like proteins can associate with U6 snRNA (Chapter Eight) 
while in the other spliceosomal snRNPs, only seven proteins are found (Neubauer et 
al., 1997; Gottschalk et al., 1998). Perhaps in the case of the U6 snRNA-associated 
particle, alternative combinations of the Sm-like proteins can exist. Some degree of 
specificity must be maintained however, since although cells deleted for SPB8, 
YDR378c and YNL147w are viable at 23°C and 30°C, they have a slow growth 
phenotype, and do not grow at 37°C. This implies that whichever protein may be 
supplying the complementing function, it is incapable of restoring the full wild-type 
activity. Conceivably, the complex formed by the Sm-like proteins may retain its 
structure and be functional at the lower temperatures, but not at 37°C, in the absence 
of one of these components. 
An examination of the growth curves from the conditional strains also highlights 
the differences between them. For example, AEMY30 cells are clearly very sick, 
doubling every 327 minutes at 23°C with cell division stopped after 4 hours at 37°C, 
whilst AEMY28 cells double every 208 minutes at 23°C and have ceased dividing 
by 9 hours after the shift to 37°C. 
Although the cells from the conditional strains grow at 23°C, these conditions are 
not considered to be truly permissive, since the cells still display a growth defect at 
this temperature (and at 30°C). This implies that these cells have a defect per Se, and 
that this defect may be exacerbated at 37°C. Alternatively, the cells may have a non-
lethal defect at 23°C in one pathway, and a lethal defect at 37°C in a separate 
pathway. Similarly, the cells may possess defects in multiple pathways, and these 
may only prove lethal when combined at 37°C. At this time, these possibilities 
cannot be formally discounted. 
It is significant that after 12 hours at 37°C, although cells for most of the 
conditional strains have stopped dividing, they are still viable, and can be 
propagated at 23°C (Figure 7.8A.). This indicates that at this point the cells have 
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stopped dividing, but that they are not dead. Thus, the process(es) which requires 
the Sm-like proteins is stalled, but can be re-activated by a return to more 
permissive conditions. After 24 hours at 37°C, only AEMY22 and AEMY30 cells 
are unable to recover, which may reflect the fact that these cells are the first to stop 
dividing at the restrictive conditions and as such are likely to have the more severe 
physiological defects. However, in all cases it was noted that the cell numbers were 
well down after 24 hours under the restrictive conditions, indicating that for the 
majority of the cells, re-growth was unrecoverable at this stage. 
Northern analysis of the conditional strains revealed further differences between 
the Sm-like proteins, as not all of the proteins are required for the stability of U6 
snRNA (Figure 7.9.). An analogous situation has been reported for U3 snIRNA, 
which associates with a number of proteins, only some of which are required for the 
stability of the RNA (Jansen et al., 1993; Dunbar et al., 1997; D. Lafontaine and D. 
Tollervey, pers. comm.). From this analysis Smx4, Yb1026p, Ydr378p and Ynl147p 
were shown to be necessary for the stability of U6 snRNA in vivo. It was also 
shown that those cells carrying deletions in YBL026w, YDR378c and YNL147w 
had decreased levels of U6 snRNA even when grown at 23°C. Therefore, the 
stability of the U6 snRNA would appear to be affected per se by the deletion of 
these ORFs, although clearly the phenotype is exacerbated at 37°C. 
The difference in the kinetics of decline of U6 snRNA seen with AEMY3 1 cells 
may reflect the need to turn over the Smx4 protein after repression of transcription 
in this strain, compared to the more rapid effect of heat treatment on the other 
strains. In this respect, AEMY3 1 resembles MCY4, in the kinetics of decline of U6 
snRNA following glucose repression of Ussip production (Cooper etal., 1995). 
The presence of low but detectable levels of U6 snRNA even 12 hours after cell 
division has ceased in cells deleted for YBL026w, YDR378c and YNL147w, may 
explain the very weak (or complete absence of any) splicing defect seen in these 
cells. The maintenance of a relatively low concentration of U6 snRNA may be 
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sufficient to allow the splicing of at least some transcripts, while the cessation of 
growth may be due to limiting splicing of other essential transcript(s). However, the 
method of RNA preparation used for these experiments disrupts subcellular 
organisation thereby allowing no conclusions to be reached as to whether this U6 
snRNA is actually in the nucleus, or capable of incorporation into functional 
spliceosomal snRNP particles. 
The observation that P RNA, MRP RNA and 5S rRNA levels were not affected 
in the conditional strains (in most cases) demonstrates that the effects seen are 
specific to U6 snRNA, and are not due to general defects in rpolIII transcription, or 
the stability of rpo 1111 transcripts. 
In addition to the reduction in U6 snRNA levels seen in AEMY30 cells, the 
levels of US L snRNA, pre-P RNA, MRP RNA and 5S rRNA were also significantly 
reduced at 3 7°C. AEMY3 1 cells also showed a reduction in the level of U51, 
snRNA, whilst maintaining the levels of the rpollll transcribed species. It is possible 
that these effects are a result of the severely disrupted physiology of these two 
strains, however another possibility exists. 
It is intriguing to note that US L snRNA (Chanfreau et al., 1997; Ursic et al., 
1997), U6 snRNA (Tazi et al., 1993; Booth and Pugh, 1997) and pre-P RNA (Lee et 
al., 1991; Lundberg and Altman, 1995) are each processed at their 3' ends, and it is 
possible (given the profiles seen in the Northern analysis) that a subset of the Sm-
like proteins may play a role in these events. In essence, endolytic cleavage events 
resemble the steps of the splicing reaction, with chemical bonds being broken within 
RNA molecules. In these terms, it is perhaps not unreasonable to imagine a role for 
these Sm-like proteins in these processes. Whether the proteins could be involved in 
the folding of the RNAs into the correct orientation (i.e. as chaperones), in retaining 
the RNAs in a particular sub-cellular compartment to allow the cleavage, or in the 
actual cleavage reactions, are all hypothetical possibilities. However, further work 
would be needed to establish if these proteins are indeed involved in such 
processing events, and what their functional role would be (see Chapter Ten). 
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Initially, the stability of yet more small RNA species could be assayed. This 
could allow a more general pattern of the species affected to be detennined, or 
alternatively, it may serve to emphasise the specificity of the effects already 
described. 
The lack of a strong splicing defect in the conditional strains described in this 
work suggests that the arrest of growth in these cells may not be due primarily to a 
defect in pre-mRNA splicing. It may be however, that these proteins are involved in 
the splicing of only a subset of intron-containing RNAs, as in the case of Slu7p and 
Prpl8p (Brys and Schwer, 1996; Zhang and Schwer, 1997). Since, to date, only the 
splicing of ACT] and RP28 pre-mRNA has been assayed, this possibility cannot be 
formally excluded. 
However, given that some of the conditional strains appear to show a partial 
defect in the splicing of the transcripts tested, it is also possible that (at least some 
of) the Sm-like proteins are involved in the general splicing pathway, and possibly 
also in another cellular process(es). Whether disruption to this additional process(es) 
alone under the restrictive conditions may confer the growth arrest phenotype in the 
conditional cells is not known. Alternatively, the phenotype observed may be due to 
a synergistic effect on the splicing reaction and this proposed additional process. 
Given that the Sm-like proteins are capable of associating with U6 snRNA 
(Chapter Eight), it is possible that U6 may also be involved in other cellular 
processes. The role of the excess U6 snRNA (compared to the other spliceosomal 
snRNAs) and the degree of conservation of U6 snRNA length and primary sequence 
(Brow and Guthrie, 1988) have long been discussed, without any experimental data 
to suggest what the function may be. 
The proposed involvement of Spb8p in mRNA decapping (Boeck et al., 1998), 
together with the two-hybrid screen data (Chapter Three and Appendix I) is 
suggestive of a link between the Sm-like proteins and the pathway of mRNA 
degradation. Further experiments would be needed to investigate the role of these 
proteins, and potentially of U6 snRNA, in such processes. 
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The involvement of a subset of the Sm-like proteins in processes other than 
splicing may explain the differences seen in Figure 7.10. Depletion of certain Sm-
like proteins can be suppressed (or partially suppressed) by the over-production of 
U6 snRNA, while the depletion of others can not. If the protein is required for 
another function, over-production of U6 snRNA alone is unlikely to suppress the 
conditional phenotype. Intrinsic in this explanation is that in those cells which can 
be rescued by U6 over-production, deletion of the ORF led to a reduction in the in 
vivo levels of U6 snRNA. Thus, for AEMY24 and AEMY29 cells in which the 
levels of U6 snRNA are not affected at 3 7°C, there is no reason why over-
production of U6 snRNA should lead to suppression of the temperature-sensitive 
phenotype of these cells. This observation also argues in favour of these Sm-like 
proteins being involved in processes distinct from pre-mRNA splicing. It should be 
noted that at this time the cause of the temperature-sensitive phenotype of AEMY29 
cells is not clear. It had been assumed that the presence of the Ga14AD:Yer146 
fusion protein was responsible, however the discovery of a putative ORF on the 
opposite DNA strand, but overlapping YER146w and therefore disrupted in these 
cells provides an alternative explanation (as discussed previously). 
The characterisation of the Sm-like protein-encoding ORFs, and the phenotypes 
produced in the conditional strains has led to some interesting findings with respect 
to their involvement in the splicing reaction and their functional association with U6 
snRNA. 
The availability of the conditional alleles for these ORFs will allow the functions 
and interactions of the encoded proteins to be studied. Genetically, high-copy 
number suppression screens and synthetic lethality tests can be utilised in order to 
identify novel interacting factors, and to determine if the proteins can indeed 
functionally substitute for one another (at least at some temperatures). 




CHARACTERISATION OF THE SM-LIKE 
PROTEiNS. 
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8.1. Two-Hybrid Screens Reveal a Network of Interactions 
Between Sm-Like Proteins. 
A comparison of the results of the exhaustive two-hybrid screens described in 
Chapter Three and in Appendix I reveal a network of potential interactions between 
the non-canonical Sm-like proteins (Figure 8.1.). By analogy to the canonical Sm 
proteins, this network of interactions suggests that these proteins may form a 
complex. The inclusion of Ussip and Smx4p in this complex, both of which 
associate with U6 snRNA (Cooper et al., 1995; Séraphin, 1995) may suggest that 
the other Sm-like proteins may also be U6 snRNA-associated. The interactions seen 
between five of the Sm-like proteins and Prp24p supports this proposal. Although 
interactions were seen with Smxlp, this protein does not associate with any of the 
spliceosomal snRNAs (Séraphin, 1995). Interactions were also seen with Smd2p, 
the homologue of the human SmD2 protein, which has been biochemically purified 
as part of the Ui snRNP (Neubauer et al., 1997). The significance of these 
interactions is not known. 
8.2. Cloning of HA-tagged Versions of Each of the Sm-Like 
Proteins. 
In order to characterise the associations, both protein-protein and protein-RNA, 
made by the novel Sm-like proteins, the proteins were tagged with the 9 amino acid 
haemagglutinin HA-i protein epitope of the influenza virus. Plasmids encoding 
these fusion proteins were then transformed into the yeast strains described in 
Chapter Seven, deleted for the appropriate open reading frame. These cells will 
subsequently express only an HA-tagged version of one of the Sm-like proteins, 
thereby allowing immunoprecipitation experiments to be performed without 
competition between the wild-type and tagged proteins. 
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Each HA-tagged Sm-like protein was assayed for its functional capacity and for 
its expression level prior to these experiments. 
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Figure 8.1. Sm-like protein linkage map derived from two-hybrid screens. A protein linkage map was derived from the results of the two-
hybrid screens described in Chapter Three and in Appendix I. Arrows run from bait proteins to prey proteins. Ovals, proteins with Sm 
motifs; Red, proteins associated with U6 snRNA; Yellow, protein associated with Ui, U2, U4 and U5 snRNAs; Grey, protein with no 
splicéosomal snRNA association (Séraphin, 1995); Green, proteins not shown to have snRNA associations prior to this work. 

8.2.1. Tagging SPB8. The SPB8 open reading frame was cloned into the two-hybrid 
prey plasmid pACTIIst, which encodes an HA-tag between the Ga14 activation 
domain and the prey protein. This construct (pAEM60) rescued the growth of 
AEMY24 cells at 3 7°C, indicating that it expressed a functional Spb8p fusion 
protein (Figure 8.2A.). Western blot analysis of the protein revealed that only a 
small proportion of the HA-tagged protein was of the molecular weight expected, 
approximately 40kDa. The majority of the protein migrated at approximately 29kDa 
(Figure 8.213.). Since the nature of this truncated fusion protein was unknown, it was 
decided to tag SPB8 at its chromosomal locus. Figure 8.3A. shows the strategy used 
to create AEMY28, replacing the TRPJ gene which itself replaces the open reading 
frame of SPB8 in AEMY24, with a DNA fragment which would express an HA-
tagged Spb8 protein. The loss of the temperature-sensitive phenotype of AEMY24, 
TRP auxotrophy and Southern blotting confirmed the integration (Figures 8.313. and 
8.3C.). Expression of a single, stable form of HA-tagged Sbp8p was confirmed by 
Western analysis (Figure 8.3D.). 
8.2.2. Tagging YBL026w. The two-hybrid prey construct expressing Yb1026p 
(pAEM55) can functionally complement the deletion of the YBL026w open reading 
frame, but only at 23°C and 30°C (see Section 7.2.). Examination of the HA-tagged 
proteins in these cells (AEMY30) revealed a number of species smaller than the 
full-length fusion protein (approximately 34kDa) (Figure 8.4.). Both of these effects 
could be due to problems removing the intron present in YBL026w, since the fusion 
construct has a very large exon 1. An HA-tag sequence was therefore introduced at 
the 3' end of the YBL026w open reading frame, and the tagged construct was cloned 
into pBM125, to generate pAEM68, i.e. a Gal-regulated HA-tagged Yb1026p (see 
Table 2.1.12.). pAEM68 was transformed into AEMY30, and the cells were cured 
of pAEM55, to produce AEMY33. In these cells, the only functional Yb1026p is 
HA-tagged at its carboxy-terminus and is under control of the GALl promoter 
thereby allowing the cells to grow on galactose medium at 37°C, but not on glucose 
medium at any temperature (Figure 8.5A.). Expression of the tagged protein was 
confirmed by Western analysis (Figure 8.513.). 
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Figure 8.2. Analysis of pAEM60. (A) AEMY24 cells were transformed with 
pACTIIst or with pAEM60, and ten fold serial dilutions spotted onto YMM -LW. 
Plates were incubated at 23°C or 37°C for 3 days. (B) Crude cell extracts were 
prepared from AEMY24 cells carrying either pACTIIst (lane 1) or pAEM60 (lane 
2). Proteins were fractionated on a 15% SDS-polyacrylamide gel, electroblotted and 
probed with antibodies against the HA-epitope. Immunodetection was with HRP-
conjugated anti-mouse antibodies and ECL (Amersham). The position of the Ga14 
activation domain: FIA fusion protein (Ga14AD:HAp) and the tagged Spb8p fusion 
protein (Ga14AD :HA: Spb8p) is indicated. 
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Figure 8.3. Tagging SPB8 at its chromosomal locus. (A) Schematic representation 
of the strategy used to tag the ORF encoding the Spb8 protein at its chromosornal 
locus. An HA:SPB8 fragment was generated by PCR using pAEM60 plasmid DNA 
as a template and oligonucleotides 5HAB and pACTIIrev. This linear DNA 
fragment was transformed into AEMY24 cells, which were plated onto YPDA 
medium and incubated at 37°C. ACT, Ga14 activation domain DNA; P, 5'-
untranslated DNA of SPB8; T, 3'-untranslated DNA of SPB8. (B) Analysis of 
growth phenotype of AEMY28. Ten-fold serial dilutions of AEMY24 or AEMY28 
cells were spotted onto YPDA or selective medium (YMM -W). Plates were 
incubated for 3 days at the temperatures indicated. (C) Southern analysis of 
AEMY28. Genomic DNA was extracted from BMA64a cells (lane I), AEMY24 
cells (lane 2) or AEMY28 cells (lane 3) and digested with restriction enzymes C/al 
and PstI. Fragments were separated on 1% w/v agarose gel and blotted to Hybond-N 
membrane. The blot was probed with a radiolabelled DNA fragment from the 5' end 
of the SPB8 coding sequence. Black arrow indicates the position of the untagged 
ORF; white arrow indicates the position of the tagged ORF. (D) AEMY28 expresses 
an HA-tagged Spb8 protein. Crude cell extracts were prepared from AEMY24 cells 
(lane 1) or AEMY28 cells (lane 2). Proteins were fractionated and analysed as 
described in Figure 8.2B. The position of the HA-tagged fusion protein (HA:Spb8p) 
is indicated. The other bands present at approximately 27kD and 40kD are due to 
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Figure 8.4. Analysis of HA-tagged protein produced from pAEM55. Crude cell 
extracts were prepared from AEMY24 cells carrying pACTIIst (lane 1) or from 
AEMY30 cells (contain the pAEM55 plasmid) (lane 2). Proteins were fractionated 
and analysed as described in Figure 8.2B. The positions of the Ga14 activation 
domain: HA fusion protein (GaI4AD:HAp) and the tagged Yb1026p fusion protein 
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Figure 8.5. Analysis of AEMY33. (A) AEMY30 cells were transformed with 
pAEM68 and the cells were subsequently cured of pAEM55, to produce strain 
AEMY33. Ten-fold serial dilutions of AEMY30 cells carrying pAEM68 or 
AEMY33 cells were spotted onto galactose (YMGa1 -UW) or glucose (YMM -UW) 
medium. Plates were incubated for 3 days at the temperature indicated. (B) 
AEMY33 expresses an HA-tagged Yb1026 protein. Crude cell extracts were 
prepared from BMA38 cells (lane 1), AEMY30 cells carrying pAEM68 (lane 2) or 
from AEMY33 cells (lane 3). Proteins were fractionated and analysed as described 
in Figure 8.2B. The positions of the Ga14 activation domain: HA-tagged Yb1026 
fusion protein (GaI4AD:HA:YblO26p) and of the C-terminally HA-tagged Yb1026 
protein (Yb1026:HAp) are indicated. 
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8.2.3. Tagging USS2. The two-hybrid prey plasmid expressing Smx4p (pAEM18) 
was unable to complement the deletion of the USS2 open reading frame (data not 
shown). However, the HA:USS2 region was cut from pAEMI8 and cloned behind 
the GALl promoter of pBM125. This construct (pAEM64) was able to support 
growth on galactose medium in haploid cells deleted for USS2 i.e. AEMY31 cells 
(see Section 7.2.), and expressed a stable HA-tagged protein (Figure 8.6.). The 
fusion protein is larger than expected due to the lack of the endogenous STOP 
codon in this plasmid. Translation therefore continues into the sequence of the 
vector before terminating. Despite this additional tag at the C-terminus, the protein 
is functional and was therefore used in these studies. 
8.2.4. Tagging YER146w. The two-hybrid prey construct expressing Yer146p 
(pAEM70) in AEMY29 cells can compensate for the deletion of the open reading 
frame at least at 23°C (see Section 7.2.) and gives a fusion protein of approximately 
the size expected (Figure 8.7.). However, this plasmid was selected from the FRYL 
library (by Yjr022p (see Appendix I)), and contains a DNA fragment lacking the 
last codon and the STOP codon of YER146w. The fusion protein therefore 
possesses an 11 amino acid tag at its C-terminal (derived from the vector sequence) 
however, these extra residues do not appear to interfere significantly with the 








Figure 8.6. Analysis of HA-tagged protein produced from pAEM64. Crude cell 
extracts were prepared from AEMY26 cells carrying pBM125 (lane I) or from 
AEMY3 I cells (contain the pAEM68 plasmid) (lane 2). Proteins were fractionated 
and analysed as described in Figure 8.213. The position of the HA-tagged Smx4 








Figure 8.7. Analysis of HA-tagged protein produced from pAEM70. Crude cell 
extracts were prepared from AEMY24 cells carrying pACTIIst (lane 1) or from 
AEMY29 cells (contain the pAEM70 plasmid) (lane 2). Proteins were fractionated 
and analysed as described in Figure 8.213. The position of the Ga14 activation 
domain: HA fusion protein (Ga14AD:HAp) and the tagged Yer146p fusion protein 
(Ga14AD:HA:Yerl46p) is indicated. 
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8.2.5. Tagging YDR378c. The two-hybrid prey construct of YDR378c (pAEM54) 
was unable to support the growth of AEMY19 cells at 37°C (data not shown). The 
open reading frame was therefore cloned into the YCpIF16 plasmid to generate a 
Gal-regulated, HA-tagged construct, pAEM61, which was capable of supporting the 
growth of AEMY19 cells at 37°C on galactose medium, but not when glucose was 
the sole carbon source (Figure 8.8A.). The expression of the tagged protein was 
confirmed by Western analysis (Figure 8.813.). 
8.2.6. Tagging YNL147w. As with YBL026w, YNLI47w contains an intron. In 
this case, the 5' oligonucleotide primer used to generate the open reading frame by 
PCR bridged the intron, and included the 18 nucleotides comprising exon 1 (see 
Table 2.1.8.). In this way, the intron sequence was not present in the PCR product. 
In order to tag the Yn1147 protein, the coding sequence was subcloned from 
pAEM59 (two-hybrid bait construct) into YCpIF 16. The Gal-regulated, HA-tagged 
construct (pAEM62) was able to support the growth of AEMY22 cells at 37°C on 
galactose medium, but not when glucose was the sole carbon source (Figure 8.9A.). 
The expression of the tagged protein was confirmed by Western analysis (Figure 
8.913.). 
8.2.7. Tagging YJR022w. The two-hybrid prey construct expressing Yjr022p 
(pAEM71) was capable of complementing the deletion of YJR022w at all 
temperatures tested (see Section 7.2.), and the fusion protein expressed was of the 
size expected (approximately 38kDa) (Figure 8.10.). This construct was therefore 
considered suitable for the experiments to be performed. 
















Figure 8.8. Analysis of pAEM61. (A) AEMY19 cells were transformed with 
YCpIF 16 or pAEM6 1. Transformants were resuspended and ten-fold serial dilutions 
spotted onto galactose (YMGa1 -HW) or glucose (YMM -HW) medium. Plates were 
incubated at 23°C or 37°C for 4 days. (B) Crude cell extracts were prepared from 
AEMYI9 cells carrying YCpIF16 (lane 1) or pAEM61 (lane 2). Proteins were 
fractionated and analysed as described in Figure 8.2B. The position of the HA-

















Figure 8.9. Analysis of pAEM62. (A) AEMY22 cells were transformed with 
YCpIF16 or pAEM62. Transformants were resuspended and ten-fold serial dilutions 
spotted onto galactose (YMGa1 -HW) or glucose (YMM -HW) medium. Plates were 
incubated at 23°C or 37°C for 4 days. (B) Crude cell extracts were prepared from 
AEMYI9 cells carrying YCpIFI6 (lane 1) or from AEMY22 cells carrying 
pAEM62 (lane 2). Proteins were fractionated and analysed as described in Figure 










Figure 8.10. Analysis of HA-tagged protein produced from pAEM7I. Crude cell 
extracts were prepared from AEMY24 cells carrying pACTIIst (lane 1) or from 
LMA4-2A cells carrying pAEM71 (lane 2). Proteins were fractionated and analysed 
as described in Figure 8.213. The positions of the Ga14 activation domain: HA fusion 
protein (GaI4AD:HAp) and the tagged Yjr022p fusion protein 
(Ga14AD:HA:YjrO22p) are indicated. 
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Table 8.1. Summary of the functional HA-tagged Sm-like proteins. For each Sm-like protein, the promoter from which it is expressed, a 
schematic representation of the fusion protein, the size of the fusion protein, the size of the wild-type protein, the strain or plasmid encoding 
the fusion protein and the strain in which the plasmid was canied for the preparation of extracts are all given. A description of each plasmid 
is given in Table 2.1.12. The genotype of each of the strains used is given in Table 2.1.7. IVS, intervening sequence. TERM and T, protein 
sequence produced by "read-through" from the Sm-like protein-encoding sequence into the terminator regions of the respective plasmids. 
Promoter 	 Fusion 	 Fusion size 	WT size 	Eflcoded by Used in strain 
Endogenous 	 23kDa 
Ivs 
GAL 1 	 1 3kDa 
GALl 	 I irnk 	22kDa 
ADH 	Ga14 AD 	 34kDa 
GALl 	 :!: 	: 	 15kDa  
20.3kDa 	AEMY28 	AEMY28 
11 .2kDa 	pAEM68 	AEMY33 
10.OkDa 	pAEM64 	AEMY31 
10.4kDa 	pAEM70 	AEMY29 
13.8kDa 	pAEM61 	AEMY19 
GALl 	 l3kDa 
	
12.lkDa 	pAEM62 	AEMY22 
ADH 1 Ga14 AD 	 I 	38kDa 	14.5 kDa 	pAEM71 	LMA4-2A 
8.3. Co-immunoprecipitation of snRNAs with Tagged Sm-Like 
Proteins. 
For each novel Sm-like protein physical association with the spliceosomal 
snRNAs was tested. Cell extracts made from the strains expressing the HA-tagged 
fusion proteins were incubated with antibodies directed against the HA epitope, and 
co-precipitation of spliceosomal snRNAs was examined by Northern analysis. At 
150mM salt Yb1026p, Yer146p, Ydr378p, Yn1147p and Yjr022p all co-precipitated 
U6 snIRNA (Figure 8.11.), and it was confirmed that, under these conditions, Smx4p 
also associates with U6 snRNA. As previously observed for Usslp and Smx4p, U4 
snRNA was co-immunoprecipitated with these other proteins due to its extensive 
base-pairing to the U6 snRNA in the U4/U6 particle. Similarly, low levels of U5 
snRNA were precipitated by Yb1026p and Yer146p, presumably due to co-
precipitation of the U4/U6.U5 tri-snRNP (and supported by co-precipitation of 
Ussip and several of the other Sm-like proteins by antibodies against Prp8p which 
is present in tri-snRNPs (Vidal, 1998). No immunoprecipitation of Ui or U2 
snRNA was detected for any of the Sm-like proteins. 
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Figure 8.11. Immunoprecipitation of snRNAs with antibodies against the HA epitope. Extracts derived from cells expressing only an HA-
tagged fusion of one of each of the Sm-like proteins (see Table 8.1.) were subjected to immunoprecipitation. Incubation of the extracts with 
antibodies and subsequent washes were in 150mM salt. RNAs were separated on 6% denaturing polyacrylamide gels, electroblotted and 
probed with radiolabelled oligonucleotides specific for the spliceosomal snRNAs. The identity of each snRNA is shown to the right. Total, 
total RNA; Beads, incubation without antibodies i.e. Protein-A Sepharose alone; a-HA, immunoprecipitation with anti-HA antibodies. 
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For Spb8p, no snRNAs were detected when the immunoprecipitations were 
performed at 150mM salt (Figure 8.12A.). However, the fusion protein was 
efficiently precipitated under these conditions (Figure 8.12B.). When the 
immunoprecipitation experiments were repeated at a range of salt concentrations, a 
low level of U6 snRNA could be co-immunoprecipitated with HA-Spb8p at 50mM 
(Figure 8. 12C.). This association was lost at higher salt concentrations, suggesting a 
looser association of this protein with U6 snRNA, compared to that seen with the 
other Sm-like proteins. 
The specificity of the RNA species immunoprecipitated with the HA-tagged Sm-
like proteins was tested by reprobing the membranes in Figures 8.11. and 8.12A. for 
P RNA, MRP RNA and 5S rRNA. None of these RNA species was detected in the 
immunoprecipitated samples for any of the HA-tagged proteins (Figure 8.13.), 
suggesting that these proteins do not possess a general RNA binding capacity. 
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Figure 8.12. Association of Spb8p with U6 snRNA is salt-sensitive. (A) Extract 
derived from AEMY28 cells expressing an HA-tagged fusion of Spb8p was 
subjected to immunoprecipitation as described in Figure 8.11. (B) Extracts from 
AEMY28 were incubated as in Figure 8.12A., with the proteins precipitated 
fractionated by SDS-PAGE and electroblotted. Immunodetection was performed 
with anti-HA antibodies, HRP-conjugated, anti-mouse secondary antibodies and 
visualised by ECL (Amersham). The position of the HA-tagged Spb8 protein 
(HA:Spb8p) is indicated. (C) Extracts from AEMY28 cells were subjected to 
immunoprecipitations as before, with incubations and washes performed at 50mM, 
100mM or 150mM salt. "Beads" sample was incubated and washed at 50mM salt. 
RNAs were recovered and analysed as described in Figure 8.11. Total, total RNA 
Beads, incubation without antibodies i.e. Protein-A Sepharose alone; a-HA, 
immunoprecipitation with anti-HA antibodies. 
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Figure 8.13. Sm-like proteins do not precipitate P RNA, MRP RNA or 5S rRNA. The membranes described in Figure 8.11. and 8.12A. 
were successively stripped and reprobed with radiolabelled oligonucleotides specific for P RNA, MRP RNA and 5S rRNA. Total, total 
RNA; Beads, incubation without antibodies i.e. Protein-A Sepharose alone: cL-HA, immunoprecipitation_with anti-HA antibodies. 
8.4. All the Sm-Like Proteins are Complexed with Ussip. 
The biochemical analyses suggest that all the Sm-like proteins may be associated 
with U6 snRNA and, together with the two-hybrid screen data, that they may be 
found together in a protein complex, analogous to the canonical Sm proteins. In 
order to investigate more directly the existence of such a complex, antibodies 
against the Ussl protein were used in immunoprecipitation experiments with 
various cell extracts each of which contained the HA-tagged version of one of the 
Sm-like proteins. It was seen that each of the HA-tagged Sm-like proteins tested, 
but not the HA:Ga14 activation domain fusion protein, could be co-
immunoprecipitated with the Ussi protein at 150mM salt (Figure 8.14.). This 
suggests that all of the Sm-like proteins can associate in a complex, or complexes, 
with the Ussi protein. 
It is interesting to note the strong co-immunoprecipitation of Spb8p with Ussip 
under these conditions, given the weak association seen between this protein and the 
U6 snRNA. Thus Ussi and Spb8 proteins may form a protein complex free from the 
U6 snRNA. 
In order to show that the anti-Ussip antiserum does not recognise and precipitate 
any of these proteins directly, the experiment was repeated with extracts in which 
the proteins had been denatured prior to immunoprecipitation. Under these 
conditions, none of the HA-tagged proteins were precipitated (data not shown). 
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Figure 8.14. Co-immunoprecipitation of Sm-like proteins with antiserum against 
Uss ip. Extracts derived from cells expressing only an HA-tagged fusion of each 
Sm-like protein were subjected to immunoprecipitation with antiserum against 
Ussip. Incubation of the extracts with antibodies and subsequent washes were in 
150mM salt. The precipitated proteins were fractionated by 15% SDS-PAGE and 
electroblotted. Immunodetection was carried out with anti-HA antiserum and anti-
mouse HRP-conjugated secondary antibodies, and was visualised by ECL 
(Amersham). Strains used were: Spb8p, AEMY28; Yb1026p, AEMY33; Smx4, 
AEMY31; Yer146p, AEMY29; Ydr378p, AEMY19 [pAEM6I]; Yn1147p, 
AEMY22 [pAEM62]; Yjr022p, LMA4-2A; Ga14AD, AEMY9 [pACTIIst]. The 
positions of the tagged fusion proteins are marked by asterisks (*).  
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8.5. Two-Hybrid Baits Encoding Sm-Like Proteins in MCY4 
Cells. 
The proposed interactions between the Sm-like proteins and Ussip were tested 
genetically by assaying the ability of the two-hybrid plasmids encoding the Sm-like 
proteins to rescue the growth of MCY4 cells on glucose medium. All available Sm-
like proteins were tested, with only Gal-Ussip (encoded by pAEM13) and Gal-
UsslAp (encoded by pAEM17) able to support the growth of MCY4 cells on 
glucose medium (Figure 8.15.). 
8.6. Investigation of Two-Hybrid Interactions Between Sm-
Like Proteins by Direct Mating. 
A two-hybrid direct mating approach was used to investigate all potential 
pairwise interactions between the Sm-like proteins. Each open reading frame was 
cloned as both a bait fusion (with either the Ga14 or LexA DNA binding domain) 
and as a prey fusion (with the Ga14 activation domain). In addition, several 
canonical Sm protein-encoding ORFs cloned into the two-hybrid plasmids in the lab 
of P. Legrain (Fromont-Racine et al., 1997 and unpublished data) were included in 
this study. Fragments of Ussip, the N-terminal 92 amino acids (UsslAp), the N-
terminal 74 amino acids encompassing Sm-motif 1 (Ussl-A) or amino acids 46-86 
encompassing Sm-motif 2 (Uss 1-B) were also produced as bait fusions Bait and 
prey fusions were combined in all pairwise combinations with resistance to defined 
levels of 3-aminotriazole (3-AT) used as a guide to the strength of any two-hybrid 
interaction seen. As variance between the expression levels and stability of different 
bait and prey proteins may affect these measurements, they are only a rough guide 
to the strength of interactions between different pairs of proteins. However, the 
number of diploid strains capable of surviving on media containing up to 50mM 3- 
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AT does suggest a number of strong, and specific two-hybrid interactions (Figure 
8.16.). Other than an interaction between Ussip and Smblp (only in the absence of 
3-AT) none of the Sm-like proteins gave any interaction with any of the canonical 
Sm proteins. Instead the Sm-like proteins would appear to form a great many 
interactions with one another. Also, no significantly strong homeotypic interactions 
were seen, thus those diploids which were able to survive on 3-AT are believed to 
represent specific associations between the two-hybrid fusion proteins expressed, 
and not due to aspecific interactions between any two proteins containing the Sm-
fold. Deletion of the C-terminal region of Ussip does not prevent the truncated 
protein from associating with the other Sm-like proteins. This UsslAp protein was 
previously shown to be functional (Cooper, 1995). In contrast, Ussl-A and Ussl-B, 
neither of which could rescue the growth of MCY4 on glucose medium, were 
unable to support the two-hybrid interactions formed by the full-length protein or 
UsslAp with the other Sm-like proteins. This reaffirms the view that both Sm-
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Figure 8.15. Two-hybrid baits encoding Sm-like proteins in MCY4 cells. MCY4 cells were transftwrned with two-hybrid bait plasmids 
encoding Sm-like proteins. Two independent transformants were resuspended and spotted onto Galactose (YMGaI-W) or Glucose (YMM-
W) medium. Plates were incubated at 30°C for 3 days. Plasmids used were: Gal, pAS2AA; Lex, pBTM 116; Lex-Spb8. pAEM56; Gal-Ussi, 
pAEMI3; Gal-UsslAp, pAEM15; Lex-Yb1026, pAEM57; Gal-Srnx4, pAEMI7; Lex-Yer146, pAEM53; Lex-Ydr378, pAEM34; Lex-
Ynl 147, pAEM59; Gal-Yj r022, pAS2M:YJR022; Lex-Yjr022, pBTM 116 :YJRO22w Gal-Smb 1, pAS2M: SrnB; Gal-Smd 1. 
pAS2AA:SrnD1 Gal-Smd3. pAS2AA:SmD3. 
Figure 8.16. Two-hybrid direct matings of Sm-like proteins. Open reading frames 
encoding the Sm-like proteins were cloned as bait and prey fusions and transformed 
into their respective yeast host strains. Strains were then mated on YPDA medium 
and the growth of diploid cells assayed by replica-plating to YMM -LWH and at 
defined concentrations of 3-AT. The Figure shows the highest 3-AT concentration 
at which each diploid displayed growth after 3 days incubation at 30°C. Uss1p, N-
terminal 92 amino acids of Ussip; Ussl-A, N-terminal 74 amino acids of Ussip; 
Ussl-B, amino acids 46-86 of Usslp. Lex baits are encoded by pBTM116 derived 
plasmids. Gal baits are encoded by pAS2AA derived plasmids. Bait plasmids used 
were: Lex, pBTM1I6; Gal, pAS2AA; Lex-Spb8, pAEM56; Lex-Yb1026, pAEM57; 
Gal-Smx4, pAEMI7; Gal-Ussi, pAEM13; Lex-Yer146, pAEM53; Lex-Ydr378, 
pAEM34; Lex-Yn1147, pAEM59; Lex-Yjr022, pBTMI 16:YJRO22w; Gal-Uss lAp, 
pAEM 15; Gal-Uss 1-A, pAEM29; Gal-Ussi -B, pAEM30; Gal-Smd 1, 
pAS2AA:SmD1; Gal-Smd3, pAS2AA:SmD3; Gal-Srnbl, pAS2AA:SmB. Prey 
plasmids used were: Ga14AD; pACTJIst; Spb8, pAEM60; Yb1026, pAEM55; Smx4, 
pAEMI8; Ussi, pAEM14; Yer146, pAEM70; Ydr378, pAEM54; Yn1147, 
pAEM72: Yjr022. pAEM71; Smh, pAFM73. 
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8.7. U6 snRNA-associated Proteins are Structurally Conserved 
Through Evolution. 
Database searches with the Sm-like proteins reveal that many of the U6 snRNA 
associated proteins would appear to have been conserved through evolution. Figure 
8.17A. shows a sequence alignment of Yb1026p structural homologues from a 
number of higher organisms, and reveals that the sequence identities extend beyond 
the Sm-motifs. Yb1026p shows 63% identity (75% similarity) to the human 
sequence, whilst the other S. cerevisiae Sm motif-containing proteins all give values 
below 32% identity (41% similarity). Fromont-Racine et al. (1997) grouped 
Yb1026p in the "Dl" family, and comparisons of all the sequences in this family 
reveal the presence of a third motif downstream of the Sm2 domain and specific to 
the Dl family (Figure 8.17B.). The "Dl box" has a consensus sequence of 
VDTQLLQD in the non-canonical group (Figure 8.17A.), and LDTLLXD in the 
canonical proteins where X is either isoleucine or valine (Figure 8.17B.). The 
presence of this domain, in addition to the Sm-domains, suggests that the genes 
encoding Yb1026p and Smd 1 p  may share a common ancestor. 
Sm-like protein-encoding sequences also exist in the genomes of ancient 
bacteria. Database searches revealed that each of the genomes of Met hanoba cierium 
thermoautoirophicum and Archaeoglobus fulgidus contains two such sequences 
(Smith ci aL, 1997; Klenk et al., 1997). An Sm-like protein, and a U6-like RNA, 
have also been identified in the miniaturised genome of the eukaryotic 
endosymbiont, Pedinomonas minulissirna (Gilson and McFadden, 1996). Each of 
these five ancient proteins contains both Sm motifs (Figure 8.1 7C.) 
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Figure 8.17. Sequence alignment of Sm proteins. (A) Putative homologues of Yb1026p were identified by BLAST searches of the NCBI nr 
and dbest databases (http://www.ncbi.nlm.nih.gov/cgi-binIBLAST/nph-blast?Jform=0) . Sequences were aligned using the PILEUP program 
in the GCG9 suite of sequence analysis programs with identities and similarities highlighted using BOXSHADE 3.21 (http://www.isrec.isb-
sib.chlsoftware/BOX_form.html) . The positions of the Sm motifs I and 2 are shown together with the "Dl box" region specific to Yb1026p-
and Smdlp-Iike sequences. White on black represents amino acid identity in at least 6 of the 7 sequence; black on grey represents 
conservation of the nature of the amino acid at that site. Accepted groupings were M=I=V=L, K=R=H, F=Y=W, S=T, E=D, A=G, Q=N. 
The accession numbers of the proteins are as follows Hono sapiens, AA3 15292; Mus musculus. U85207; Branchiosiornafloridae, Z83273; 
Drosophila nielanogaster, AA82 1196; Brugia malayi, AA228204; Caenorhabdiiis elegans, Z8 1118; Saccharomyces cerevisiae, P38203. 
The sequence shown for the C. elegans protein differs from that published in the database due to the use of alternative splice sites. The 
conceptual translation used here produces a protein of the size expected for a Yb1026p homologue, whilst that in the database gives a much 
larger product with a disrupted Sm architecture. (B) Canonical Smdl protein sequences were identified from protein databases, and analysed 
as above. The C-terminal region containing the "Dl box" is shown. Accession numbers are as follows Homo sapiens, P13641; 
Schizosaccharoniyces pombe, AL009227; C'aenorhabditis elegans, U28738; Saccharomyces cerevisiae, Z72858. (C) Sm-like proteins from 
ancient bacteria. Protein sequences containing the Sm motifs were identified from bacterial sources using BLAST searches of protein 
databases. Sequences were aligned with identities and similarities highlighted as for Figure 8.1 7A. The positions of the Sm motifs 1 and 2 
are shown. Shadings and accepted groupings are as for Figure 8.1 7A. MTH649, Met hanobacteriurn thermoautotrophicunz protein (acc. no. 
AE000845); MTH 1440, Methanobacteriurn thernioautotrophicum protein (acc. no. AE000905); AF0362, Archaeoglobus fulgidus protein 
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8.8. Discussion. 
Database searches of the completed S. cerevisiae genome revealed the existence 
of 16 potential protein sequences containing the Sm motifs (Fromont-Racine et al., 
1997). Seven of these proteins have been demonstrated to be part of the Ui snRNP 
particle (Neubauer et al., 1997; Gottschalk et al., 1998) and as such are considered 
as the canonical Sm proteins also common to the U2, U4 and U5 snRNPs. 
The sequences of the non-canonical Sm-like proteins have been aligned with the 
canonical Sm protein sequences from humans and from yeast, and assigned to an 
Sm sub-family i.e. B, Dl, D2 etc. (Fromont-Racine et al., 1997). While such 
sequence comparisons may give useful clues as to the evolution of the proteins and 
their respective ORFs (see below), the roles of the Sm-like proteins are not directly 
comparable to those of their Sm counterparts, and the sub-families may not 
represent functionally meaningful groupings. 
Since Usslp and Smx4p are non-canonical Sm-like proteins which associate with 
the U6 snRNA (Cooper et al., 1995; Séraphin, 1995), it was hypothesised that a 
subset of the Sm-like proteins may also associate with U6. 
This theory was supported by the exhaustive two-hybrid screens performed using 
the Sm-like proteins as bait (Chapter Three and Appendix I) which revealed 
numerous potential interactions within the set of non-canonical Sm-like proteins. In 
this respect these proteins are very different from the canonical Sm-proteins which 
show a more limited range of interactions (Fury etal., 1997; Camasses et al., 1998). 
In all cases, the two-hybrid prey fusions isolated in the screens contained both 
Sm motifs. Given that the FRYL library contains random genomic fragments, with 
an insert beginning (statistically) every 4 bases, this would suggest that both the 
conserved motifs are necessary for each of the two-hybrid interactions. An 
analogous situation has been reported for the canonical proteins, where deletion of 
either of the Sm motifs leads to loss of interaction (Hermann et al., 1995, Camasses 
etal., 1998). 
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The promiscuity of the non-canonical proteins in the two-hybrid screens is in 
agreement with the proposal that certain of the Sm-like proteins may be able to (at 
least partially) functionally substitute for one another (see Section 7.7.), while the 
identification of potential interactions with Ussip, Smx4p and Prp24p in the two-
hybrid screens supports the hypothesis that (some of) the non-canonical Sm-like 
proteins may be associated with U6 snRNA. 
The association of the non-canonical Sm-like proteins with U6 snRNA was 
demonstrated by co-immunoprecipitation experiments. Each of the proteins was 
tagged with the HA-epitope and expressed in cells deleted for the corresponding 
ORF. In each case the demonstration that these cells could survive under previously 
restrictive conditions confirmed that the protein was functional, and that the tag did 
not significantly interfere with that function. By performing the experiment in a 
genetic background deleted for the wild-type ORF, any problems of competition 
between the wild-type and the tagged version of the protein were avoided. However, 
given the proposal that the Sm-like proteins may be able to substitute for one 
another, it cannot be formally excluded that the tagged proteins may be competing 
with one (or more) of the other Sm-like proteins. 
The co-immunoprecipitation experiments demonstrated differences between the 
Sm-like proteins with respect to their snRNA associations. At 150mM salt, four of 
the proteins (Smx4p, Ydr378p, Yjr022p and Yn1147p) co-precipitated U4 and U6 
snRNAs, with Yb1026p and Yer146p also able to precipitate U5 snRNA (Figure 
8.11.). Spb8p only weakly precipitated U6 snRNA alone, and only at 50mM salt. 
The significance will be discussed below. 
The co-precipitation of U4 snRNA with U6 in all cases (except Spb8p), and U5 
snRNA with Yb1026p and Yer146p suggests that these proteins are in functional 
snRNP complexes. Whether the Sm-like proteins remain with these complexes after 
their incorporation into the spliceosome remains to be determined. 
Although all of the Sm-like proteins tested here are capable of co-
immunoprecipitating U6 snRNA, whether this is mediated by direct protein-RNA 
contacts, or whether it is via more distant tertiary associations cannot be determined 
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by these experiments. However, through the use of in vitro reconstitution and cross-
linking experiments, it has been shown that Ussip, Ydr378p and Yn1147p are in 
close proximity to U6 snRNA in the U6 snRNP, in the U4/1J6 di-snRNP and in the 
U4/U6.U5 tri-snRNP (Vidal, 1998). Yb1026p and Yjr022p were also shown to have 
the same associations although the cross links seen with these proteins are weaker, 
while Smx4p and Yerl46p could not be cross-linked to U6 snRNA. Spb8p could be 
weakly cross-linked to U6 snRNA, U2 snRNA and ACT] pre-mRNA, indicating 
that the RNA associations made by this protein may not be specific. 
The specificity of the RNA associations of the other Sm-like proteins was tested, 
with none of these proteins able to co-immunoprecipitate pre-P RNA, P RNA, MRP 
RNA or 5S rRNA (Figure 8.13.). Although this is by no means an exhaustive 
analysis, it does demonstrate that the Sm-like proteins do not display a general RNA 
binding capacity, nor do they stably associate with all rpolIII transcribed RNA 
species. However, the possibility that these proteins may associate with non-
spliceosomal RNA species cannot be formally discounted at this time. 
The two-hybrid data from the direct mating experiments (Section 8.6.) also 
suggest greater promiscuity in the protein-protein interactions than for the canonical 
Sm proteins (Fury et al., 1997; Camasses et al., 1998). No strong homeotypic 
interactions were seen in these tests, and with the exception of Smblp and Ussip, 
none of the canonical Sm proteins tested could interact with the Sm-like proteins 
(see Figure 8.16.). It is interesting that in the alignment of Fromont-Racine et al. 
(1997), Ussip was placed in the D3 sub-family, and that Smblp and Smd3p have 
been shown to directly interact in vitro. Thus, the two-hybrid interaction seen in this 
study may reflect the similarity between Ussip and Smd3p, rather than any 
physiological interaction. Indeed a more stringent two-hybrid experiment using 
Smblp as bait in an exhaustive screen of a yeast genomic library did not identify 
Ussip as an interacting factor (Fromont-Racine et al., 1997). The direct matings 
also revealed that the C-terminal tail of Ussip is dispensable for the interactions 
made with the other Sm-like proteins, whereas the failure of Ussi-Ap and Ussl-Bp 
to interact indicates the requirement for both Sm motifs. The Uss1p fusion has 
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previously been shown to be functional by rescuing the MCY4 conditional yeast 
strain (Cooper, 1995) whereas neither Ussi-Ap nor Ussl-Bp fusions were 
functional (data not shown). It may be this loss of interactions with other Sm-like 
proteins which prevents the Ussi-Ap or Ussl-Bp fragments from functioning in 
vivo. 
Although the stoichiometry of the proteins present in the canonical Sm complex 
has been studied (Raker et al., 1996; Plessel et al., 1997), the use of subsets of 
proteins for reconstitution experiments has led to difficulties due to the formation of 
artifactual complexes and this has prevented a definitive answer from emerging. 
Nevertheless, available data suggest that there may be a single copy of each protein 
present in a seven-membered complex. The discovery of eight interacting Sm-like 
proteins that are capable of precipitating U6 snRNA suggests that either there are 
more proteins in this complex than in the canonical Sm complex, or that the Sm-like 
complex may exist in more than one form, with alternative protein compositions. 
Different Sm-like complexes may have a common core of proteins, with only one or 
two that are specific for a particular complex. The co-immunoprecipitation of all of 
the Sm-like proteins with antiserum against Ussip would suggest that Ussip is 
common to all such complexes. It should be noted however that no conclusion can 
be reached as to whether all the proteins are capable of interacting with Uss 1 p 
simultaneously. Similarly, no conclusions can be drawn as to whether the 
associations seen represent direct protein-protein interactions, or whether they may 
be mediated through the U6 snRNA, or via other protein components. 
Considering all pairwise two-hybrid combinations (Figure 8.16.), the weak 
interaction between Spb8p and Yjr022p suggests that these proteins may not be 
present in the same complex. However, both proteins are strongly co-precipitated 
with Ussip (Figure 8.14.) and may thus be present in independent complexes. The 
fragile U6 association of Spb8p resembles the situation seen previously with 
Smblp, the canonical Sm protein which shows greatest identity to Spb8p (Fromont-
Racine et al., 1997). Smblp could not be biochemically purified with the Ui snRNP 
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(Neubauer et al., 1997), although a tagged version of the protein could 
immunoprecipitate the Ui snRNA (Gottschalk et al., 1998). The relatively 
inefficient precipitation of U6 snRNA by Spb8p may indicate a similarly weak 
interaction. However, the strong co-immunoprecipitation of Spb8p and Ussip 
suggests that either the tag of Spb8p is inaccessible in the U6 snRNA-associated 
complex, or that Ussip and Spb8p are present in an alternative complex. This could 
be compatible with the reported role for Spb8p in decapping mRNA (Boeck et al., 
1998). 
Alternative Sm-like complexes (which may or may not be associated with U6 
snRNA) were also suggested in Chapter Seven. The lack of a strong splicing defect 
in the conditional strains described suggests that the arrest of growth in these cells 
may not be due primarily to a defect in pre-mRNA splicing. 
Database searches with the Sm-like proteins reveal that many of the U6-
associated proteins would appear to have been conserved through evolution (Figure 
8.17.). The identification of a U6-like RNA in the miniaturised genome of a 
eukaryotic endosymbiont (Pedinomonas minutissima) together with an Sm-like 
protein suggests that these are ancient macromolecules (Gilson and McFadden, 
1996). The presence of Sm motif sequences in the genomes of Methanobacterium 
thermoautotrophicum and Archaeoglobusfulgidus (Smith et al., 1997; Kienk et al., 
1997) reinforces this theory (see Figure 8.17C.). Since neither of these 
archaebacteria contains recognisable splicing machinery these Sm-like proteins and 
the U6 snRNA (or its progenitor species) may have a more fundamental function (in 
all living cells) than nuclear pre-mRNA splicing, which only occurs in eukaryotes. It 
is possible that these ancient bacteria contain Sm-like complexes comprised of only 
one or two Sm-like species each present in multiple copies, in order to produce the 
required stoichiometry. Evolution of the proteins of such a complex could have 
produced proteins with specific functions and given rise to the multiple Sm-motif 
containing proteins found in higher eukaryotes today. At present, such proteins 
would appear to be either U6 snRNA-associated, or associated with the other 
spliceosomal snRNAs. However, higher eukaryotes may contain still more members 
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of this family and these may form other classes of Sm-like complexes. Since the 
binding site for the Sm-like complex on U6 snRNA has not been defined, the 
possibility exists that other RNA species may also encode such a site. 
The binding of some of the Sm-like proteins to an RNA other than U6 may 
explain the differences seen in Figure 7.1 OA. If the Sm-like proteins are involved in 
associations with another RNA species, then the over-production of U6 snRNA 
alone is unlikely to suppress the conditional phenotype seen in these cells. 
Further analyses will be needed to map the Sm-like protein binding site on the 
U6 snRNA, and subsequently to determine if a consensus sequence may exist on 
other RNA molecules which may also bind these proteins. 
The data from the two-hybrid experiments and the co-immunoprecipitations 
suggest that the Sm-like proteins can form a novel complex associated with U6 
snRNA, analogous to the canonical Sm complex. Whether the Sm-like complex 
would play roles in the biogenesis of the U6 snRNP, and possibly the U4/U6 di-
snRNP remains to be determined. The associations between some of these proteins 
and Prp24p may indicate a role in the recycling of the U4 and U6 snRNAs after the 
splicing reaction (Raghunathan and Guthrie, 1998) 
In addition, the possibility that this protein complex, and potentially U6 snRNA, 
may be involved in other cellular processes should be examined together with an 
analysis of the details of the protein-protein contacts, the assembly pathway of the 
complex(es) and the stoichiometry of the proteins involved. 
The subcellular localisation of this protein complex(es) and indeed of U6 snRNA 
still remains to be determined. Most current evidence would suggest a nuclear 
localisation for U6 snRNA, however its presence in the cytosol cannot be excluded. 
U6 snRNA, free from U4 snRNA, has been reported to be present and is matured in 
the cytosol of mouse fibroblasts, prior to nuclear import and association with U4 
snRNA (Fury and Zieve, 1996). Whether this cytosolic U6 snRINA has a function 
and whether it is associated with Sm-like proteins is not known, however given the 
association of U6 with Spb8p, and the proposed role for this protein in pre-mRNA 
decapping, it is intriguing to hypothesise that this U6 snRNA may indeed have a 
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function. Alternatively, the Sm-like proteins may simply act as (part of) a nuclear 
localisation signal analogous to the canonical Sm proteins, facilitating the nuclear 
import of U6 snRNA, although why U6 would have left the nucleus is not obvious. 
It is should be noted that for the co-immunoprecipitation experiments (both of 
proteins and of snRNAs) with the tagged Sm-like proteins, the preparation of total 
cell extracts disrupts the internal compartmentalisation of the cell and that no 
conclusions can be drawn as to the subcellular localisation of the factors involved. 
From this then it is impossible to make firm conclusions as to whether the 





Ussip is an Sm-like protein which associates with the U6 snRNA and is essential 
for its stability (Cooper et al., 1995). The Ussi protein is also required for pre-
mRNA splicing in vivo and in vitro. The work described in this thesis has identified 
a number of additional proteins which interact with Ussip. Several of these proteins 
also contain the Sm-motifs. 
Extensive two-hybrid analyses, including the exhaustive screening of a genomic 
library and direct mating experiments have been used to study these molecular 
interactions. Co-immunoprecipitation has revealed seven Sm-like proteins are 
capable of associating with Ussip (see Section 8.4.), suggesting the existence of a 
novel Sm-like complex, or complexes. Each of the Sm-like proteins present in the 
complex has also been shown to associate with U6 snRNA. The co-precipitation of 
U4 snRNA in all cases (except Spb8p) suggests that either these proteins also 
associate with U4 snRNA, or that they are found in functional snRNP particles, i.e. 
the U41U6 di-snRNP. 
Gene deletion analyses have revealed that a subset of the Sm-like proteins are not 
essential for vegetative growth, although the deletion of these ORFs did confer a 
temperature-sensitive phenotype to haploid cells (see Section 7.2.). A subset of the 
Sm-like proteins was also demonstrated to be essential specifically for the 
maintenance of normal levels of U6 snRNA in vivo, while other rpollll transcripts 
are not affected by depletion of these proteins. 
Interestingly, depletion of any of the Sm-like proteins studied here did not confer 
a strong in vivo splicing defect to the cells, at least for those transcripts which were 
tested (see Section 7.6.). This suggests that these proteins may have roles in other 
cellular processes. 
Through a program of exhaustive two-hybrid screens performed in this lab 
(Chapter Three and Appendix I) and in the lab of P. Legrain, Paris (Fromont-Racine 
et al., 1997 and Appendix I) a protein linkage map has been produced which 
provides clues as to the potential roles of these Sm-like proteins (Figure 9.1.). 
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Figure 9.1. Protein linkage map derived from two-hybrid screens performed with Sm-like proteins and Patip. A protein linkage map was 
derived from the results of the two-hybrid screens described in Chapter Three and in Appendix I. Arrows run from bait proteins to prey 
proteins. Ovals represent proteins with Sm motifs; Red indicates proteins associated with U6 snRNA; Green indicates proteins known to be 
involved in pre-mRNA splicing; Blue indicates proteins involved in other RNA metabolism pathways. 

Encouragingly, a number of proteins known to be involved in pre-mRNA 
splicing were identified. Prp4p is a component of the U4/U6 di-snRNP (Banroques 
and Abelson, 1989; Petersen-Bjørn et al., 1989; Ayadi et al., 1997), Prpl ip is a U2 
snRNA-associated protein (Ruby et al., 1993; Wells and Ares, 1994), Prp24p is also 
a U4/U6 di-snRNP protein and has been proposed to play a role in the recycling of 
this particle after splicing (Shannon and Guthrie 1991; Jandrositz and Guthrie, 
1995; Raghunathan and Guthrie, 1998) while Smd2p is a canonical Sm protein 
shown to be associated with at least the Ui snRNP (Neubauer et al., 1997; 
Gottschalk et al., 1998). 
The interaction with Prp lip, together with other spliceosomal proteins described 
in Chapter Six, suggests that the Sm-like proteins may remain associated with U6 
snRNA during the assembly of the spliceosome. The interaction with Prp4p and 
Prp24p may indicate links with the dissociation and/or the recycling pathway of the 
U4/U6 di-snRNP. This could also be a possible explanation for the co-
immunoprecipitation of U4 and U6 snRNA with these proteins. It was suggested 
previously that Ussip has links with Prp4p and Prp24p since the over-expression of 
Uss ip in either prp4-1 or prp24- 7 cells exacerbated the temperature-sensitive 
phenotype of these cells (Cooper, 1995). 
The two-hybrid screens also identified a number of proteins known to be 
involved in other aspects of RNA metabolism. Dcp 1 p  has been shown to play a role 
in the decapping of mRNA (Beelman et al., 1996; LeGrandeur and Parker, 1998) 
whilst Xrnlp is a 5'-3' exonuclease whose primary role is to degrade decapped 
mRNA molecules (reviewed in Caponigro and Parker, 1996). Links were also found 
to Pcfl ip, a component of the pre-mRNA cleavage and polyadenylation factor I 
(Amrani et al., 1997) and to Mtr3p which is involved in mRNA transport 
(Kadowaki et al., 1994). 
These observations suggest some cross-talk between different aspects of mRNA 
metabolism, although the characterisation of mutant alleles of SPB8 with decapping 
defects (Boeck et al., 1998) may indicate a more direct link for the Sm-like proteins 
in these pathways. 
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A comparison of the datasets from the screens with Sm-like proteins also 
identified a number of proteins found in multiple screens with no reported links to 
RNA metabolism (Figure 9.1.). Most notable is Patip, which was identified by all 8 
Sm-like proteins which associate with U6 snRNA. Chapter Four describes the 
characterisation of this protein, but as yet the way in which this protein may 
function in RNA metabolism andlor why it associates with the Sm-like proteins has 
not been determined. 
Of the other proteins, Neolp, Psuip, Yjrl38p and Yor320p have all been 
identified in three independent screens with Sm-like proteins. None of these four 
proteins has any documented involvement in RNA processing. However, Psuip was 
identified in a screen with the Patip protein (C-H. Chua and I. Dix, pers. comm.) 
further increasing its statistical significance and the likelihood that it is 
physiologically associated with the Sm-like proteins. This protein has been 
demonstrated to interact, biochemically and genetically with Hrr25p (A.J. 
DeMaggio, pers. comm.), a casein kinase I protein kinase involved in DNA repair 
(Hoekstra et al., 1991; DeMaggio et al., 1992; Ho et al., 1997). 
Neolp is an ATPase whose over-expression leads to neomycin resistance 
(Prezant et al., 1996) whilst Yjrl38p and Yor320p are hypothetical proteins of 
unknown function. Further work will be needed in order to determine if these 
proteins are involved in RNA metabolism. 
Given the existence of Sm-like proteins in ancient bacteria (Section 8.7.) it has 
been proposed that they may play a more fundamental role to cell survival than pre-
mRNA splicing. This role may be as a chaperone-type protein involved in the 
correct folding or processing of RNA molecules (Herschlag, 1995). Protein 
chaperones normally function as multimeric ring-like complexes, with those of the 
GroEL family functioning as two seven-membered rings. It is interesting to compare 
this to the Sm-like proteins since (at least for the canonical proteins) these are 
believed to form seven membered ring-like structures (Plessel et al., 1997). Several 
examples already exist of chaperone proteins involved in RNA processing. For 
example, in Sulfolobus solfataricus the 60kDa chaperonin has RNA binding 
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properties and is involved in the processing of ribosomal RNA (Ruggero et al., 
1998). In E. coil, GroEL has been implicated in the processing of 5S rRNA and in 
the degradation of mRNA (Sohlberg et al., 1993), whilst mitochondrial Hsp60 has 
been suggested to play a role in mRNA processing (Sanyal et al., 1995). Whether 
the Sm-like proteins function in a similar manner is not known at present. 
Following the analysis described here, a number of intriguing questions remain 
about the Sm-like proteins, their interactions with other proteins, their RNA 
associations and their functional role or roles in the cell. A fuller examination of 
these outstanding questions, and the experiments which may give some of the 





During the work described in this thesis, many of the strains and constructs 
needed to perform the experiments proposed in this Chapter have been made, in 
particular, the conditional yeast strains described in Chapters Four and Seven and 
the HA-tagged Sm-like protein constructs described in Chapter Eight. The 
temperature-sensitive strains described may prove particularly informative, since it 
is possible that the slow-growth phenotype observed at 23°C and the arrest of cell 
growth seen at 37°C may result from the disruption of different cellular processes. It 
should also be emphasised that simply because each of these proteins possesses the 
Sm-motifs and associates with U6 snRNA, they need not all behave in the same 
manner, nor all be involved in the same process or processes. 
Investigation of the Molecular Interactions of the Sm-like Proteins. 
Although the two-hybrid analyses and co-immunoprecipitations have identified 
interactions between the Sm-like proteins, and interactions with other proteins, 
further analyses must still be performed. At present it is not clear whether the Sm-
like proteins co-precipitated by anti-Ussip antiserum associate with one another 
only in an RNA-bound form, or whether a protein-only complex(es) can also exist. 
If the Sm-like protein complex relies upon an RNA molecule for its structure, 
oligonucleotide-directed RNase H digestion of the extracts prior to the 
immunoprecipitation could be used in order to deplete specific RNA species (in 
particular U6 and/or U4 snRNA) and to determine the identity of the RNA molecule 
upon which the structure depends. 
As an alternative approach to study the protein-protein interactions within the 
complex, in vitro transcription and translation experiments should be performed, as 
was done for the human canonical Sm proteins (Lehmeier et al., 1994; Raker et al., 
1996). Similarly, the tagged proteins could be used to biochemically purify the Sm-
like protein complex, and determine its full composition. 
These experiments should help determine if the Sm-like proteins can form into 
more than one complex, perhaps with different functions, and also if some of the 
proteins compete with andlor substitute for one another in such complexes as has 
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been previously suggested (see Chapter Seven). If the proteins are involved in a 
number of cellular processes, the results of these experiments should also give 
insights into whether the complexes which form have alternative compositions 
specific to each process. 
The availability of the conditional strains will allow the interactions of the Sm-
like proteins to be studied using genetic techniques. This could take the form of 
high-copy number suppression screens in which proteins would be identified whose 
over-production is capable of by-passing the requirement for one of the Sm-like 
proteins. Alternatively, synthetic lethal screens could be performed, or pairs of non-
lethal mutants could be assayed directly. This type of analysis may prove especially 
useful in determining synergistic relationships between individual Sm-like proteins. 
These genetic approaches should prove complementary to the analyses already 
performed, and could also yield new information on the role(s) of the Sm-like 
proteins. 
The RNA associations of the Sm-like proteins, and those other proteins of 
interest (e.g. Patip, Psuip, etc.) should also be investigated further. Primarily the 
associations of the Sm-like proteins with the spliceosomal snRNAs should be 
studied in more detail, by either native gel electrophoresis (as described by Brow 
and Guthrie (1988)) or by analysis on glycerol gradients (as described by Bordonné 
et al. (1990) or Laggerbauer etal. (1998)). These analyses will determine if the Sm-
like proteins associate with free U6 (as previously demonstrated for Ussip (Cooper 
et al., 1995) and Smx4p (Séraphin, 1995)), with free U4 snRINA, and or with the 
U41U6 di-snRNP. 
As an extension of this work, any association of these proteins with other RNA 
species could be investigated by 3' end-labelling those RNAs co-
immunoprecipitated with the tagged proteins (England et al., 1980). Following 
electrophoresis, the size of the labelled RNA is used as a guide to its identity. 
However, three main problems exist with such "pCp-labelling" analyses i) if the 
Sm-like proteins associate with mRNA e.g. during decapping or degradation, the 
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pattern of radiolabelled species would be uninterpretable; ii) if the Sm-like proteins 
are involved in the processing of RNAs, they may precipitate intermediates of the 
processing event which may not run at a characteristic size during electrophoresis 
and iii) RNA species such as U6 which has a cyclic phosphate structure at its 3' 
terminus may be labelled inefficiently. If this structure is important for the 
association with the Sm-like proteins, these species may not be detected in this 
analysis. 
In order to determine where the Sm-like proteins bind to U6 snRNA, in vitro 
reconstitution and site-specific photo-crosslinking studies could be performed 
(Fabrizio, et al., 1989; Dix et al., 1998). The identification of the binding domain 
will allow searches to be carried out to determine if other RNA species also contain 
this motif. These searches should also be extended to other organisms in order to 
determine if the domain has been evolutionarily conserved. 
Chimeric RNAs could be produced in which the binding domain for the Sm-like 
proteins would be fused to an RNA species which does not ordinarily associate with 
these proteins. Analysis of the behaviour and associations of such a molecule may 
give important clues as to the functional role of these proteins. 
Some of the experiments suggested above are already in progress in this lab, and 
preliminary data suggest that in order to bind to the U6 snRNA, the Sm-like proteins 
require the 3' half of the RNA molecule (Vidal, 1998; L. Verdonne, pers. comm.). 
The Role of the Sm-like Proteins in pre-mRNA Splicing. 
The conditional strains can be utilised to further investigate whether the Sm-like 
proteins have a role in the splicing of pre-mRNA. The effects of depletion of the 
Sm-like proteins can be studied by examining the splicing activity of extracts made 
from these strains in vitro (see Lin et al. (1985)). These experiments should be 
performed either with extracts made from cells which have been grown at different 
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temperatures, or with extracts which have been heat-treated prior to the splicing 
reaction. 
Similarly, the effects of depletion of these proteins on spliceosome assembly 
could be examined by electrophoresis of splicing complexes on native gels (see 
Pikielny et al. (1986)). These analyses have been performed previously for Ussip 
which was shown to be required prior to the first step of splicing (Cooper et al., 
1995). 
The presence of the Sm-like proteins in the spliceosome can be examined 
immunologically by determining whether the HA-tagged proteins can co-
immunoprecipitate active spliceosomes (Ben Yehuda et al., 1998). This would 
involve performing an in vitro splicing reaction with a radio-labelled substrate and 
subsequently determining if the intermediates of the splicing reaction could be 
immunoprecipitated. 
The proposed role for the Sm-like proteins in the recycling of the U4 and U6 
snRNPs could be studied by performing the range of experiments used to show the 
involvement of Prp24p in this process (Raghunathan and Guthrie, 1998). 
The Role of the Sm-like Proteins in mRNA Stability. 
The description of mutations within SPB8 which affect mRNA decapping, and the 
data from the two-hybrid screens suggest (at least a subset of) the Sm-like proteins 
may be involved in the mechanisms of mRNA stability. As for pre-mRNA splicing, 
assays exist to determine the effect of conditional mutants on mRNA stability 
(Beelman et al., 1996; Hatfield etal., 1996; Jacobs Anderson and Parker, 1998). 
In collaboration with the lab of Roy Parker (University of Arizona, Tucson) such 
experiments will be performed with the strains containing conditional alleles of the 
Sm-like protein-encoding ORFs and of PAT]. 
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Interactions between the components of the decapping and degradation 
machinery, and the Sm-like proteins could also be studied, either biochemically 
and/or genetically. Here again genetic crosses to test for synthetic lethality may be 
particularly informative since DCP] and XRN] are both non-essential genes, and 
deletions could be combined with those of the non-essential Sm-like protein-
encoding ORFs, with disruption of PAT], or of PSU] which are also non-essential 
(A.J. DeMaggio, pers. comm.). 
Other Processes in which the Sm-like Proteins may be Involved. 
The instability of U6 snRNA, US L snRNA and pre-P RNA seen in some of the 
conditional strains (Chapter Seven) led to the suggestion that the Sm-like proteins 
may be involved in the processing of some RNA molecules. This could be 
investigated by examining links between the Sm-like proteins and factors already 
identified as being involved in RNA processing e.g. Senip and Rntlp (Ursic et al., 
1997; Chanfreau et al., 1997). 
Similarly it is possible that the Sm-like proteins may be involved in the 
localisation of some RNA species by analogy to the canonical Sm proteins which 
form part of the nuclear localisation signal for the Ui, U2, U4 and U5 snRNAs. The 
majority of cellular U6 snRNA is believed to be retained in the nucleus, although 
this has been demonstrated to be an active and saturable process (Boelens et al., 
1995). It is interesting to note that these authors saw an increase in U6 export from 
the nucleus upon truncation of the 3' end of U6 snIRNA i.e. the region believed to be 
involved in the binding of the Sm-like proteins. However, as the authors point out, 
there may be more than one factor involved in the nuclear retention and it is 
possible that the cap structure of U6 snRNA may also play a role. Thus, the 
identification of the Sm-like protein binding domain on U6 snRNA and the 
production of chimeric RNAs can also be utilised here to determine if these proteins 
are indeed involved in the localisation of RNAs. 
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The localisation of the proteins themselves should also be studied, and may give 
clues as to their cellular function(s). This could be done either by 
immunofluorescence microscopy or by subcellular fractionation and 
immunoblotting. Similarly, the localisation of U6 snRNA could be studied. U6 
snRNA, free from U4, has been described in the cytosol of mouse fibroblasts (Fury 
and Zieve, 1996) although its cytosolic function is unknown. 
The Pati protein has also been shown to be both nuclear and cytosolic, in 
roughly equal levels (M. Minet and F. Wyers, pers. comm.), although whether it 
associates with the Sm-like proteins in both compartments is not known at this time. 
Studying the role of U6-associated proteins should facilitate a better 
understanding of the role of the U6 snRNA. U6 is present in excess over U4 within 
yeast cells and neither the form nor function of this "extra" U6 RNA is known. By 
utilising the conditional U6 allele described by Luukkonen and Séraphin (1998), the 
role of this RNA could be studied. In particular the effects of in vivo depletion of U6 
on the processes in which the Sm-like proteins are implicated should be studied i.e. 
pre-mRNA splicing, mRNA decapping and degradation, RNA processing, nuclear 
retention of RNA, etc. 
Characterisation of Novel Proteins. 
In addition to the Sm-like proteins, the experiments described in this thesis have 
identified a number of proteins (some novel) which were not previously believed to 
be involved in RNA metabolism. These proteins should now also be assayed for 
their potential roles in the processes in which the Sm-like proteins are implicated. 
For novel proteins, the ORF encoding them should be deleted, with a conditional 
allele and a tagged version of the protein also constructed. These should then be 
used to determine if these protein do indeed associate with the Sm-like proteins, 




TWO-HYBRID SCREEN RESULTS. 
JI 
The A-category prey identified in two-hybrid screens performed with the Sm-like 
proteins as bait are given. These screens were performed either by other members of 
this lab, or in the lab of P. Legrain (Paris) with baits constructed as part of this work 
(see Tables 3.4. and 2.1.12.), except for Ybl026p and Yjr022p, the screens for which 
were performed with baits constructed in the lab of P. Legrain. The Table for the 
Ga14:YjrO22p bait contains the data from two screens performed with this bait (one 
of these screens is described in Fromont-Racine etal. (1997)). 
Summary Information of Two-Hybrid Screens Performed. 
Bait ORF 	Bait Protein 	System 	Diploids Screened Identified Clones 
YER1 12w 	Ussi Ga14 47 x 106 169 
YDR378c LexA 3 0 x 106 79 
YJL124c 	Spb8 LexA 22x 106 137 
YLR438c-A 	Smx4 Ga14 20 x 106 53 
YBL026w Ga14 34 x 10 235 
YNL147w LexA 60x 106 119 
YER146wa LexA 1 x 106 9 
YER146w 	 LexA 	3 4 x 106 	 138 
YJR022w 	 Ga14 	96 x 106 	 74 
YJR022w 	 LexA 	51 x 106 	 143 
a Mini-screen. 
In the following Tables, the prey plasmid inserts are ordered by ORF number, 
with all ORF and gene names used as defined by the Saccharomyces Genome 
Database, SGD. The categories are as described in Section 3.1. (as defined by 
Fromont-Racine et al., 1997). Clones gives the total number of prey identified for 
each ORF, with the number of different fusions given in parenthesis. 
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Bait System Prey ORF Prey Gene Category Clones 
Spb8 LexA YBL026w  Al 4(3) 
Spb8 LexA YBR214w  A4 1 
Spb8 LexA YBR274w  A4 2 
SpbB LexA YCR077c PATI Al 12(4) 
Spb8 LexA YDL013w HEX3 A2 1 
Spb8 LexA YDL175c  A2 1 
Spb8 LexA YDR002w YRBI A2 1 
Spb8 LexA YDR378c  A4 1 
Spb8 LexA YDR422c SIPI A4 I 
Spb8 LexA YEL060c PRB1 Al 2(2) 
Spb8 LexA YER028c  A4 1 
Spb8 LexA - YGL207w SPTI6 A4 3 
Spb8 LexA YGR158C MTR3 A2 1 
Spb8 LexA YIL048w NEOI A4 1 
Spb8 LexA YJRI43c PMT4 A4 2 
Spb8 LexA YKL173w GINIO A4 1 
Spb8 LexA - YKR026c GCN3 Al 3(2) 
Spb8 LexA - YLRO03c  Al 4(2) 
Spb8 LexA YLR438c-A USS2 P2 1 
Spb8 LexA YML088w  Al 2(2) 
Spb8 LexA YMR250w  A4 I 
Spb8 LexA YNL032w S!W14 A4 1 
Spb8 LexA YNLI63c EF4 A4 1 
Spb8 LexA YNL276c  A4 1 
Spb8 LexA YOR109w PIE2 A4 1 
Spb8 LexA YOR320c  A4 1 
Spb8 LexA YPL084w BRO1 P2 1 
Bait System Prey ORF Prey Gene Category Clones 
Smx4 Ga14 YBR108w  1 
Smx4 Ga14 YCR066w RADI8 A4 1 
Smx4 Ga14 YCR077c PATI Al 10(5) 
Smx4 Ga14 YDL013w HEX3 A2 1 
Smx4 Ga14 YDL240w LRGI A4 1 
Smx4 Ga14 YJR022w  Al 6(4) 
Smx4 Ga14 YJR138w  Al 3(2) 
Smx4 Ga14 YKR099w BASI A3 3 
Smx4 Ga14 YLR067c PET309a Al 8(3) 
Smx4 Ga14 YLR281c  P2 2 
Smx4 Ga14 YMR142c BBCI P2 1 
Smx4 Ga14 YOR96w RP30 P2 1 
Smx4 Ga14 YPL084w BROI P2 2 
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Bait System Prey ORE Prey Gene Category Clones 
Yb1026w Ga14 YAR003w FUNI6 A4 1 
Yb1026w Ga14 YBL066c SEFI A4 1 
Yb1026w Ga14 YCR020C-A SMXI A2 I 
Yb1026w Ga14 YCR066w RADI8 A3 1 
Yb1026w Ga14 YCR077c PATI Al 4(2) 
Yb1026w Ga14 YDL175c  Al 4(2) 
Yb1026w Ga14 YDR440w  A4 1 
Yb1026w Ga14 YELO15w ______ Al 12(5) 
Yb1026w Ga14 YERO25w GCDII A4 1 
Yb1026w Ga14 YGL173c XRNI A3 1 
Yb1026w Ga14 YGLI85c  A4 I 
Yb1026w Ga14 YGRO77c _____ A4 1 
Yb1026w Ga14 YIL048w NEO1 A4 4 
Yb1026w Ga14 YIL066c RNR3 A4 3 
Yb1026w Ga14 YlL132c  A4 I 
Yb1026w Ga14 YLR039c RICI A3 1 
Yb1026w Ga14 YLR120c YAP3 A2 3 
Yb1026w Ga14 YLR126c  Al 2(1) 
Yb1026w Ga14 YMR066w  A4 I 
Yb1026w Ga14 YMR207c HFAI A4 I 
Yb1026w Ga14 YMR237w  Al 2(1) 
Yb1026w Ga14 YMR268c PRP24 A3 2 
Yb1026w Ga14 YNL118c PSUI Al 23(8) 
Yb1026w Ga14 YOLI02c TPTI A4 1 
Yb1026w Ga14 YOLI63w  A4 1 
Yb1026w Ga14 YOR017w PETI27 A4 1 
Yb1026w Ga14 YOR043w WHI2 A4 2 
Yb1026w Ga14 YOR191w DISI A4 1 
Yb1026w Ga14 YPL042c SSN3 A4 1 
Yb1026w Ga14 YPL115c BEM3 A4 1 
Yb1026w Ga14 YPLII9c  A4 1 
Yb1026w Ga14 YPL249c  A4 I 
Yb1026w Ga14 YPR184w  A4 I 
Bait System Prey ORF Prey Gene Category Clones 
YNL147w lexA YBL101w-B  A4 4 
YNL147w lexA YCR077c PATI Al 14(7) 
YNL147w lexA YDL077c VAM6 A4 8 
YNL147w lexA YILI12w  Al 45(17) 
YNL147w lexA YLR336c SGD1 A2/A3 2 
YNL147w lexA YLR438c-A USS2 A2/A3 2 
YNL147w lexA YMR268c PRP24 A4 I 
YNL147w lexA YPR178w PRP4 A3 1 
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Bait System Prey ORF Prey Gene Category Clones 
Yer146w LexA YBL026w  A2 3 
Yer146w LexA YCR024c  A4 I 
Yer146w LexA YCR077c PATI Al 9(3) 
Yer146w LexA YDL1 12w  Al 2(2) 
Yer146w LexA YDR378c  A2 6 
Yer146w LexA YDR545w  A3 1 
Yer146w LexA YER1I2w USSI A2 1 
Yer146w LexA YGR21Oc  Al 6(3) 
Yerl46w LexA YHLO08c  Al 4(2) 
Yer146w LexA YIL038c NOT3 A4 2 
Yerl46w LexA YIL048w NEOI A4 1 
Yerl46w LexA YJL084c  A4 I 
Yerl46w LexA YJR138w  A4 1 
Yerl46w LexA YKL209c STE6 A4 I 
Yerl46w LexA YKR026c GCN3 A4 1 
Yerl46w LexA YLR438c-A USS2 A2 I 
Yerl46w LexA YMR268c PRP24 Al 2(2) 
Yerl46w LexA YOR201c PET56 A2 1 
Yerl46w LexA YOR320c  Al 5(4) 
Yer146w LexA YPL090c RPS6A A4 I 
Yer146w LexA YPLI52w  A4 1 
Yer146w LexA YPROIOc RPAI35 A3 I 
Bait System Prey ORF Prey Gene Category Clones 
Yjr022w Ga14 YBL026w  Al 4 (1 & 2) 
Yjr022w Ga14 YBRO03w COQI A4 1 
Yjr022w Ga14 YCR077c PATI A4 1 
Yjr022w Ga14 YDR228c PCFII Al 2 (2) 
Yjr022w Ga14 YDR277c MTHI A2/A3 1 
Yjr022w Ga14 YEL015w  Al 5 (3) 
Yjr022w Ga14 YER112W USSI A2 1 
Yjr022w Ga14 YGL096w  Al 2 (2) 
Yjr022w Ga14 YGL173c XRN1 A4 1 
Yjr022w Ga14 YGRI58c MTR3 A2 I 
Yjr022w Ga14 YHR034c  A4 1 
Yjr022w Ga14 YHR035w  A4 I 
Yjr022w Ga14 YlL173w  A4 I 
Yjr022w Ga14 YNL050c  A4 3 
Yjr022w Ga14 YNL118c PSUI Al 10(2 & 3) 
Yjr022w Ga14 YNR050c LYS9 A4 1 
Yjr022w Ga14 YNR053c  A2/A3 7 
Yjr022w Ga14 YOR076c  A3 1 
Yjr022w Ga14 YOR319w HSH49 A2 1 
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Bait System Prey ORF Prey Gene Category Clones 
Yjr022w LexA YBL026w  A2 1 
Yjr022w LexA YBR034c HMTI A2 1 
Yjr022w LexA YBR044c  Al 2(2) 
Yjr022w LexA YCR020c-A SMXI A2 2 
Yjr022w LexA YCR077c PATI Al 6(2) 
Yjr022w LexA YCR107w  A4 1 
Yjr022w LexA YDR127w AROI A2 1 
Yjr022w LexA YDR135c YCFI A4 1 
Yjr022w LexA YDR184c  A4 1 
Yjr022w LexA YDR228c PCFII A4 2 
Yjr022w LexA YDR378c  A2 4 
Yjr022w LexA YEL023c  A2 1 
Yjr022w LexA YER146w  Al 2(2) 
Yjr022w LexA YGL028c  A4 1 
Yjr022w LexA YGL096w  A4 1 
Yjr022w LexA YGR158c MTR3 A2 I 
Yjr022w LexA YHR035w  A4 1 
Yjr022w LexA YJL004c SYS1 A4 2 
Yjr022w LexA YJL021C  A4 I 
Yjr022w LexA YKR021w  A2 2 
Yjr022w LexA YKRI04w  A4 I 
Yjr022w LexA YLL0I5w  A4 1 
Yjr022w LexA YLR133w CKII A4 I 
Yjr022w LexA YLR143w  Al 5(4) 
Yjr022w LexA YLR430w SENI A4 4 
Yjr022w LexA - YLR438c-A USS2 A2 4 
Yjr022w LexA 'YMR205c PFK2 A2 1 
Yjr022w _exA YMR268c PRP24 A4 1 
Yjr022w LexA YNL227c  A4 1 
Yjr022w LexA YNL242w  A4 2 
Yjr022w LexA YNL329C PAS8 A3 2 
Yjr022w LexA YOL03Ic  A4 1 
Yjr022w LexA YOL140w ARG8 A4 1 
Yjr022w LexA YOR076c  A3 1 
Yjr022w LexA YOR319w HSH49 Al 5 (2) 
Yjr022w LexA YPR178w PRP4 A3 1 
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APPENDIX II. 
SM-LIKE PROTEIN NOMENCLATURE. 
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In order to standardise the nomenclature of the ORFs encoding the Sm-like 
proteins, each was given an LSM- prefix, for Like Sm. The ORFs were numbered 
with respect to the canonical Sm protein to which the encoded protein shows 
greatest similarity (as defined by Fromont-Racine et al., 1997) e.g. the protein 
encoded by LSMJ is most similar to Smblp, the protein encoded by LSM2 is most 
similar to Smd2p, etc. 
The Table below gives the LSM name for each of the Sm-like protein-encoding 
ORFs. This nomenclature has now been submitted and accepted by the 
Saccharomyces Genome Database. It should also be noted that the proteins encoded 
by these ORFs will also be described with the same nomenclature e.g. LSMJ 
encodes the Lsml protein, LSM2 encodes the Lsm2 protein etc. 
ORF Namea 	Other Names 	Most similar LSMName 
Sm protein' 
YJL124c SPB8C 5mB LSMJ 
YBL026w SMX5d , SNp3a SmDl LSM2 
YLR438c-A USS2d SmD2 LSM3 
YER1 12w SDB23e, USS1 SmD3 LSM4 
YER146w SmE LSM5 
YDR378c SmF LSM6 
YNL147w 5mG LSM7 
YJR022w LSM8 
YCR020c-A SMXJd LSM9 
a As defined by SGD. 	 b As defined by Fromont-Racine et al. (1997). 
Boeck etal. (1998). 	
d Séraphin (1995). 
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